{"path":"200 FILES/202 PDF/Adult medical emergencies/Coagulation disorders/Acute treatment of bleeding and surgery in hemophilia A and B - UpToDate.pdf","text":"O f f ic ia l r e p r in t f r o m U p To D a t e w w w .u p t o d a t e .c o m © 2 0 2 4 U p To D a t e , I n c . a n d / o r it s a f f ilia t e s . A ll R ig h t s R e s e r v e d . Ac u t e t r e a t m e n t o f b le e d in g a n d s u r g e r y in h e m o p h ilia A a n d B I N T R O D U C T I O N H e m o p h ilia A (f a c t o r V I I I [f a c t o r 8 ] d e f ic ie nc y ) a nd he m o p hilia B (f a c t o r I X [f a c t o r 9 ] d e f ic ie nc y ) a r e X - lin k e d c lo t t in g f a c t o r d e f ic ie n c ie s a s s o c ia t e d w it h b le e d ing o f v a r ia b le s e v e r it y , f r o m lif e - t h r e a t e n in g t o c lin ic a lly s ile n t . T h e a v a ila b ilit y o f f a c t o r r e p la c e m e nt p r o d u c t s ha s d r a m a t ic a lly im p r o v e d c a r e f o r ind iv id ua ls w it h t h e s e c o n d it io n s . H o w e v e r, p a t ie nts m a y p r e s e nt w it h a c ute b le e d ing s y m p t o m s t ha t r e q u ir e r a p id t r e a t m e n t , a n d p la n n in g is r e q u ir e d f o r p a t ie nts und e r g o ing s ur g e r y o r inv a s iv e p r o c e d u r e s . T h is t o p ic d is c u s s e s t h e t r e a t m e n t o f b le e d ing a nd p e r io p e r a t iv e m a na g e m e nt f o r ind iv id ua ls w it h h e m o p h ilia A a n d B . O u r a p p r o a c h is c o n s is t e n t w it h t h e W o r ld F e d e r a t io n o f H e m o p h ilia (W F H ) G uid e line up d a t e d in 2 0 2 0 (a v a ila b le a t h t t p s :/ / w w w 1 .w f h .o r g / p u b lic a t io n s / f ile s / p d f - 1 8 6 3 .p d f ) [1 ]. O t h e r a s p e c t s o f h e m o p h ilia A a n d B d ia g n o s is a nd m a na g e m e nt a r e d is c usse d in s e p a r a t e t o p ic r e v ie w s : ® \u0000 \u0000 \u0000 \u0000 \u0000 \u0000 \u0000 : W K e it h H o o t s , M D , M a g d a le n a L e w a n d o w s k a , M D , C A C P \u0000 \u0000 \u0000 \u0000 \u0000 \u0000 \u0000 \u0000 \u0000 \u0000 \u0000 \u0000 \u0000 : A m y D S h a p ir o , M D \u0000 \u0000 \u0000 \u0000 \u0000 \u0000 \u0000 \u0000 \u0000 \u0000 \u0000 \u0000 : Je n n if e r S T ir n a u e r, M D A ll t o p ic s a r e u p d a t e d a s n e w e v id e n c e b e c o m e s a v a ila b le a n d o u r p e e r r e v ie w p r o c e s s is c o m p le t e . L it e r a t u r e r e v ie w c u r r e n t t h r o u g h : J a n 2 0 2 4 . T h is t o p ic la s t u p d a t e d : F e b 2 2 , 2 0 2 4 . D i a g n o s i s – (s e e \" C lin ic a l m a n if e s t a t io n s a n d d ia g n o s is o f he m o p hilia \" )● P r o p h y l a x i s – (s e e \" H e m o p h ilia A a n d B : R o u t in e m a na g e m e nt inc lud in g p r o p h y la x is \" )● A C U T E T H ER A P Y F O R B L EED I N G F o r a c u t e b le e d in g in p a t ie n t s w it h he m o p hilia , t he im m e d ia t e g o a l is t o r a is e t he f a c t o r a c t iv it y t o a le v e l s u f f ic ie n t f o r h e m o s t a s is . T he t a r g e t e d f a c t o r a c t iv it y le v e l d e p e nd s o n t he lo c a t io n a n d s e v e r it y o f t h e b le e d in g , t h e e x p e c t e d ha lf - lif e o f t he p r o d u c t a d m inis t e r e d , a nd t he p r e s e n c e o f a n a s s o c ia t e d in ju r y o r o c c ur r e nc e in a t a r g e t jo int. D a t a t o s u p p o r t t h e d e s ir e d f a c t o r le v e ls f o r t r e a t ing a c ute b le e d ing c o m e f r o m e x t e nsiv e c lin ic a l e x p e r ie n c e a n d o b s e r v a t io n a l s t ud ie s [1 - 3 ]. R a n d o m iz e d t r ia ls c o m p a r in g d if f e r e nt t a r g e t f a c t o r le v e ls h a v e n o t b e e n c o nd u c t e d . S e r i o u s , l i f e - t h r e a t e n i n g b l e e d i n g a n d h e a d t r a u m a K e y p o i n t s f o r m a n a g e m e n t i n t h e e m e r g e n c y d e p a r t m e n t  — S e r io u s o r lif e - t h r e a t e n in g b le e d in g in a p a t ie n t w it h h e m o p h ilia is a m e d ic a l e m e r g e n c y t ha t r e q uir e s im m e d ia t e a s s e s s m e n t a n d t r e a t m e n t w it h r e p la c e m e n t f a c t o r. G uid e lin e s f r o m t he U nit e d K ing d o m H a e m o p h ilia C e n t r e D o c t o r s O r g a n iz a t io n (U K H C D O ) s ug g e s t t ha t t he m a x im um t im e b e t w e e n a r r iv a l t o t h e h o s p it a l a n d c lin ic a l a s s e s s m e n t s ho uld no t e x c e e d 1 5 m inute s , a nd if t r e a t m e nt f o r b le e d in g is r e q u ir e d , t h e m a x im um t im e t o it s d e liv e r y s ho uld no t e x c e e d 3 0 m inute s [4 ,5 ]. T h e s e in c lu d e : P r e g n a n c y – (s e e \" C lin ic a l m a n if e s t a t io n s a n d d ia g n o s is o f he m o p hilia \" , s e c t io n o n 'O b s t e t r ic c o n s id e r a t io n s ') ● I n h i b i t o r e r a d i c a t i o n – (s e e \" I n h ib it o r s in h e m o p h ilia : M e c h a n is m s , p r e v a le nc e , d ia g n o s is , a n d e r a d ic a t io n \" ) ● G e n e t i c s – (s e e \" G e n e t ic s o f h e m o p h ilia A a n d B \" )● A c q u i r e d h e m o p h i l i a A – A c q u ir e d h e m o p h ilia A is a n a u t o im m u ne d is o r d e r c a use d b y a u t o a n t ib o d ie s t o f a c t o r V I I I , r e f e r r e d t o a s inhib it o r s . M a na g e m e nt d if f e r s b e c a use f a c t o r V I I I p r o d u c t s m a y b e in a c t iv a t e d b y t he inhib it o r, a nd im m uno s up p r e s s io n is o f t e n r e q u ir e d . T h e s e in t e r v e n t io n s a r e p r e s e nte d s e p a r a t e ly . (S e e \"A c q u ir e d h e m o p h ilia A (a n d o t h e r a c q u ir e d c o a g u la t io n f a c t o r inhib it o r s )\" , s e c t io n o n 'M a na g e m e nt '.) ● T r e a t f i r s t – F o r p a t ie n t s w it h p o t e n t ia lly s e r io us o r lif e - t hr e a t e ning b le e d ing , it is im p o r t a n t t o in it ia t e t r e a t m e n t i m m e d i a t e l y , e v e n b e f o r e t h e d ia g n o s t ic a s s e s s m e n t is c o m p le t e d . S t a t e d a n o t h e r w a y : t r e a t f i r s t , e v a l u a t e s e c o n d , p l a n f u r t h e r t h e r a p y a f te r w e i g h i n g a l l r e l e v a n t i s s u e s . ● I d e n t i f y s e r i o u s b l e e d i n g – S e r io u s o r lif e - t h r e a t e n in g b le e d ing inc lud e s a ny o f t he f o llo w in g [6 ]: ● C e n t r a l n e r v o u s s y s t e m• E y e• H ip• M u s c le (e g , ilio p s o a s a n d / o r w it h n e ur o v a s c ula r c o m p r o m is e o r p o t e ntia l f o r n e u r o v a s c u la r c o m p lic a t io n s ) • A b d o m in a l• G a s t r o in t e s t in a l• A ir w a y (e g , t h r o a t o r n e c k )• A n y b le e d in g s e v e r e e n o u g h t o r e s ult in a ne m ia a nd p o t e ntia lly r e q u ir e r e d b lo o d c e ll t r a n s f u s io n (s ) • A n y p r o lo n g e d b le e d in g t h a t is n o t a d e q ua t e ly r e s p o n d in g t o ho m e - b a s e d t he r a p y• A n y s ig n if ic a n t in ju r ie s s u c h a s m o t o r v e hic le a c c id e n t s o r f a lls f r o m d is t a nc e s o f s e v e r a l f e e t o r m o r e • O t h e r lo c a t io n s w h e r e c o m p a r t m e nt s y nd r o m e a nd ne ur o v a s c ula r c o m p lic a t io ns c o uld o c c u r in c lu d e t h e h a n d / w r is t a n d t h e a nte r io r c o m p a r t m e n t o f t he lo w e r le g . I f t h e r e is d o u b t a b o u t t h e s e r io u s n e s s o f b le e d ing , it is p r e f e r a b le t o t r e a t t he p a t ie nt a s if t h e b le e d in g is s e r io u s (\" if in d o u b t , t r e a t \" [2 ]). T r a n s p o r t i f n e e d e d – I f t h e f a c ilit y is n o t e q u ip p e d t o p r o v id e f a c t o r o r b y p a s s ing p r o d u c t s o r n o t c a p a b le o f m o n it o r ing using t im e ly a nd s p e c if ic c o a g ula t io n s t ud ie s , t he p a t ie n t s h o u ld b e t r a n s p o r t e d t o a f a c ilit y t ha t c a n p r o v id e t his le v e l o f c a r e [7 ,8 ]. I f p o s s ib le , f a c t o r s h o u ld b e a d m in is t e r e d b e f o r e o r d u r ing t r a nsf e r. ● W h i c h p r o d u c t t o g i v e● G i v e t h e i r o w n f a c t o r p r o d u c t i f a v a i l a b l e – I f t h e p a t ie n t h a s t h e a p p r o p r ia t e r e p la c e m e n t t h e r a p y a t h o m e (o r w it h t he m , if t r a v e ling ), t he p r o d u c t m a y b e a d m in is t e r e d b e f o r e le a v in g o r e n r o ute t o t he f a c ilit y , a s lo ng a s t his d o e s no t r e s ult in d e la y s . I n lif e - t h r e a t e n in g c ir c u m s t a nc e s , e m e r g e n c y m e d ic a l t r a nsp o r t s ho uld b e c a lle d , a n d t h e p r o d u c t s h o u ld b e a d m in is t e r e d a s s o o n a s p o s s ib le , inc lud ing e n r o ute if n e e d e d . • F o r h e m o p h ilia A , e m ic iz u m a b d o e s n o t t r e a t a c u t e b le e d in g o n c e it ha s o c c ur r e d t r e a t m e n t ; a f a c t o r p r o d u c t m u s t b e use d . F a c t o r d o s i n g f o r s e v e r e b l e e d i n g (p a t i e n ts w i t h o u t i n h i b i t o r s ) — A d m in is t r a t io n o f f a c t o r s h o u ld n o t b e d e la y e d w h ile a w a it ing im a g in g s t ud ie s o r o t he r t e s t ing . F o r s e v e r e b le e d in g , t h e f a c t o r a c t iv it y le v e l s ho uld b e m a inta ine d a b o v e 5 0 p e r c e n t a t a l l t i m e s . A n im m e d ia t e d o s e o f f a c t o r s h o u ld b e g iv e n t o r a is e t he p e a k f a c t o r le v e l t o 8 0 t o 1 0 0 p e r c e n t ( t a b le 1 ). (S e e 'K e y p o in t s f o r m a n a g e m e n t in t h e e m e r g e n c y d e p a r t m e n t ' a b o v e .) I f t h e i r o w n f a c t o r p r o d u c t i s n o t a v a i l a b l e – I f t h e p a t ie n t d o e s n o t h a v e t h e ir o w n f a c t o r w it h t h e m , r e c o m b in a n t f a c t o r is p r e f e r r e d . P la s m a - d e r iv e d f a c t o r c a n b e use d if r e c o m b in a n t f a c t o r is n o t a v a ila b le . (S e e 'F a c t o r d o s in g f o r s e v e r e b le e d in g (p a t ie nts w it h o u t in h ib it o r s )' b e lo w .) • G iv e f a c t o r V I I I f o r h e m o p h ilia A .- G iv e f a c t o r I X f o r h e m o p h ilia B .- T h e im p o r t a n c e o f u r g e n t l y g i v i n g t h e f a c t o r i n f u s i o n o u t w e ig h s c o n s id e r a t io n s o f t h e s p e c if ic f a c t o r p r e p a r a t io n (\"g iv e t he a p p r o p r ia t e p r o d u c t t ha t is a v a ila b le r a t he r t h a n s p e n d in g t im e t r y in g t o o b t a in a d if f e r e nt p r o d u c t \" ). P a t i e n t s w i t h i n h i b i t o r s – P a t ie n t s w it h h ig h t it e r in h ib it o r s (> 5 B e t he s d a unit s a t a ny t im e in t h e ir h is t o r y , r e g a r d le s s o f c ur r e nt t it e r ) g e n e r a lly r e q u ir e a b y p a s s ing a g e nt (r e c o m b in a n t a c t iv a t e d f a c t o r V I I [r F V I I a ] o r a c t iv a t e d p r o t h r o m b in c o m p le x c o n c e n t r a t e [a P C C ]). (S e e 'I n h ib it o r s ' b e lo w .) • I m a g i n g – F a c t o r a d m in is t r a t io n s h o u ld n o t b e d e la y e d w hile a w a it ing im a g in g s t ud ie s in a p a t ie n t w it h a c o n c e r n in g in ju r y o r s usp e c t e d c e ntr a l ne r v o us s y s t e m b le e d ing [9 - 1 1 ]. ● A ll s ig n if ic a n t h e a d in ju r ie s m u s t b e c o nsid e r e d no ntr iv ia l unle s s p r o v e n o t he r w is e b y im a g in g (e g , w it h c o m p u t e d t o m o g r a p h y [C T ] o r m a g n e t ic r e s o na nc e im a g ing [M R I ]); s e r ia l o b s e r v a t io n m a y n o t id e n t if y injur y until d a m a g e is a lr e a d y d o n e . Q u i c k c a l c u l a t i o n f o r t h e f i r s t d o s e – D o s in g c a lc u la t io n s s h o u ld n o t b e a n o b s t a c le t o im m e d ia t e t r e a t m e n t o f lif e - t h r e a t e ning b le e d ing . A q u ic k c a lc ula t io n is a s f o llo w s : ● H e m o p h i l i a A – G iv e f a c t o r V I I I a t 4 0 t o 5 0 u n i t s / k g t o p r o d u c e a f a c t o r V I I I le v e l o f 8 0 t o 1 0 0 p e r c e n t . • F a c t o r V I I I is r e q u ir e d f o r p e o p le using e m ic iz u m a b p r o p h y la x is . (S e e \" H e m o p h ilia A a n d B : R o u t in e m a n a g e m e n t in c lu d ing p r o p h y la x is \" , s e c t io n o n 'E m ic iz um a b f o r h e m o p h ilia A '.) F o r p a t ie n t s r e c e iv in g e f a n e s o c t a c o g a lf a (A lt uv iiio ), w hic h ha s a ha lf - lif e o f a p p r o x im a t e ly 4 8 h o u r s , a d d it io n a l f a c t o r s ho uld g e n e r a lly no t b e g iv e n if it ha s b e e n < 2 d a y s s in c e t h e p a t ie n t ’s p r o p h y la x is inf u s io n. H o w e v e r, t his d o e s no t s up e r s e d e c lin ic a l ju d g m e n t in s p e c ia l c ir c u m s t a nc e s s uc h a s intr a c r a nia l b le e d ing , in w hic h a d d it io n a l d o s e s m a y b e a d m in is t e r e d a s ne e d e d b a s e d o n f a c t o r V I I I a c t iv it y . (S e e \" H e m o p h ilia A a n d B : R o u t in e m a na g e m e nt inc lud in g p r o p h y la x is \" , s e c t io n o n 'E f a n e s o c t o c o g a lf a (f a c t o r V I I I - V W F f u s io n)'.) H e m o p h i l i a B – G iv e f a c t o r I X a t 1 0 0 t o 1 4 0 u n i t s / k g t o p r o d u c e a f a c t o r I X le v e l o f 8 0 t o 1 0 0 p e r c e n t . I f t h e r e is s u f f ic ie n t t im e t o d o t he d o s ing c a lc ula t io n, d e t e r m ine t he d o s e b a s e d o n t h e f o r m u la : D o s e (u nit s ) = % c o r r e c t io n x V d x w e ig h t (k g ), using t he V d lis t e d in t h e t a b le f o r t h e s p e c if ic p r o d u c t . • D o n o t w a s t e f a c t o r (a d m in is t e r e x c e s s r a t he r t ha n d is c a r d in g ). M e a s u r e p e a k a n d t r o u g h f a c t o r a c t i v i t y – T h e p e a k f a c t o r a c t iv it y le v e l s h o uld b e c h e c k e d a p p r o x im a t e ly 5 t o 1 5 m in ute s a f t e r t he f ir s t d o s e o f f a c t o r. I f t his w a s no t d o ne , m e a s u r e a t r o u g h f a c t o r a c t iv it y a n d o b t a in a p e a k a f t e r t he s e c o nd d o s e . (S e e 'M o n it o r in g a n d d o s e c a lc u la t io n f o r s u b s e q u e nt d o s e s ' b e lo w .) ● C a l c u l a t i o n f o r s u b s e q u e n t d o s e s● T i m i n g o f n e x t d o s e – A d d it io n a l d o s e s s h o u ld b e t im e d t o o c c ur w he n a f a c t o r a c t iv it y le v e l o f a p p r o x im a t e ly 5 0 p e r c e n t is a ntic ip a t e d (o r d o c u m e n t e d ), e q u iv a le nt t o a p p r o x im a t e ly o n e h a lf - lif e o f t h e inf u s e d p r o d u c t , s o t he p a t ie nt 's c ir c ula t ing f a c t o r le v e l d o e s n o t d r o p b e lo w 5 0 p e r c e nt. T he s e c a lc ula t io ns a r e b a s e d o n p e a k a nd t r o ug h f a c t o r le v e ls . • A n t ic ip a t e d t r o u g h le v e ls a r e b a s e d o n t he p r o d u c t use d a nd d e s ir e d t r o ug h le v e l, w it h is > 5 0 p e r c e n t f o r m a jo r b le e d s . I t is im p o r t a n t t o b e f a m ilia r w it h t h e s p e c if ic a s s a y use d a nd ho w t o inte r p r e t r e s ult s , e s p e c ia lly f o r p a t ie n t s r e c e iv in g e m ic iz u m a b a n d A lt u v iiio . H e m o p h i l i a A – F o r lif e - t h r e a t e n in g b le e d in g , c h e c k t he t r o ug h a p p r o x im a t e ly f o u r t o s ix h o u r s a f t e r t h e f ir s t d o s e o f a s t a nd a r d ha lf - lif e f a c t o r V I I I p r o d uc t . T he ne x t d o s e is d u e a p p r o x im a t e ly 8 t o 1 2 ho ur s a f t e r t he f ir s t d o s e f o r a s t a nd a r d ha lf - lif e p r o d u c t . L o n g e r in t e r v a ls a p p ly f o r e x t e nd e d ha lf - lif e p r o d u c t s (1 0 t o 2 0 ho ur s f o r m o s t p r o d u c t s , a p p r o x im a t e ly 4 8 h o u r s f o r e f a ne s o c t a c o g a lf a [A lt uv iiio ], w hic h s h o u ld b e g iv e n a t a r e p e a t d o s e o f 3 0 t o 5 0 inte r na t io na l unit s e v e r y t w o t o t hr e e - H e m a r t h r o s e s C o n s i d e r a t i o n s f o r h e m a r t h r o s e s  — B le e d in g in t o a jo in t (h e m a r t h r o s is ) is o ne o f t he m o s t c o m m o n m a n if e s t a t io n s o f h e m o p hilia . Jo int b le e d s a r e c ha r a c t e r iz e d b y r e d uc e d r a ng e o f m o t io n a s s o c ia t e d w it h p a in o r o t he r unusua l s e nsa t io n (e g , t ing lin g t ha t o f t e n p r e c e d e s p a in), p a lp a b le s w e llin g o r w a r m t h , o r o t he r t y p ic a l f in d in g s f o r t ha t p a t ie nt. B le e d ing into hip jo ints is c o n c e r n in g d u e t o t h e g r e a t e r r is k o f inc r e a s e d intr a - a r t ic ula r p r e s s ur e a nd o s t e o ne c r o s is o f t he d a y s a s c lin ic a lly w a r r a n t e d if t h is p r o d u c t is c o ntinue d f o r b le e d t r e a t m e nt). D e t a ils o f s p e c if ic p r o d u c t s a r e s u m m a r iz e d in t he t a b le ( t a b le 2 ) a n d d is c u s s e d s e p a r a t e ly . (S e e \" H e m o p h ilia A a n d B : R o u t in e m a na g e m e nt inc lud in g p r o p h y la x is \" , s e c t io n o n 'F a c t o r V I I I p r o d u c t s f o r he m o p hilia A '.) H e m o p h i l i a B – F o r lif e - t h r e a t e n in g b le e d in g , c h e c k t he t r o ug h a p p r o x im a t e ly 8 t o 1 2 h o u r s a f t e r t h e f ir s t d o s e o f a s t a nd a r d ha lf - lif e f a c t o r I X p r o d u c t . T he ne x t d o s e is d u e a p p r o x im a t e ly 1 8 t o 2 4 h o u r s a f t e r t he f ir s t d o s e f o r a s t a nd a r d ha lf - lif e p r o d u c t . L o n g e r in t e r v a ls a p p ly f o r e x t e nd e d ha lf - lif e p r o d u c t s (f r o m 5 4 t o 1 0 4 h o u r s ). D e t a ils o f s p e c if ic p r o d u c t s a r e s um m a r iz e d in t he t a b le ( t a b le 3 ) a n d d is c u s s e d s e p a r a t e ly . (S e e \" H e m o p h ilia A a n d B : R o u t in e m a na g e m e nt inc lud in g p r o p h y la x is \" , s e c t io n o n 'P r o d u c t s f o r he m o p hilia B '.) - A n o t h e r o p t io n is t o g iv e a d o s e o f f a c t o r t o r a is e t he le v e l t o 8 0 t o 1 0 0 p e r c e nt, f o llo w e d b y c o n t in u o u s in f u s io n t o m a inta in a c o nsis t e nt he m o s t a t ic le v e l. T his s ho uld b e d is c u s s e d w it h t h e h e m a t o lo g is t o r he m o p hilia t r e a t m e n t c e nte r (H T C ). T he a b ilit y t o m o n it o r s t a t f a c t o r a c t iv it y le v e ls is o f utm o s t im p o r t a nc e in t his c linic a l s c e na r io . (S e e 'C o n t in u o u s in f u s io n ' b e lo w .) S u b s e q u e n t d o s e c a l c u l a t i o n – T h e v o lu m e o f d is t r ib u t io n v a r ie s b e t w e e n f a c t o r r e p la c e m e n t p r o d u c t s , a n d t h e a c c ur a t e d o s e c a lc ula t io n s ho uld b e use d t o a v o id s ig n if ic a n t u n d e r - o r o v e r - d o s in g t ha t c a n o c c ur w he n t he p r o p e r c a lc ula t io ns a r e no t m a d e . P a t ie n t a g e c a n a ls o a f f e c t t he v o lum e o f d is t r ib u t io n. S ub s e q u e nt d o s e s o f f a c t o r p r o d u c t w ill g e n e r a lly r e q u ir e o ne - ha lf t he p e r c e nt c o r r e c t io n a s t he init ia l d o s e , p r o v id e d t h e p a t ie n t h a s a t r o u g h f a c t o r le v e l o f a p p r o x im a t e ly 5 0 p e r c e nt. (S e e 'M o n it o r in g a n d d o s e c a lc u la t io n f o r s ub s e q u e nt d o s e s ' b e lo w .) • Te s t i n g f a c t o r a c t i v i t y l e v e l s – D e t a ils , in c lu d in g c a v e a t s w it h f a c t o r a c t iv it y t e s t ing , a r e d is c u s s e d b e lo w . (S e e 'M o n it o r in g a n d d o s e c a lc u la t io n f o r s ub s e q u e nt d o s e s ' b e lo w a n d 'C h e c k t h e f a c t o r le v e l' b e lo w .) • D u r a t i o n o f t r e a t m e n t – (S e e 'D u r a t io n o f t r e a t m e n t ' b e lo w .)• f e m o r a l h e a d . (S e e \" C lin ic a l m a n if e s t a t io n s a n d d ia g n o s is o f he m o p hilia \" , s e c t io n o n 'Jo ints a nd m u s c le '.) S o m e p a t ie n t s d e v e lo p a \" t a r g e t jo int \" in w hic h r e p e a t e d b le e d ing e p is o d e s a nd c hr o nic in f la m m a t o r y c h a n g e s o c c u r. T r e a t m e nt o f a b le e d ing e p is o d e in a t a r g e t jo int m a y r e q uir e h ig h e r d o s e s o f f a c t o r a n d m o r e p r o lo ng e d t he r a p y t o r e s o lv e t he b le e d ing . (S e e \" C lin ic a l m a n if e s t a t io n s a n d d ia g n o s is o f h e m o p hilia \" , s e c t io n o n 'H e m o p h ilic a r t hr o p a t hy '.) M a jo r a s p e c t s o f a s s e s s m e n t a n d m a na g e m e nt o f jo int b le e d ing inc lud e [1 2 ]: P r o m p t f a c t o r i n f u s i o n – F a c t o r s h o u ld b e in f u s e d p r o m p t ly a t t he f ir s t s ig n o f jo int b le e d in g (e g , a t t h e o n s e t o f t in g lin g , p a in, o r t y p ic a l s y m p t o m s o f jo int b le e d ing r a t he r t h a n w a it in g f o r r e d u c e d r a n g e o f m o t io n o r s w e lling ). D o s ing d e p e nd s o n t he s p e c if ic jo in t a n d w h e t h e r it h a s b e c o m e a t a r g e t jo int. (S e e 'F a c t o r d o s in g f o r jo in t b le e d s ' b e lo w .) ● A s s e s s m e n t o f b l e e d i n g – A r t h r o c e n t e s is is n o t r e q u ir e d t o d ia g n o s e jo int b le e d ing in p a t ie n t s w it h h e m o p h ilia . I f u s e d (e g , t o e v a lua t e f o r s usp e c t e d inf e c t io n), f a c t o r s ho uld b e a d m in is t e r e d b e f o r e t h e p r o c e d u r e . (S e e 'A r t h r o c e n t e s is (t y p ic a lly n o t u s e d )' b e lo w .) ● R e d u c e i n f l a m m a t i o n , p a i n , a n d b l e e d i n g – A d d it io n a l in t e r v e n t io n s t o r e d u c e b le e d ing , p a in , a n d in f la m m a t io n in c lu d e a v o id a nc e o f w e ig h t b e a r ing o r use o f t he a f f e c t e d e x t r e m it y , a p p lic a t io n o f ic e p a c k s , im m o b iliz a t io n, a nd / o r s p lin t ing a s r e c o m m e nd e d . S t a n d a r d r e s t , ic e c o m p r e s s io n , a n d e le v a t io n (R I C E ) p r o t o c o ls a p p ly . (S e e \" M u s c u lo s k e le t a l in ju r y in c h ild r e n a n d s k e le t a lly im m a t ur e a d o le s c e nts: O v e r v ie w o f r e ha b ilit a t io n f o r n o n o p e r a t iv e in ju r ie s \" , s e c t io n o n 'I nf la m m a t o r y p h a s e ' a n d \" I n it ia l m a n a g e m e n t o f s o f t t is s u e m u s c u lo s k e le t a l in ju r ie s \" , s e c t io n o n 'I nit ia l inte r v e ntio ns: U t ilit y a nd e v id e nc e '.) ● G iv e a n a lg e s ic s a s n e e d e d , g e n e r a lly a v o id in g a g e n t s w it h a ntip la t e le t a c t iv it y s uc h a s no n- s e le c t iv e n o n s t e r o id a l a n t iin f la m m a t o r y a g e n t s (N S A I D s ). A n N S A I D m a y b e use d in s o m e c ir c u m s t a n c e s s u c h a s s ig n if ic a n t jo int inf la m m a t io n in a p a t ie nt r e c e iv ing f a c t o r r e p la c e m e n t . S e le c t iv e c y c lo o x y g e n a s e 2 (C O X 2 ) inhib it o r s m a y b e use d s inc e t he y d o no t h a v e s ig n if ic a n t a n t i- p la t e le t a c t iv it y . (S e e \" O v e r v ie w o f C O X - 2 s e le c t iv e N S A I D s \" .) I d e n t i f y o t h e r c o n t r i b u t i n g f a c t o r s – C lin ic a l e v a lu a t io n is u s e d t o d is t in g u is h a n a c ute b le e d f r o m o t h e r c o n d it io n s s u c h a s p a in d u e t o c hr o nic a r t hr o p a t hy , a c ute f r a c t ur e o r s p r a in , o r in f e c t io n . I n m a n y c a s e s , t his a s s e s s m e n t is b a s e d o n t he his t o r y a nd p hy s ic a l e x a m in a t io n r a t h e r t h a n r a d io g r a p hy o r ult r a s o und e x a m in a t io ns. ● B o t h h ip a n d ilio p s o a s b le e d in g s h o uld b e t r e a t e d a s m a jo r b le e d ing e p is o d e s , a s s ho uld b le e d in g in a n y a r e a w h e r e im p e n d ing c o m p a r t m e n t s y nd r o m e c a n d e v e lo p , inc lud ing b le e d in g n e a r t h e w r is t s a n d h a n d s a nd t he a nte r io r c o m p a r t m e n t o f t he lo w e r le g . I t m a y b e c h a lle n g in g t o d is t in g u is h h e m a r t hr o s is o f t he hip f r o m b le e d ing into t he ilio p s o a s m u s c le . I n g e n e r a l, h e m a r t h r o s is o f t he hip r e s ult s in s e v e r e p a in w it h hip m o t io n, w h e r e a s ilio p s o a s b le e d in g p r im a r ily c a use s lim it e d hip e x t e nsio n. I lio p s o a s b le e d ing m a y a ls o c a u s e r e d u c e d s e n s a t io n o v e r t he ip s ila t e r a l t hig h d u e t o c o m p r e s s io n o f t he s a c r a l p le x u s r o o t o f t h e f e m o r a l n e r v e . U lt r a s o no g r a p h y o r o t he r r a d io lo g ic e v a lua t io n m a y b e h e lp f u l in id e n t if y in g h e m a t o m a in t he ilio p s o a s r e g io n v e r s us t he hip jo int. (S e e 'M u s c le / s o f t t is s u e b le e d in g ' b e lo w .) H o s p i t a l a d m i s s i o n v e r s u s h o m e c a r e – A d e c is io n m u s t b e m a d e r e g a r d ing w he t he r t he p a t ie n t is s a f e t o b e t r e a t e d a t h o m e v e r s us r e q u ir ing t r e a t m e n t in t he ho s p it a l. T he m a jo r it y o f h e m a r t h r o s e s a r e m a n a g e d a t ho m e . I nd ic a t io ns f o r ho s p it a liz a t io n inc lud e : ● H e m a r t h r o s is t h a t m a y b e lif e o r lim b - t hr e a t e ning , s uc h a s s usp e c t e d b le e d ing into t he h ip o r ilio p s o a s m u s c le • I n it ia l d e la y in t h e r a p y , le a d in g t o a m o r e s e v e r e b le e d o r a b le e d r e q uir ing m o r e a g g r e s s iv e in it ia l t h e r a p y • S u s p ic io n o f a n in f e c t io n• N e e d f o r jo in t a s p ir a t io n d u e t o in c r e a s e d jo int p r e s s ur e o r p o s s ib le inf e c t io n• B le e d in g in a n in d iv id u a l w it h a n in hib it o r t ha t is no t r e s p o n d in g w e ll a t ho m e• F e a t u r e s t h a t w o u ld f a v o r c o n t in u o u s f a c t o r inf u s io n r a t he r t ha n inte r m it t e nt d o s ing• B le e d in g e p is o d e s t h a t a r e n o t r e s p o nd in g a s e x p e c t e d a t ho m e• A s s o c ia t e d p a in t h a t is n o t c o n t r o lle d w it h ho m e o r a l a na lg e s ia• I n a b ilit y t o a d h e r e t o h o m e in s t r u c t io ns/ b e d r e s t f o r a ny r e a s o n, inc lud ing c hild r e n w ho c a n n o t b e n o n - w e ig h t b e a r in g , a d u lt s w it h s ig n if ic a nt a r t hr o p a t hy , p a t ie nts w it h in h ib it o r s r e q u ir in g v e r y f r e q u e n t d o s ing , a nd p a t ie nts w it h m ild d is e a s e w ho ha v e no t le a r n e d h o w t o u s e f a c t o r in f u s io n s • O t h e r m e d i c a t i o n s a n d h e m o s t a ti c p r o d u c ts – A c u t e m a n a g e m e n t n e e d s t h a t m a y b e a d d r e s s e d in p a t ie n t s w h o s e b le e d in g d o e s no t r a p id ly r e s p o n d t o f a c t o r inf usio n a nd lo c a l m e a s u r e s a t h o m e in c lu d e p o s s ib le a d m is s io n w it h use o f c o ntinuo us inf usio n, inhib it o r t e s t in g t o e n s u r e a n in h ib it o r h a s no t d e v e lo p e d , p o s s ib le jo int a s p ir a t io n t o r e m o v e b lo o d a n d r e lie v e p r e s s u r e , o t h e r h e m o s t a t ic t he r a p ie s , a nd g lu c o c o r t ic o id s . ● O t h e r h e m o s t a t ic t h e r a p ie s f o r in d iv id u a ls w it h inhib it o r s o r t ho s e w ho s e b le e d ing is n o t c o n t r o lle d b y f a c t o r in f u s io n a r e p r e s e nte d b e lo w . (S e e 'A d ju v a n t t h e r a p ie s ' b e lo w .) • I f a t a r g e t jo in t h a s u n d e r g o n e r e p e a t e d he m o r r ha g e , w e o f t e n a d m inis t e r a s ho r t c o u r s e o f g lu c o c o r t ic o id s a s a p p r o p r ia t e t o r e d u c e p a in a nd s w e lling a s s o c ia t e d w it h • s y n o v ia l in f la m m a t io n (e g , p r e d n is o n e f o r t h r e e t o f iv e d a y s ), if t h e p a t ie n t d o e s no t h a v e a n a c t iv e in f e c t io n . A b e n e f it f r o m a s ho r t c o ur s e o f g lu c o c o r t ic o id s w a s d e m o n s t r a t e d in a p a ir o f t r ia ls t h a t r a nd o m ly a s s ig n e d 3 5 c hild r e n w it h he m o p hilia a n d a jo in t b le e d t o r e c e iv e p r e d n is o n e (1 m g p e r p o u nd o f b o d y w e ig ht p e r d a y [e q u iv a le n t t o a p p r o x im a t e ly 0 .4 5 m g / k g ; m a x im u m d o s e , 8 0 m g ] f o r t hr e e d a y s ) o r p la c e b o a lo n g w it h f a c t o r r e p la c e m e n t t he r a p y [1 3 ]. C o m p a r e d w it h c o n t r o ls , t h e c h ild r e n a s s ig n e d t o p r e d n is o n e h a d s im ila r o utc o m e s b u t r e q u ir e d le s s f a c t o r inf usio n. T r e a t m e n t d u r a t i o n – I t c a n b e c h a lle n g in g t o d e t e r m ine w he n a c ute b le e d ing into a jo int h a s s t o p p e d . P a t ie n t r e p o r t o f b le e d in g is m o s t c o m m o nly use d , a nd ult r a s o und m a y b e h e lp f u l a s w e ll. M o s t e x p e r t s c o n t in ue t o t r e a t w it h a c o ur s e o f t he r a p y d e s ig ne d t o a llo w b le e d r e s o lu t io n a n d p r e v e n t r e b le e d in g b a s e d up o n p a t ie nt c ir c um s t a nc e s a nd t he p r e s e n c e o f a t a r g e t jo in t , in ju r y , o r inhib it o r. T he d u r a t io n o f t he r a p y d e p e nd s o n t he jo int a f f e c t e d , t h e s iz e o f t h e h e m a r t h r o s is , a nd t he a b ilit y t o a v o id w e ig h t b e a r ing , w hic h a f f e c t s t h e p a c e o f h e a lin g . S o m e e x p e r t s t r e a t f o r a p p r o x im a t e ly t hr e e t o f o ur d a y s a f t e r b le e d in g h a s s t o p p e d ; f e w e r in f u s io n s m a y b e ne e d e d f o r p a t ie nts r e c e iv ing p r o p hy la x is w it h e m ic iz u m a b o r a n e x t e n d e d h a lf - lif e p r o d u c t . Q ue s t io ns a b o u t ind iv id ua l t r e a t m e nt p la n s s h o u ld b e d ir e c t e d t o t h e lo c a l H T C . ● J o i n t r e h a b i l i t a t i o n – F o llo w in g r e s o lu t io n o f a jo in t b le e d , it is im p o r t a nt t o init ia t e a r e h a b ilit a t io n p r o g r a m t h a t in v o lv e s g r a d u a l inc r e a s e d r a ng e o f m o t io n, w e ig ht b e a r ing , a n d s t r e n g t h t r a in in g . A t t e n t io n t o b o n e he a lt h (e g , a d e q ua t e v it a m in D a nd k no w le d g e r e g a r d in g t h e p r e s e n c e o f o s t e o p e nia ) is a ls o ind ic a t e d . ● I n v o lv e m e n t o f a p h y s ic a l t h e r a p is t w it h e x p e r t is e in he m o p hilia t o d e s ig n a r e ha b ilit a t iv e p r o g r a m is h e lp f u l. A f t e r a jo in t b le e d , he m o s t a t ic c o v e r a g e w it h f a c t o r inf usio n is ne e d e d d u r in g p h y s ic a l t h e r a p y t o a llo w f u ll r e ha b ilit a t io n. I nd iv id ua ls w ho a r e no t r e c e iv ing r o u t in e p r o p h y la x is s h o u ld c o n s id e r using p r o p h y la x is , inc lud in g lim it e d s ho r t - t e r m p r o p h y la x is f o llo w in g r e c u r r e n t t a r g e t jo int he m a r t hr o s is , w it h f a c t o r a d m inis t r a t io n f o r s e v e r a l w e e k s t o m o n t h s t o r e d u c e o r p r e v e nt r e c ur r e nt b le e d ing , o r t o use a m o r e a g g r e s s iv e d o s in g s c h e d u le in in d iv id u a ls w ho a r e a lr e a d y r e c e iv ing r o utine p r o p hy la x is . D e t a ils o f p r o p h y la x is a r e d is c u s s e d s e p a r a t e ly . (S e e \" C h r o n ic c o m p lic a t io n s a n d a g e - r e la t e d c o m o r b id it ie s in p e o p le w it h he m o p hilia \" , s e c t io n o n 'A r t hr o p a t hy ' a n d \" H e m o p h ilia A a n d B : R o u t in e m a na g e m e nt inc lud in g p r o p h y la x is \" , s e c t io n o n 'E x e r c is e a n d a t h le t ic p a r t ic ip a t io n ' a n d \" H e m o p h ilia A a n d B : R o u t in e m a na g e m e nt inc lud in g p r o p h y la x is \" , s e c t io n o n 'P r o p h y la x is t o r e d u c e b le e d ing e p is o d e s '.) F a c t o r d o s i n g f o r j o i n t b l e e d s  — F a c t o r s h o u ld b e a d m in is t e r e d a t t he e a r lie s t s ig n o f b le e d in g , p r e f e r a b ly w it h in t w o h o u r s o f b le e d id e n t if ic a t io n. T his s ho uld b e p e r f o r m e d a t ho m e w h e n e v e r p o s s ib le t o a v o id d e la y s in inf u s io n. T h e d e s ir e d f a c t o r a c t iv it y le v e l d e p e nd s o n t he s it e o f b le e d ing a nd w he t he r t he jo int ha s b e c o m e a t a r g e t jo in t ( t a b le 1 ). D o n o t w a s t e f a c t o r (a d m in is t e r e x c e s s r a t he r t ha n d is c a r d in g ). This formula is too large to be displayed at your current browser width. T ry increasing the browser width, or close the topic outline to gain more space. This formula is too large to be displayed at your current browser width. T ry increasing the browser width, or close the topic outline to gain more space. T h e n e e d f o r a d d it io n a l d o s e s a n d t he d u r a t io n o f t he r a p y a r e ind iv id ua liz e d a c c o r d ing t o t he p a t ie n t 's s y m p t o m s , a f f e c t e d jo in t , c o nc ur r e nt is s ue s (b le e d ing into t he hip , ilio p s o a s m usc le , o r a t a r g e t jo in t ; o r b le e d in g a s s o c ia t e d w it h injur y ), a nd init ia l r e s p o n s e . (S e e 'M o n it o r in g a n d d o s e c a lc u la t io n f o r s u b s e q u e n t d o s e s ' b e lo w .) F o r s o m e p a t ie n t s w h o c a n id e n t if y t he e a r ly s y m p t o m s o f a jo int b le e d a nd r a p id ly a d m inis t e r f a c t o r, a s in g le d o s e o f f a c t o r m a y b e s uf f ic ie nt. H o w e v e r, s o m e c o m p r e he nsiv e t r e a t m e nt c e n t e r s u s e m o r e in t e n s iv e t h e r a p y f o r he m a r t hr o s e s f o r s p e c if ic p a t ie nts o r a ll p a t ie nts (e g , f o r h e m o p h ilia A , a n in it ia l f a c t o r V I I I d o s e o f 4 0 unit s / k g f o llo w e d b y a d d it io na l d o s e s o f 2 0 u n it s / k g a t 2 4 a n d 7 2 h o u r s a f t e r t h e f ir s t d o s e ; f o r he m o p hilia B , a n init ia l f a c t o r I X d o s e t o p r o v id e a t a r g e t le v e l o f 8 0 p e r c e n t a c t iv it y f o llo w e d b y a d d it io na l d o s e s t o p r o v id e 4 0 p e r c e nt a c t iv it y , w it h t h e in t e r v a l d e t e r m in e d b y t he ha lf - lif e o f t he f a c t o r I X p r o d uc t use d ) [1 4 ]. A t t h e o t h e r e x t r e m e , s o m e in d iv id ua ls m a y r e q u ir e s e v e r a l d a y s o f f a c t o r inf usio n t o a llo w b le e d r e s o lu t io n a n d r e d u c e t h e r is k o f r e b le e d ing f o r a s e v e r e b le e d , a b le e d into a t a r g e t jo int, o r a b le e d w it h c o n c u r r e n t in ju r y . H ip jo int o r a c e t a b u la r he m o r r ha g e s m a y r e s ult in inc r e a s e d in t r a - a r t ic u la r p r e s s u r e a n d o s t e o n e c r o s is (a s e p t ic ne c r o s is ) o f t he f e m o r a l he a d [1 5 ]. T h e r a p y M o r e s e r i o u s b l e e d i n g – H ig h e r f a c t o r le v e ls (e g , 8 0 t o 1 0 0 p e r c e nt) a r e use d f o r b le e d ing in t o t h e h ip , ilio p s o a s , o r t a r g e t jo int, o r b le e d ing a s s o c ia t e d w it h injur y . I nit ia l d o s ing is a s p r e s e n t e d a b o v e . (S e e 'F a c t o r d o s in g f o r s e v e r e b le e d in g (p a t ie nts w it ho ut inhib it o r s )' a b o v e .) ● O t h e r j o i n t s – F o r e a r ly h e m a r t h r o s is in p e r ip he r a l jo ints s uc h a s k ne e s , e lb o w s , o r a nk le s , t h e f a c t o r a c t iv it y le v e l s h o u ld b e r a is e d t o a t le a s t 4 0 t o 5 0 p e r c e nt. T he f o r m ula f o r init ia l d o s in g t o a c h ie v e a p p r o x im a t e ly 4 0 t o 5 0 p e r c e nt f a c t o r a c t iv it y use s a p e r c e nt c o r r e c t io n o f 5 0 p e r c e n t . ● d e s ig n e d t o s u s t a in a f a c t o r le v e l a b o v e a t r o ug h o f 4 0 p e r c e nt f o r a t le a s t t hr e e d a y s s ho uld b e g iv e n , a lo n g w it h e n f o r c e d b e d r e s t ; o f t e n t his is d o n e in t he ho s p it a l using c o ntinuo us inf usio n. A r t h r o c e n t e s i s (t y p i c a l l y n o t u s e d ) — A r t h r o c e n t e s is is n o t r e q u ir e d t o d ia g n o s e jo int b le e d in g in p a t ie n t s w it h h e m o p h ilia . I f a r t hr o c e nte s is is d e e m e d ne c e s s a r y (d ue t o c o nc e r n o f a s e p t ic jo in t o r t o r e d u c e p r e s s u r e f r o m a c c um u la t e d b lo o d ) it s ho uld o nly b e p e r f o r m e d a f t e r f a c t o r h a s b e e n a d m in is t e r e d t o r a is e t he f a c t o r le v e l t o 1 0 0 p e r c e nt in c o njunc t io n w it h a c o m p r e h e n s iv e h e m o p h ilia t r e a t m e nt c e nte r. U s e o f p o in t - o f - c a r e m u s c u lo s k e le t a l ult r a s o und (P O C - M S K U S ) is e x p a nd ing [1 6 - 1 8 ]. P O C - M S K U S p e r f o r m e d b y t r a in e d o p e r a t o r s o r f u ll- jo int ult r a s o und p e r f o r m e d b y a r a d io lo g is t ) m a y b e u s e f u l t o d is t in g u is h a n a c u t e b le e d f r o m p a in a s s o c ia t e d w it h c hr o nic a r t hr o p a t hy . P O C - M S K U S is a ls o h e lp f u l in jo in t a s p ir a t io n . (S e e 'O v e r v ie w o f s u r g ic a l p la n n in g ' b e lo w .) M u s c l e / s o f t t i s s u e b l e e d i n g  — M u s c le b le e d in g m a y p r e s e n t w it h a c hing , s t if f ne s s , p a in, o r s w e llin g . I n m u s c le g r o u p s s u c h a s t he up p e r a r m , f o r e a r m , w r is t , v o la r ha nd , a nd a nte r io r o r p o s t e r io r t ib ia l c o m p a r t m e n t , s o f t t is s ue he m o r r ha g e m a y r e s ult in a c o m p a r t m e nt s y nd r o m e w it h im p in g e m e n t o n t h e n e u r o v a s c ula r b u nd le . T his m a y b e a s s o c ia t e d w it h t ing ling , n u m b n e s s , a n d in s e v e r e s it u a t io n s , lo s s o f d is t a l a r t e r ia l p u ls e s . T h e r a p y s h o u ld b e in it ia t e d a s s o o n a s p o s s ib le (a t t he f ir s t s ig n o f s y m p t o m s o r im m e d ia t e ly a f t e r in ju r y o r t r a u m a ). F o r s e v e r e m u s c le he m a t o m a s , a p e a k f a c t o r a c t iv it y le v e l o f a t le a s t 5 0 p e r c e n t is a p p r o p r ia t e a s a m in im u m , b u t usua lly hig h e r p e a k le v e ls a r e use d f o r s e v e r e m usc le b le e d in g . A r t h r o c e n t e s is m a y b e a p p r o p r ia t e if t he r e is ne ur o v a s c ula r c o m p r o m is e , s e v e r e p a in, o r o t h e r e v id e n c e o f in c r e a s e d jo in t p r e s s ur e t ha t ha s no t im p r o v e d w it h o t he r t r e a t m e nt, o r t h e r e is s u s p ic io n o f a n in f e c t io n . I f jo int a s p ir a t io n is p e r f o r m e d , r e p la c e m e nt t he r a p y s h o u ld b e a d m in is t e r e d t o r a is e t h e f a c t o r le v e l t o 1 0 0 p e r c e nt b e f o r e t he p r o c e d ur e . I n h ib it o r p a t ie n t s r e q u ir e u s e o f b y p a s s ing t he r a p y a nd s ho uld b e t r e a t e d a t a c o m p r e h e n s iv e h e m o p h ilia t r e a t m e nt c e nte r. T h is r e q u ir e s t r e a t m e n t / f a c t o r r e p la c e m e n t t he r a p y f o r ind iv id ua ls w it h a ny d e g r e e o f f a c t o r d e f ic ie n c y in h e m o p h ilia A a nd B . D o s ing is a s f o r jo int b le e d ing a b o v e . (S e e 'F a c t o r d o s in g f o r jo in t b le e d s ' a b o v e .) ● F o r in d iv id u a ls w it h m ild h e m o p h ilia A , it m a y b e p o s s ib le t o r a is e t he f a c t o r V I I I le v e l u s in g D D A V P [1 9 ]. (S e e 'D D A V P f o r m ild h e m o p h ilia A ' b e lo w .) ● S e v e r e m u s c le b le e d s r e q u ir e m o r e t ha n o ne f a c t o r inf u s io n. S ur g ic a l d e c o m p r e s s io n is u n d e r t a k e n o n ly if m e d ic a l t h e r a p y f a ils t o f o r e s t a ll p r o g r e s s io n, a nd in c o nsult a t io n w it h a c o m p r e h e n s iv e h e m o p h ilia t r e a t m e nt c e nte r. (S e e \"A c u t e c o m p a r t m e n t s y n d r o m e o f t he e x t r e m it ie s \" , s e c t io n o n 'M a n a g e m e nt '.) M u s c le b le e d s c a n r e s u lt in a s ig n if ic a nt d r o p in he m o g lo b in le v e l, a nd t he he m o g lo b in s ho uld b e m o n it o r e d u n t il it is c le a r t h a t b le e d in g ha s c e a s e d . M i n o r b l e e d i n g  — M in o r b le e d in g s u c h a s e p is t a x is o r s k in b le e d ing m a y b e t r e a t e d w it h lo c a l m e a s u r e s in c lu d in g ic e , p r e s s u r e , o r e le v a t io n. To p ic a l t he r a p ie s inc lud ing a ntif ib r ino ly t ic a g e nts o r o t h e r a d ju n c t iv e lo c a l t h e r a p ie s m a y a ls o b e he lp f ul. A t t im e s , e p is o d e s o f e p is t a x is m a y b e p r o lo n g e d o r m a y r e s u lt in la r g e r v o lum e b lo o d lo s s t ha t w ill ne c e s s it a t e r e p la c e m e nt t he r a p y . (S e e 'A n t if ib r in o ly t ic t h e r a p y f o r m u c o s a l b le e d ing o r s ur g e r y ' b e lo w a n d 'A d ju n c t iv e lo c a l t h e r a p ie s ' b e lo w .) M O N I T O R I N G A N D D O S E C A L C U L A T I O N F O R S U B S EQ U E N T D O S E S C h e c k t h e f a c t o r l e v e l  — T h e f a c t o r a c t iv it y le v e l (p e a k a n d t r o ug h ) is c he c k e d using a s p e c if ic f a c t o r a s s a y r a t h e r t h a n a n a c t iv a t e d p a r t ia l t hr o m b o p la s t in t im e (a P T T ). T he s p e c if ic a s s a y s a r e a P T T - b a s e d o r c h r o m o g e n ic . I t is im p o r t a nt t o b e c o m e f a m ilia r w it h t he m e t ho d o f t e s t ing a t o n e 's in s t it u t io n in o r d e r t o in t e r p r e t t he r e s ult s a c c ur a t e ly . A p e a k f a c t o r le v e l is n o t r e q u ir e d w it h e v e r y d o s e . I d e a lly it is o b t a ine d a f t e r t he f ir s t d o s e , t o a s s e s s f a c t o r r e c o v e r y a n d e n s u r e t he r e is no inhib it o r, b u t if no t a s s e s s e d init ia lly it c a n b e o b t a in e d w it h a s u b s e q u e n t in f u s io n. I n it ia l d o s in g m a y r e s u lt in lo w e r - t h a n- e x p e c t e d t r o ug h le v e ls if t he r e is o ng o ing b le e d ing , p a r t ic u la r ly a f t e r m a jo r s u r g e r y . F o r m a jo r lif e - t hr e a t e ning b le e d ing , f a c t o r V I I I a c t iv it y is c h e c k e d t w o t o f o u r h o u r s a f t e r in it ia l d o s ing f o r s t a nd a r d ha lf - lif e f a c t o r V I I I a nd f o ur t o s ix h o u r s a f t e r in it ia l d o s in g o f s t a n d a r d ha lf - lif e f a c t o r I X . S lig h t ly lo ng e r inte r v a ls b e f o r e t he f ir s t t r o u g h le v e l m a y b e u s e d f o r m in o r b le e d ing . A f t e r init ia l d o s ing , m o nit o r ing m a y ne e d t o b e t a ilo r e d t o t h e e x p e c t e d h a lf - lif e o f t he p r o d u c t b e in g use d . H e m o p h i l i a A● F o r p e o p le w it h h e m o p h ilia A r e c e iv ing f a c t o r V I I I p r o p h y la x is , f a c t o r V I I I is m e a s ur e d u s in g a s t a n d a r d a P T T - b a s e d f a c t o r V I I I a c t iv it y a s s a y . • F o r p e o p le w it h h e m o p h ilia A r e c e iv ing e m ic iz u m a b p r o p h y la x is , a s t a n d a r d a P T T - b a s e d a s s a y f o r f a c t o r V I I I a c t iv it y c a n n o t b e u s e d b e c a u s e it is f a ls e ly • C a l c u l a t e t h e s e c o n d a n d s u b s e q u e n t d o s e s  — W h ile t h e in it ia l d o s e is g iv e n r a p id ly f o r lif e - t h r e a t e n in g b le e d in g , s u b s e q u e n t d o s ing is b a s e d o n t he p e a k a nd t r o ug h le v e ls a f t e r t he init ia l d o s e a n d t h e v o lu m e o f d is t r ib u t io n (V d ) o f t he s p e c if ic f a c t o r p r o d u c t b e ing a d m inis t e r e d . S ig n if ic a n t o v e r - d o s in g o r u n d e r - d o s ing m a y o c c ur if t his c a lc ula t io n is no t use d o r if t he f a c t o r is g iv e n o n a f ix e d s c h e d u le w it h o u t m o n it o r ing . T he s e c o nd a nd s ub s e q ue nt d o s e s w ill b e a p p r o x im a t e ly o n e - h a lf o f t h e in it ia l d o s e w he n g iv e n a f t e r o ne ha lf - lif e , p r o v id e d t he p a t ie nt 's t r o u g h f a c t o r le v e l is a p p r o x im a t e ly 5 0 p e r c e nt. H o w e v e r, in d iv id u a l p h a r m a c o k in e t ic s c a n s ig n if ic a ntly im p a c t f a c t o r ha lf - lif e a nd ult im a t e h e m o s t a s is . T h e v o lu m e o f d is t r ib u t io n m a y v a r y b y p a t ie nt a nd c a n b e a f f e c t e d b y a c ute h e m o r r h a g e a n d b o d y f a t c o n t e n t [2 1 ]. T h e f o llo w in g c a lc u la t io n s h o u ld b e use d t o d e t e r m in e t he a p p r o p r ia t e f a c t o r d o s e : F o r t h e % c o r r e c t io n , u s e 1 0 0 f o r a d e s ir e d f a c t o r a c t iv it y o f 1 0 0 p e r c e nt. I f t he p a t ie nt 's t r o ug h le v e l is 5 0 p e r c e n t a n d t h e d e s ir e d f a c t o r a c t iv it y is 1 0 0 p e r c e nt, t he n t he p e r c e nt c o r r e c t io n is 5 0 % . F o r t h e V d : S a m p le c a lc u la t io n s : n o r m a liz e d / e le v a t e d w it h e m ic iz u m a b . F a c t o r V I I I a c t iv it y m u s t b e m o nit o r e d using a b o v in e s u b s t r a t e - b a s e d c h r o m o g e nic a s s a y [2 0 ]. (S e e 'P a t ie n t s w it h h e m o p h ilia A r e c e iv in g e m ic iz u m a b ' b e lo w .) F o r p e o p le w it h h e m o p h ilia A r e c e iv ing e f a ne s o c t a c o g a lf a (A lt uv iiio ), a v a lid a t e d o ne s t a g e c lo t t in g a s s a y s h o u ld b e u s e d t o m e a s ur e f a c t o r V I I I a c t iv it y . O t he r a s s a y s (c h r o m o g e n ic o r a P T T - b a s e d ) m a y o v e r e s t im a t e f a c t o r V I I I a c t iv it y b y a p p r o x im a t e ly 2 .5 - f o ld . (S e e \" H e m o p h ilia A a n d B : R o u t in e m a na g e m e nt inc lud in g p r o p h y la x is \" , s e c t io n o n 'E f a n e s o c t o c o g a lf a (f a c t o r V I I I - V W F f u s io n)'.) • H e m o p h i l i a B● F o r p e o p le w it h h e m o p h ilia B r e c e iv in g f a c t o r I X p r o p h y la x is , f a c t o r I X a c t iv it y is m e a s u r e d u s in g a s t a n d a r d a P T T - b a s e d f a c t o r I X a c t iv it y a s s a y . • Dose (units) = % correction x Vd x patient weight (kg) F a c t o r V I I I – A ll p r o d u c t s h a v e a V d o f a p p r o x im a t e ly 0 .5 d L / k g .● F a c t o r I X – T h e V d v a r ie s b y p r o d u c t .● D o n o t w a s t e f a c t o r (a d m in is t e r e x c e s s r a t he r t ha n d is c a r d in g ). S u b s e q u e n t d o s e s a r e g iv e n a t in t e r v a ls o f a p p r o x im a t e ly o ne ha lf - lif e o f t he inf use d p r o d uc t , w h ic h is m o d if ie d b a s e d o n p e a k a nd t r o ug h le v e ls f o r t ha t ind iv id ua l d ur ing t ha t b le e d ing e v e n t . A p p r o x im a t e h a lf - liv e s f o r s p e c if ic p r o d u c t s a r e lis t e d in t he t a b le ( t a b le 3 ). I f t h e t r o u g h f a c t o r a c t iv it y is lo w e r t ha n e x p e c t e d , t he d o s ing inte r v a l m a y b e s ho r t e ne d a nd / o r t h e s u b s e q u e n t d o s e in c r e a s e d d e p e n d in g o n p e a k le v e ls . I f t he t r o ug h f a c t o r a c t iv it y le v e l is h ig h e r t h a n e x p e c t e d , t h e d o s in g inte r v a l m a y b e inc r e a s e d a nd / o r t he s ub s e q ue nt d o s e m a y b e lo w e r e d . C o n t i n u o u s i n f u s i o n  — C o n t in u o u s in f u s io n is a n o t h e r o p t io n f o r m a inta ining s t a b le f a c t o r a c t iv it y le v e ls [2 2 - 2 7 ]. T h is o f f e r s t h e a d v a n t a g e s o f c o n s is t e nt f a c t o r le v e ls , le s s - f r e q u e nt m o n it o r in g , a n d d e c r e a s e d f a c t o r use o v e r t im e . F a c t o r a c t iv it y le v e ls s h o u ld b e c h e c k e d p e r io d ic a lly d u r ing c o ntinuo us inf usio n, w it h t he in t e r v a l d e t e r m in e d b y t h e p r e v io u s le v e l, d o s e a d ju s t m e n t s , a nd c linic a l b le e d ing . C o ntinuo us in f u s io n s s h o u ld n o t h a v e a n a t t a c he d f ilt e r, a nd t he f a c t o r p r o d u c t s ho uld o nly b e m ix e d w it h n o r m a l s a lin e . H e m o p h i l i a A – F o r a 6 0 k g p a t ie n t t r e a t e d w it h a r e c o m b ina nt f a c t o r V I I I p r o d u c t w it h V d o f 0 .5 d L / k g w h o r e q u ir e s a f a c t o r le v e l o f 1 0 0 p e r c e nt a nd ha s a t r o ug h v a lue o f 5 0 p e r c e n t , t h e d o s e is c a lc u la t e d a s f o llo w s : ● 5 0 (% c o r r e c t io n ) x 0 .5 (V d ) x 6 0 k g (w e ig h t ) = 1 5 0 0 inte r na t io na l unit s o f r e c o m b ina nt f a c t o r V I I I c o n c e n t r a t e . H e m o p h i l i a B – F o r a n 8 0 k g p a t ie n t t r e a t e d w it h B e n e f ix (V d = 1 .3 f o r a g e ≥ 1 2 y e a r s ) w ho r e q u ir e s a f a c t o r I X le v e l o f 1 0 0 p e r c e nt a nd ha s a t r o ug h v a lue o f 5 0 p e r c e nt, t he d o s e is c a lc u la t e d a s f o llo w s : ● 5 0 (% c o r r e c t io n ) x 1 .3 (V d ) x 8 0 k g (w e ig h t ) = 5 2 0 0 inte r na t io na l unit s o f B e ne f ix . F a c t o r V I I I – A d o s e o f a p p r o x im a t e ly 4 in t e r n a t io na l unit s / k g / ho ur o f s t a nd a r d ha lf - lif e f a c t o r V I I I c o n c e n t r a t e w ill o f t e n m a in t a in t h e le v e l in it ia lly a c hie v e d b y t he b o lu s inf u s io n. ● F a c t o r I X – A d o s e o f a p p r o x im a t e ly 6 u n it s / k g / ho ur o f s t a nd a r d ha lf - lif e f a c t o r I X c o n c e n t r a t e w ill o f t e n m a in t a in t h e le v e l in it ia lly a c hie v e d b y t he b o lu s inf u s io n. ● L o n g e r h a l f - l i f e p r o d u c t s – L o n g e r h a lf - lif e p r o d u c t s h a v e b e e n use d in c o ntinuo us in f u s io n , b u t lo w e r d o s e s a n d c lo s e r m o n it o r ing o f le v e ls a r e r e c o m m e nd e d . ● D u r a t i o n o f t r e a t m e n t  — T h e d u r a t io n o f h ig h d o s e f a c t o r a d m in is t r a t io n is ind iv id ua liz e d b a s e d o n t h e s it e o f b le e d in g , s e v e r it y , ne e d f o r s ur g e r y , a nd a s s ur a nc e t ha t b le e d ing ha s s t o p p e d . U R G EN T /EM ER G EN C Y S U R G ER Y P a t ie n t s w h o r e q u ir e a n e m e r g e n c y p r o c e d u r e s ho uld b e m a na g e d w it h ur g e nt inf usio n o f f a c t o r t o r a is e t h e f a c t o r a c t iv it y t o a le v e l a p p r o p r ia t e f o r t he p r o c e d ur e . (S e e 'M a jo r s u r g e r y ' b e lo w a n d 'E le c t iv e s u r g e r y ' b e lo w .) EL EC T I V E S U R G ER Y O v e r v i e w o f s u r g i c a l p l a n n i n g  — P la n n in g f o r e le c t iv e s u r g e r y s h o u ld inc lud e t he p a t ie nt, f a m ily / c a r e g iv e r s , a n d a ll r e le v a n t c linic ia ns t o e nsur e t ha t b e s t p r a c t ic e s a r e f o llo w e d . C o lla b o r a t io n w it h e x p e r t s f r o m a h e m o p h ilia t r e a t m e n t c e nte r t o d e v e lo p a he m o s t a t ic , e f f e c t iv e , a n d s a f e c a r e p la n is s t r o ng ly a d v is e d . A c o m p r e he nsiv e p la n f o r m a na g e m e nt b e f o r e , d u r in g , a n d a f t e r t h e p r o c e d u r e , a n d e x c e lle nt c o m m unic a t io n b e t w e e n t he o p e r a t ing p h y s ic ia n , a n e s t h e s io lo g is t , p a t ie n t , f a m ily / c a r e g iv e r s , p h a r m a c y o r o t he r lo c a t io n w he r e t he p r o d u c t is s t o r e d , a n d t h e h e m a t o lo g is t is r e q u ir e d t o a s s ur e a n o p t im a l o utc o m e [2 8 ]. (S e e H e a d t r a u m a – W e o f t e n t r e a t f o r a t le a s t t h r e e d a y s , inc lud in g s ig n if ic a nt t r a um a w it h n e g a t iv e im a g in g . ● D o c u m e n t e d i n t r a c e r e b r a l h e m o r r h a g e (I C H ) – P r o lo n g e d t h e r a p y (e g , f o r t h r e e w e e k s ) is g e n e r a lly r e q u ir e d , f o llo w e d b y a p e r io d o f p r o p h y la x is o r init ia t io n o f lo ng - t e r m p r o p h y la x is , a s t h e r is k o f r e c u r r e n t I C H is o f t e n inc r e a s e d . ● J o i n t o r m u s c l e – P a t ie n t s w h o r e q u ir e p h y s ic a l t h e r a p y o r r e ha b ilit a t io n m a y ne e d t o use p r o p h y la c t ic d o s in g u n t il t h e p a t ie nt is f u lly r e c o v e r e d . D o s ing r e la t iv e t o p hy s ic a l t he r a p y s h o u ld b e t im e d s o t h a t p h y s ic a l t he r a p y c a n o c c ur w he n t he f a c t o r le v e l is hig h, no t d u r in g t h e t r o u g h . ● L a t e b le e d in g f o llo w in g h e a d t r a u m a c a n o c c ur up t o t hr e e t o f o u r w e e k s f o llo w ing t he e v e n t . I n d iv id u a ls w it h h e a d t r a u m a o r o t he r s e v e r e b le e d ing s ho uld b e instr uc t e d a b o ut s ig n s o f la t e o r r e c u r r e n t b le e d in g , p la ns f o r f a c t o r d o s ing s ho uld t he s e o c c ur, a nd p a r a m e t e r s f o r s e e k in g m e d ic a l a t t e ntio n, s o t ha t t r e a t m e n t c a n b e g in a t t he e a r lie s t m a n if e s t a t io n o f r e c u r r e n t b le e d in g . \" H e m o p h ilia A a n d B : R o u t in e m a na g e m e nt inc lud in g p r o p h y la x is \" , s e c t io n o n 'H e m o p hilia t r e a t m e n t c e n t e r s '.) S u r g e r y s h o u ld b e p e r f o r m e d in a s e t t ing t ha t inc lud e s t im e ly a c c e s s t o la b o r a t o r y m o nit o r ing o f f a c t o r a c t iv it y le v e ls a n d im m e d ia t e a v a ila b ilit y o f r e p la c e m e n t f a c t o r (o r p la s m a c o m p o ne nts, in r e s o u r c e - lim it e d s e t t in g s ) a n d o t he r he m o s t a t ic p r o d u c t s , a nd c linic ia ns w it h e x p e r t is e in m a n a g in g p a t ie n t s w it h h e m o p h ilia . M e t ic ulo us o p e r a t iv e t e c hniq u e s ho uld b e use d , w it h lo c a l h e m o s t a t ic a g e n t s a s a p p r o p r ia t e . T h e p r e o p e r a t iv e a s s e s s m e n t s h o u ld inc lud e : D e s ir e d f a c t o r le v e ls a n d d u r a t io n o f t he r a p y d e p e nd o n t he t y p e o f p r o c e d ur e , a s d e s c r ib e d b e lo w , w it h lo n g e r d u r a t io n s f o r g r e a t e r b le e d ing r is k p r o c e d u r e s o r p r o c e d ur e s w he r e he a ling r e q u ir e s a lo n g e r d u r a t io n o f c o v e r a g e . D D A V P m a y b e use d in p a t ie nts w it h m ild he m o p hilia A w h o h a v e b e e n d e m o n s t r a t e d t o ha v e a n a d e q ua t e r e s p o n s e a nd in a p p r o p r ia t e p r o c e d ur e s (e g , d e n t a l p r o c e d u r e s ). A n t if ib r in o ly t ic s a r e o f t e n use f u l in d e n t a l p r o c e d ur e s o r o t he r G e n e r a l m e d ic a l e x a m in a t io n t o id e ntif y a s s o c ia t e d is s ue s inc lud in g o r a l he a lt h p r io r t o jo in t r e p la c e m e n t , o t h e r h e m o s t a t ic d e f e c t s (e g , c o nc o m it a nt liv e r d is e a s e ), use o f m e d ic a t io n s t h a t c a n a f f e c t t h e c o a g ula t io n s y s t e m (inc lud in g o v e r - t he - c o unte r a nd he r b a l m e d ic a t io n s ), a n d / o r c a r d io v a s c u la r r is k f a c t o r s o r c a r d io v a s c ula r d is e a s e . ● I n h ib it o r s c r e e n in g t o id e n t if y n e w ly d e v e lo p e d inhib it o r s a nd / o r d e t e r m ine t he inhib it o r t it e r. (S e e \" I n h ib it o r s in h e m o p h ilia : M e c h a n is m s , p r e v a le nc e , d ia g n o s is , a nd e r a d ic a t io n \" , s e c t io n o n 'R o u t in e s c r e e n in g a n d p r e o p e r a t iv e t e s t ing '.) ● C o n s id e r a t io n o f is s u e s r e la t e d t o m o nit o r ing o f f a c t o r r e p la c e m e n t (e g , r a p id t ur na r o und t im e f o r f a c t o r a s s a y s ). A v a ila b ilit y o f s p e c if ic m o n it o r ing t e s t s s ho uld b e c o nf ir m e d , in c lu d in g a p p r o p r ia t e b o v in e s u b s t r a t e - b a s e d c hr o m o g e nic a s s a y s f o r ind iv id ua ls r e c e iv in g e m ic iz u m a b a s w e ll a s a v a lid a t e d o n e - s t a g e c lo t t ing a s s a y t o e v a lua t e f a c t o r V I I I a c t iv it y in p a t ie n t s r e c e iv in g e f a n e s o c t a c o g a lf a (A lt uv iiio ). (S e e \" H e m o p h ilia A a n d B : R o u t in e m a n a g e m e n t in c lu d in g p r o p h y la x is \" , s e c t io n o n 'E m ic iz um a b f o r he m o p hilia A ' a n d \" H e m o p h ilia A a n d B : R o u t in e m a na g e m e nt inc lud in g p r o p h y la x is \" , s e c t io n o n 'E f a n e s o c t o c o g a lf a (f a c t o r V I I I - V W F f u s io n)'.) ● D D A V P (1 - d e a m in o , 8 - D a r g in in e - v a s o p r e s s in, a ls o c a lle d d e s m o p r e s s in) t e s t d o s e f o r in d iv id u a ls w it h m ild h e m o p h ilia A f o r w ho m t his a p p r o a c h is b e in g c o nsid e r e d a nd ha s n o t b e e n p e r f o r m e d a lr e a d y ; t h is s h o uld b e d o n e a t le a s t o ne w e e k b e f o r e p la nne d s u r g e r y . (S e e \" H e m o p h ilia A a n d B : R o u t in e m a na g e m e nt inc lud in g p r o p h y la x is \" , s e c t io n o n 'D D A V P t e s t d o s e f o r m ild h e m o p hilia A '.) ● in t e r v e n t io n s a f f e c t in g m u c o s a l s u r f a c e s . (S e e 'M a jo r s u r g e r y ' b e lo w a n d 'C ir c u m c is io n ' b e lo w a n d 'D e n t a l p r o c e d u r e s ' b e lo w a n d 'E n d o s c o p y ' b e lo w a n d 'A d ju v a n t t h e r a p ie s ' b e lo w .) F o r p a t ie n t s w h o r e q u ir e p e r io p e r a t iv e f a c t o r a d m inis t r a t io n, t he init ia l (p r e o p e r a t iv e ) d o s e s h o u ld b e t im e d t o p r o v id e m a x im a l c o v e r a g e a t t he t im e o f g r e a t e s t b le e d ing r is k (t y p ic a lly 3 0 t o 6 0 m in u t e s b e f o r e t h e p r o c e d u r e ). T he d o s e is c a lc ula t e d f r o m t he p a t ie nt 's w e ig ht, b a s e line f a c t o r le v e l, d e s ir e d f a c t o r le v e l, v o lum e o f d is t r ib u t io n, a nd p r e s e nc e o f a n inhib it o r a s d e s c r ib e d in t h e d o s in g s e c t io n s a b o v e . F o r t he f ir s t d o s e , w e a s s um e t he b a s e line f a c t o r le v e l t o b e 0 p e r c e n t . I t is g e n e r a lly n o t n e c e s s a r y t o s ub t r a c t t he p a t ie nt 's b a s e line f a c t o r a c t iv it y le v e l. A f t e r in f u s io n , a n im m e d ia t e (s t a t ) f a c t o r le v e l s ho uld b e c he c k e d b e f o r e p r o c e e d ing w it h t he o p e r a t iv e in t e r v e n t io n f o r a ll p r o c e d ur e s o t he r t ha n r o utine o utp a t ie nt d e nta l p r o c e d ur e s . I n a p a t ie n t w h o h a s b e e n r e c e iv in g e m ic iz u m a b , a b o v in e s u b s t r a t e - b a s e d c h r o m o g e n ic f a c t o r V I I I a s s a y m u s t b e u s e d . I n a p a t ie n t w it h a n inhib it o r w ho is using b y p a s s ing t he r a p y , t he r e is no c o a g u la t io n t e s t t h a t r e f le c t s c lin ic a l e f f ic a c y ; t he r e f o r e , la b o r a t o r y m o nit o r ing o f f a c t o r a c t iv it y le v e ls is n o t u s e d . S u b s e q u e n t d o s in g is b a s e d o n t h e p la n o f c a r e d e v e lo p e d , t he p a t ie nt 's c linic a l s t a t us, a nd t he m e a s u r e d le v e ls , w h ic h , if b o lu s d o s ing is use d , a r e t y p ic a lly m e a s ur e d a t 8 t o 1 2 ho ur s a f t e r t he p r e v io u s d o s e f o r f a c t o r V I I I a n d 1 2 t o 2 4 ho ur s a f t e r t he p r e v io us d o s e f o r f a c t o r I X [2 9 ,3 0 ]. I n a d d it io n , le v e ls a r e o f t e n o b t a in e d in t he r e c o v e r y r o o m t o a s s ur e a d e q ua t e he m o s t a s is . I f t h e r e is u n e x p e c t e d in t r a o p e r a t iv e a nd / o r p o s t o p e r a t iv e b le e d ing , it is im p o r t a nt t o o b t a in a n im m e d ia t e (s t a t ) f a c t o r le v e l a n d , a s lo ng a s no t using a b y p a s s ing a g e nt, t o c o nsid e r t he p o s s ib ilit y t h a t b le e d in g m a y b e d u e t o a n a na t o m ic o r m e c h a nic a l c a use (e g , ne e d f o r lig a t io n o f b lo o d v e s s e ls ) if a d e q u a t e h e m o s t a t ic f a c t o r le v e ls a r e d o c u m e n t e d . T h e e f f ic a c y a n d s a f e t y o f e x t e n d e d ha lf - lif e f a c t o r V I I I p r o d u c t s (r e c o m b ina nt f a c t o r V I I I - F c f u s io n ; P E G y la t e d r e c o m b in a n t f a c t o r V I I I ) ha s b e e n d e m o nstr a t e d in s m a ll s t ud ie s in w hic h p a t ie n t s w it h h e m o p h ilia A w e r e m a na g e d p e r io p e r a t iv e ly f o r m a jo r a nd m ino r s ur g e r ie s a nd h a d e x c e lle n t h e m o s t a s is w it h o u t s e r io us a d v e r s e e v e nts [3 1 ,3 2 ]. W id e r c lin ic a l e x p e r ie n c e h a s a c c u m u la t e d s in c e t h e lic e n s u r e o f t he s e p r o d u c t s , a nd e x p e r ie nc e s up p o r t s t he s a f e t y a nd e f f ic a c y s e e n in e a r lie r s t u d ie s . P r o d u c t c o nsis t e nc y d u r ing o utp a t ie nt a nd inp a t ie nt use is a c o n s id e r a t io n , a n d if t h e p a t ie n t u s e s a lo ng e r - la s t ing p r o d u c t o r s p e c if ic p r o d uc t a t ho m e , w e u s e t h e s a m e p r o d u c t in t h e h o s p it a l if p o s s ib le . (S e e 'B r e a k t h r o u g h b le e d in g d u r in g p r o p h y la x is w it h a lo n g e r - la s t in g f a c t o r ' b e lo w .) P a t ie n t s w it h m ild h e m o p h ilia A a n d t ho s e w ho ha v e r e c e iv e d inte nsiv e f a c t o r r e p la c e m e nt f o r t h e f ir s t t im e s h o u ld b e r e - s c r e e n e d f o r inhib it o r s a t t he c o m p le t io n o f t he r a p y , a nd a t a p p r o x im a t e ly t w o t o t h r e e w e e k s p o s t o p e r a t iv e ly [2 ]. P a t ie n t s f o r w h o m f a c t o r a d m in is t r a t io n is in e f f e c t iv e a n d t h o s e r e q u ir in g h ig he r t ha n e x p e c t e d d o s e s o f f a c t o r m a y a ls o r e q uir e e a r lie r in h ib it o r s c r e e n in g . (S e e \" I n h ib it o r s in h e m o p h ilia : M e c h a n is m s , p r e v a le nc e , d ia g n o s is , a nd e r a d ic a t io n \" , s e c t io n o n 'S c r e e n in g a nd e a r ly d ia g n o s is '.) M a j o r s u r g e r y  — M a jo r s u r g e r y in c lu d e s a n y s u r g e r y w it h a r is k o f c linic a lly s ig n if ic a nt b le e d ing o r p e n e t r a t io n o f a m a jo r b o d y c a v it y , inc lud in g o r t ho p e d ic s ur g e r y . D e c is io ns r e g a r d ing m a jo r s u r g e r y a r e b e s t m a d e in c lo s e c o nsult a t io n w it h t he p a t ie nt a nd a n e x p e r ie nc e d m u lt id is c ip lin a r y t e a m in c lu d in g a c o m p r e he nsiv e he m o p hilia t r e a t m e nt c e nte r he m a t o lo g is t (t o c o n f ir m t h a t f a c t o r r e p la c e m e nt a nd o t he r he m o s t a t ic t he r a p ie s a r e o p t im a lly a d m inis t e r e d ) a n d t h e s u r g e o n (t o a s s e s s t h e f e a s ib ilit y o f t he p r o c e d u r e a nd lik e liho o d o f e f f ic a c y ) [3 ]. F o r t h e m a n a g e m e n t o f m a jo r s u r g e r y in w hic h p o s t o p e r a t iv e c o ntinuo us inf usio n is p la nne d , t h e in f u s io n is o f t e n s t a r t e d b e f o r e t he s ur g e r y , a f t e r t he init ia l b o lu s is a d m inis t e r e d . F a c t o r V I I I a n d f a c t o r I X c le a r a n c e (c o n s u m p t io n) is inc r e a s e d d u r ing s ur g e r y d u e t o e x p e c t e d in t r a o p e r a t iv e b lo o d lo s s . A f o llo w - u p b o lu s m a y b e ne e d e d b e f o r e init ia t ing t he c o ntinuo us in f u s io n . T h is is e s p e c ia lly p e r t in e n t t o o r t ho p e d ic p r o c e d u r e s . O r t h o p e d ic p r o c e d u r e s a r e t h e m o s t c o m m o nly p e r f o r m e d m a jo r s ur g ic a l p r o c e d ur e s in p e o p le w it h h e m o p h ilia . Jo in t s u r g e r y m a y b e ind ic a t e d in s o m e c a s e s o f c hr o nic s y no v it is o r a r t h r o p a t h y . V a r io u s p r o c e d u r e s m a y b e o f f e r e d , inc lud in g : A 2 0 1 6 m e t a - a n a ly s is o f s t u d ie s e v a lua t ing t he r o le o f t o t a l k ne e a r t hr o p la s t y (T K A ) in p e o p le w it h h e m o p h ilia r e v ie w e d o u t c o m e s o f 3 3 6 p r o c e d u r e s in 2 5 4 ind iv id ua ls a nd f o und a n o v e r a ll im p r o v e m e n t in r a n g e o f m o t io n , a lt ho ug h no t a s g r e a t a s t ha t o f ind iv id ua ls w it ho ut h e m o p h ilia [3 3 ]. T h e c o m p lic a t io n r a t e w a s 3 2 p e r c e nt; c o m m o n c o m p lic a t io ns inc lud e d in f e c t io n s , b le e d in g , a n d b o n e a b n o r m a lit ie s . T his e m p ha s iz e s t he im p o r t a nc e o f b o ne he a lt h a n d m a in t a in in g o p t im a l b o n e d e n s it y . I n d iv id u a ls w it h h e m o p h ilia c a n u n d e r g o a ny t y p e o f m a jo r s ur g e r y (e g , c a nc e r s ur g e r y , c o r o n a r y a r t e r y b y p a s s g r a f t in g [C A B G ]) a s lo ng a s f a c t o r r e p la c e m e n t is g iv e n a nd a d e q ua t e h e m o s t a s is e n s u r e d . (S e e \" C h r o n ic c o m p lic a t io n s a n d a g e - r e la t e d c o m o r b id it ie s in p e o p le w it h h e m o p h ilia \" , s e c t io n o n 'C a n c e r ' a n d \" C h r o n ic c o m p lic a t io n s a n d a g e - r e la t e d c o m o r b id it ie s in p e o p le w it h h e m o p h ilia \" , s e c t io n o n 'C a r d io v a s c ula r d is e a s e '.) T h e t a r g e t f a c t o r a c t iv it y le v e l a n d d ur a t io n o f t he r a p y a r e ind iv id ua liz e d a c c o r d ing t o t he p a t ie n t a n d p r o c e d u r e . M o s t r e c o m m e n d a t io ns, inc lud in g t he 2 0 2 0 W o r ld F e d e r a t io n o f S y n o v e c t o m y , e it h e r is o t o p ic o r s ur g ic a l, f o r r e c ur r e nt b le e d ing● Jo in t r e p la c e m e n t o r jo in t f u s io n f o r e x t e nsiv e jo int d a m a g e● H e m o p h ilia g u id e lin e , u s e a d e s ir e d p r e o p e r a t iv e f a c t o r le v e l f o r m a jo r s ur g e r y o f 8 0 t o 1 0 0 p e r c e n t f o r h e m o p h ilia A a n d 6 0 t o 8 0 p e r c e nt f o r he m o p hilia B , w it h p o s t o p e r a t iv e le v e ls g r a d u a lly t a p e r in g t o a p p r o x im a t e ly 5 0 p e r c e nt until t he w o und is he a le d (t y p ic a lly o v e r a p e r io d o f 1 0 t o 1 4 d a y s ) [1 ]. F o r w o u n d o r jo in t m a n ip u la t io n , a le v e l o f a t le a s t 5 0 p e r c e nt is n e c e s s a r y . D o s in g t o a c h ie v e t h e a p p r o p r ia t e f a c t o r le v e l, inc lud in g c a lc ula t io ns f o r b o lus d o s ing o r c o n t in u o u s in f u s io n , w h ic h m a y p r o v id e m o r e c o nsis t e nt f a c t o r le v e ls a nd r e d uc e f a c t o r usa g e , is d e s c r ib e d a b o v e . (S e e 'A c u t e t h e r a p y f o r b le e d in g ' a b o v e .) C i r c u m c i s i o n  — C ir c u m c is io n is a n im p o r t a n t d e c is io n f o r s o m e f a m ilie s / c a r e g iv e r s a nd is o f r e lig io u s s ig n if ic a n c e f o r c e r t a in p o p u la t io ns s uc h a s M u s lim s . C ir c um c is io n in t he ne o na t a l p e r io d is o f t e n t h e f ir s t h e m o s t a t ic c ha lle ng e in a n ind iv id ua l w it h he m o p hilia , a nd in s o m e c a s e s t h e f ir s t c lu e t o t h e d ia g n o s is . A ll ind iv id ua ls f o r w ho m t he d ia g no s is o f he m o p hilia is p o s s ib le b a s e d o n f a m ily h is t o r y s h o uld ha v e f a c t o r a c t iv it y t e s t ing w it h r e s ult s o b t a ine d a nd d is c u s s e d w it h a h e m o p h ilia t r e a t m e n t c e nte r he m a t o lo g is t b e f o r e a c ir c um c is io n is p e r f o r m e d . (S e e \" C lin ic a l m a n if e s t a t io n s a n d d ia g n o s is o f he m o p hilia \" , s e c t io n o n 'N e o na t a l d ia g no s is '.) I f t h e d ia g n o s is o f h e m o p h ilia is c o nf ir m e d a nd t he f a m ily / c a r e g iv e r s r e q ue s t c ir c um c is io n, t he f o llo w in g is a d v is e d : T h e u s e o f p r e o p e r a t iv e f a c t o r is in d iv id ua liz e d . A t o ur c e nte r, w e g e n e r a lly d o no t a d m in is t e r f a c t o r p r io r t o t h e p r o c e d u r e if c ir c um c is io n is p e r f o r m e d v ia a m e t ho d s uc h a s t h e P la s t ib e ll d e v ic e b e c a u s e b le e d in g is g e n e r a lly no t e x c e s s iv e . H o w e v e r, w e e nsur e t ha t r e p la c e m e n t f a c t o r is a v a ila b le a t t he t im e o f t he p r o c e d u r e s ho uld it b e ne e d e d . ● I f a n e s t h e s ia is n e e d e d b e f o r e a p e nile b lo c k , f a c t o r m a y b e a d m inis t e r e d b e f o r e ha nd . I f c ir c u m c is io n is p e r f o r m e d v ia a m e t ho d s uc h a s a t he G o m c o c la m p , t he n o ne d o s e o f r e p la c e m e n t t h e r a p y (t h e s m a lle s t v ia l s iz e a v a ila b le ) is a d m inis t e r e d p r io r t o t he p r o c e d u r e ; in a d d it io n , lo c a l h e m o s t a t ic t he r a p ie s m a y b e use d a nd t he f a m ily / c a r e g iv e r is e d u c a t e d t o a s s u r e t h e w o u n d is no t d is r up t e d . (S e e \" N e o n a t a l c ir c u m c is io n : Te c h n iq u e s \" , s e c t io n o n ' Te c h n iq u e s '.) O b s e r v a t io n p o s t - p r o c e d u r e is lik e ly t o r e q u ir e a lo ng e r p e r io d t ha n use d f o r ne o na t e s w it h o u t h e m o p h ilia . I f p o s t o p e r a t iv e b le e d ing o c c ur s , f u r t he r o r init ia l r e p la c e m e nt t h e r a p y is r e q u ir e d a s w e ll a s u s e o f lo c a l he m o s t a t ic a g e n t s . P r o lo ng e d b le e d ing m a y r e q u ir e a d d it io n a l d o s e s . ● F o r t h e m o s t p a r t , p r a c t ic e is b a s e d o n c linic a l e x p e r ie nc e r a t he r t ha n e v id e nc e f r o m r a n d o m iz e d t r ia ls . T h e v a r ia t io n in p r a c t ic e a m o n g e x p e r t s is illustr a t e d in t he f o llo w ing : F ib r in g lu e (a ls o c a lle d f ib r in s e a la n t ) c o m e s a s a k it m a d e f r o m p la s m a - d e r iv e d c lo t t ing p r o t e in s t h a t is a p p lie d t o t h e e x t e r na l s ur f a c e o f a w o und a s a s p r a y o r p a t c h. T he p r o d u c t s c o n t a in c o n c e n t r a t e d f ib r ino g e n (t he p r e c ur s o r o f f ib r in) a nd c o a g ula t io n f a c t o r X I I I , w h ic h c r o s s lin k s f ib r in . F ib r in s e a la nt c a n b e use d f o r t ho s e w it h he m o p hilia w it h b le e d in g t h a t c a n n o t b e c o n t r o lle d w it h lo c a l m e a s ur e s . T his p r o d u c t le s s e ns t he ne e d f o r f a c t o r r e p la c e m e n t a n d is n o t a s s o c ia t e d w it h s o m e o f t he r is k s a nd e x p e nse o f f a c t o r a d m in is t r a t io n [3 4 ]. S p e c if ic p r o d u c t s a n d t h e ir u s e s a r e d is c usse d in m o r e d e t a il s e p a r a t e ly . (S e e \" F ib r in s e a la n t s \" .) ● G e la t in g r a n u le s a n d o t h e r t o p ic a l a g e n t s c a n a ls o b e use d . (S e e \" O v e r v ie w o f t o p ic a l h e m o s t a t ic a g e n t s a n d t is s u e a d h e s iv e s \" , s e c t io n o n 'G e la t in m a t r ix ' a n d \" O v e r v ie w o f t o p ic a l h e m o s t a t ic a g e n t s a n d t is s ue a d h e s iv e s \" , s e c t io n o n ' To p ic a l t hr o m b in '.) A n t if ib r in o ly t ic a g e n t s s u c h a s t r a n e x a m ic a c id o r e p s ilo n a m in o c a p r o ic a c id r e d u c e b le e d in g b y in t e r f e r in g w it h f ib r in o ly s is a nd t hus r e d u c ing c lo t b r e a k d o w n; t he y c a n b e u s e d o r a lly o r in t r a v e n o u s ly . I n o u r e x p e r ie nc e , t he s e a g e n t s a r e le s s e f f e c t iv e a s a s ing le a g e n t in c ir c u m c is io n . (S e e 'A n t if ib r in o ly t ic t h e r a p y f o r m u c o s a l b le e d ing o r s ur g e r y ' b e lo w .) ● T h e p r o c e d u r e s h o u ld b e p e r f o r m e d s o t ha t t he r is k o f b le e d ing is m inim iz e d (e g , e x p e r ie n c e d h a n d s , u s e o f P la s t ib e ll d e v ic e if a v a ila b le ). T his a nd o t he r t e c hniq ue s a r e d is c u s s e d s e p a r a t e ly . (S e e \" N e o n a t a l c ir c u m c is io n : Te c h n iq u e s \" , s e c t io n o n ' Te c hniq u e s '.) ● A 2 0 1 5 s u r v e y o f p e d ia t r ic h e m a t o lo g is t s a f f ilia t e d w it h he m o p hilia t r e a t m e nt c e nte r s (H T C s ) in t h e U n it e d S t a t e s d o c u m e nte d a w id e r a ng e o f a p p r o a c he s a m o ng 6 4 r e s p o n d e n t s a n d la c k o f e s t a b lis h e d p r o t o c o ls in m o s t c a s e s [3 5 ]. ● A l l r e s p o n d e n t s s t a t e d t h e y w o u ld u s e a t le a s t o n e d o s e o f f a c t o r b e f o r e t he p r o c e d u r e ; a p p r o x im a t e ly o n e - t h ir d use d t w o o r t hr e e d o s e s ; a nd a n a d d it io na l 1 2 (1 9 p e r c e n t ) u s e d m o r e p r o lo n g e d t h e r a p y . • M a jo r c o n c e r n s in c lu d e d t h e r is k s o f b le e d ing a nd inhib it o r d e v e lo p m e nt a f t e r e a r ly e x p o s u r e t o r e p la c e m e n t p r o d u c t . • T w o r e s p o n d e n t s (3 p e r c e n t ) w o u ld no t a llo w t he p r o c e d u r e unle s s t he r e w a s a ur o lo g ic in d ic a t io n , 1 8 (2 8 p e r c e n t ) w o u ld p e r f o r m t he p r o c e d u r e a t t he t im e o f a no t he r • A d d it io n a l in f o r m a t io n a b o u t r is k s a nd b e n e f it s o f c ir c um c is io n, m e t ho d s f o r a na lg e s ia , a nd c o m p lic a t io n s a r e p r e s e n t e d s e p a r a t e ly . (S e e \" N e o n a t a l c ir c u m c is io n : R is k s a n d b e n e f it s \" a n d \" N e o n a t a l c ir c u m c is io n : Te c h n iq u e s \" a n d \" C o m p lic a t io n s o f c ir c u m c is io n \" .) To n s i l l e c t o m y  — To n s ille c t o m y is a h ig h - r is k p r o c e d ur e in ind iv id ua ls w it h he m o p hilia . I n p a r t ic u la r, t h e r is k o f b le e d in g f r o m t o nsille c t o m y m a y b e e s p e c ia lly c o nc e r ning b e c a use t he b le e d in g m a y b e n o t o n ly o r a l b u t a ls o r e t r o p h a r y ng e a l; t he la t t e r m a y b e a s s o c ia t e d w it h a ir w a y c o m p r o m is e . D e la y e d b le e d ing is a s ig n if ic a nt r is k a nd c a n le a d t o hy p o t e nsio n a nd s h o c k . D u e t o t h e lo c a t io n o f p o t e n t ia l b le e d ing , a t t e ntio n t o he m o s t a s is is e s p e c ia lly im p o r t a nt. p r o c e d u r e t h a t r e q u ir e d f a c t o r a d m in is t r a t io n, a nd 2 0 (3 1 p e r c e nt) w o uld d e f e r t he p r o c e d u r e u n t il t h e c h ild w a s o ld e r. T h e r e m a in in g 2 4 (3 8 p e r c e n t ) w o u ld p e r f o r m t he p r o c e d u r e (s o m e r e luc t a ntly ).• M o s t u s e d a t a r g e t f a c t o r le v e l o f a p p r o x im a t e ly 7 5 p e r c e nt; o f t e n a le v e l o f 1 0 0 p e r c e nt o r h ig h e r is u s e d b e c a u s e t h e s m a lle s t v ia l s iz e p r o v id e s t his le v e l f o r a s m a ll inf a nt, a nd t h e e n t ir e v ia l is g iv e n s o a s n o t t o w a s t e t he p r o d u c t . • A p p r o x im a t e ly o n e - t h ir d u s e d a n t if ib r ino ly t ic t he r a p y , a nd s m a lle r num b e r s use d f ib r in g lu e , t o p ic a l t h r o m b in , g e la t in s p o n g e , o r w o u n d s e a l. • A 2 0 0 9 r e v ie w a n d s u r v e y c o n d u c t e d b y t he E ur o p e a n H a e m o p hilia T he r a p y S t a n d a r d iz a t io n B o a r d (E H T S B ) id e ntif ie d s ix s t ud ie s inv o lv ing 1 6 3 p a t ie nts w it h h e m o p h ilia w h o u n d e r w e n t c ir c u m c is io n [3 6 ]. F iv e o f t h e s t u d ie s u s e d f a c t o r r e p la c e m e n t p lu s lo c a l t h e r a p y (f ib r in g lu e , a n t if ib r ino ly t ic a g e n t s ) a nd o ne use d a ntif ib r ino ly t ic a g e nts a lo n e . Ta r g e t f a c t o r le v e ls w h e n r e p o r t e d w e r e in t he r a ng e o f 3 0 t o 6 0 p e r c e nt. T he s ur v e y o f e x p e r t s s u g g e s t e d a t a r g e t f a c t o r a c t iv it y le v e l o f 8 0 p e r c e nt f o r t hr e e t o f o ur d a y s , w it h a d ju n c t iv e f ib r in g lu e a n d / o r a n t if ib r ino ly t ic t he r a p y . ● F a c t o r r e p l a c e m e n t – F a c t o r r e p la c e m e n t is u s e d f o r t h o s e w it h s e v e r e o r m o d e r a t e , a nd o f t e n m ild h e m o p h ilia , t y p ic a lly f o r a p r o lo ng e d p e r io d o f a t le a s t s e v e r a l d a y s o r lo ng e r (1 4 d a y s is c o m m o n ), s in c e t h e r is k o f b le e d ing c o ntinue s until t he e s c ha r f a lls o f f. ● D o s in g t o a c h ie v e t h e a p p r o p r ia t e f a c t o r le v e l, inc lud in g c a lc ula t io ns f o r b o lus d o s ing o r c o n t in u o u s in f u s io n , w h ic h m a y p r o v id e m o r e c o nsis t e nt f a c t o r le v e ls a nd r e d uc e f a c t o r u s a g e , is d e s c r ib e d a b o v e . (S e e 'A c u t e t h e r a p y f o r b le e d in g ' a b o v e .) A n t i f i b r i n o l y t i c a g e n t – A n a n t if ib r in o ly t ic a g e n t is a lw a y s use d . T he d u r a t io n m a y c o n t in u e u n t il t h e e s c h a r f a lls o f f, w hic h c a n o c c ur a t d a y 1 2 o r e v e n la t e r. ● D e n t a l p r o c e d u r e s  — D if f e r e n t d e n t a l p r o c e d u r e s a r e a s s o c ia t e d w it h d if f e r e nt b le e d ing r is k s . C lo s e c o n s u lt a t io n b e t w e e n t h e d e ntis t a nd he m o p hilia t r e a t m e n t c e nte r p r io r t o t he p r o c e d ur e is a d v is e d . A s u m m a r y o f r e c o m m e n d a t io ns f r o m t he U nit e d K ing d o m H a e m o p hilia C e nte r D o c t o r s ' O r g a n iz a t io n (U K H C D O ) in 2 0 1 3 inc lud e d t he f o llo w in g r e c o m m e nd a t io ns, la r g e ly b a s e d o n lo w q u a lit y e v id e n c e [3 7 ]: I n d i c a t i o n s f o r f a c t o r a d m i n i s t r a t i o n● I n f e r i o r d e n t a l b l o c k – F o r c h ild r e n a n d a d u lt s w it h h e m o p h ilia und e r g o in g inf e r io r d e n t a l b lo c k s , f a c t o r r e p la c e m e n t t o a le v e l o f 5 0 p e r c e nt a c t iv it y d u r ing t he p r o c e d ur e is r e q u ir e d . T h e d o s e o f f a c t o r s h o uld b e a d m inis t e r e d a s c lo s e t o t he p r o c e d ur e a s p o s s ib le . • I m p a c t e d w i s d o m t e e t h – S e r io u s r is k s a r e a s s o c ia t e d w it h e x t r a c t io n o f im p a c t e d m a n d ib u la r t h ir d m o la r s (w is d o m t e e t h), d u e t o t he p o t e ntia l f o r r e t r o p ha r y ng e a l b le e d in g a n d a ir w a y c o m p r o m is e . • L o c a l a n e s t h e s i a• C h i l d r e n , m o d e r a t e t o s e v e r e h e m o p h i l i a – F o r c h ild r e n w it h m o d e r a t e t o s e v e r e h e m o p h ilia , f a c t o r le v e ls m a y r a r e ly ne e d t o b e r a is e d f o r lo c a l a ne s t he t ic in f ilt r a t io n . - A d u l t s , m o d e r a t e t o s e v e r e h e m o p h i l i a – F o r a d u lt s w it h m o d e r a t e t o s e v e r e h e m o p h ilia , c e r t a in d e n t a l p r o c e d ur e s m a y no t r e q u ir e f a c t o r inf u s io n; e x a m p le s in c lu d e b u c c a l in f ilt r a t io n , in t e r - p a p illa r y inje c t io n, e nd o d o ntic (r o o t c a na l) t r e a t m e n t , a n d in t r a - lig a m e n t a r y inje c t io ns. H o w e v e r, w e d o ha v e p a t ie nts inf use f a c t o r f o r lo w e r p o s t e r io r r o o t c a n a ls . F o r a d u lt s und e r g o in g d e n t a l e x t r a c t io ns, t he u s e o f s u t u r e s a n d t o p ic a l h e m o s t a t ic g e la t in m a t r ic e s o r c y a no a c r y la t e t is s ue a d h e s iv e s m a y m in im iz e b le e d in g . (S e e \" O v e r v ie w o f t o p ic a l h e m o s t a t ic a g e nts a nd t is s u e a d h e s iv e s \" , s e c t io n o n 'G e la t in m a t r ix ' a n d \" M in o r w o u n d r e p a ir w it h t is s u e a d h e s iv e s (c y a n o a c r y la t e s )\" .) - Ta r g e t f a c t o r l e v e l – F o r c h ild r e n a n d a d u lt s w it h h e m o p h ilia und e r g o in g d e n t a l p r o c e d u r e s t h a t r e q u ir e f a c t o r r e p la c e m e n t , a t a r g e t f a c t o r le v e l a b o v e 5 0 p e r c e nt f o r o ne t o t w o d a y s is u s u a lly s u f f ic ie n t . T h is o f t e n c a n g e n e r a lly b e a c hie v e d w it h o ne inf usio n o f f a c t o r p lu s a n t if ib r in o ly t ic t h e r a p y . F a c t o r inf u s io ns s ho uld b e s c he d u le d in s uc h a w a y t ha t t h e n u m b e r o f in f u s io n s is m in im iz e d . D o s ing t o a c hie v e t he a p p r o p r ia t e f a c t o r le v e l is d e s c r ib e d a b o v e . (S e e 'A c u t e t h e r a p y f o r b le e d in g ' a b o v e .) ● E n d o s c o p y  — D u e t o t h e lo c a t io n o f p o t e n t ia l b le e d in g , a t t e ntio n t o he m o s t a s is is e s p e c ia lly im p o r t a n t . S P EC I A L P O P U L A T I O N S M i l d h e m o p h i l i a – F o r c h ild r e n a n d a d u lt s w it h m ild he m o p hilia (f a c t o r a c t iv it y le v e l a b o v e 5 p e r c e n t ), t h e m a jo r it y o f n o n - s u r g ic a l d e n t a l p r o c e d u r e s c a n b e p r o v id e d b y t he p e d ia t r ic a n d a d u lt d e n t is t s w it h o u t a d d it io n a l inte r v e ntio ns. E x c e p t io ns inc lud e b lo c k inje c t io ns a s n o t e d a b o v e . P e r io d o n t it is a n d g ing iv a l inf la m m a t io n inc r e a s e t he r is k o f b le e d ing . ● A n t i f i b r i n o l y t i c t h e r a p y – A n t if ib r in o ly t ic a g e n t s (e g , t r a n e x a m ic a c id , e p s ilo n a m in o c a p r o ic a c id ) a r e v e r y u s e f u l f o r o r a l p r o c e d u r e s b e c a use f ib r ino ly s is is hig h ly a c t iv e o n m u c o s a l s u r f a c e s . T h e s e c a n b e g iv e n o r a lly , intr a v e no usly , o r a s a m o uthw a s h; t he m o u t h w a s h s h o u ld b e r e s t r ic t e d t o o ld e r c hild r e n a nd a d u lt s b e c a use it m a y b e in a d v e r t e n t ly s w a llo w e d b y y o u n g e r c hild r e n (s e e 'A n t if ib r in o ly t ic t h e r a p y f o r m u c o s a l b le e d in g o r s u r g e r y ' b e lo w ). A n t if ib r in o ly t ic a g e n t s c a n a ls o b e s a f e ly c o m b ine d w it h f a c t o r r e p la c e m e n t ; c a r e s h o u ld b e t a k e n w he n c o - a d m inis t e r e d w it h F E I B A [3 8 ]. A t y p ic a l r e g im e n is t o g iv e t h e f ir s t d o s e o f t he a ntif ib r ino ly t ic a g e n t t w o ho ur s b e f o r e t he p r o c e d u r e a n d c o n t in u e f o r u p t o 7 t o 1 0 d a y s p o s t - p r o c e d u r e . ● M o d e r a t e t o s e v e r e h e m o p h i l i a – F a c t o r r e p la c e m e n t is u s e d f o r ind iv id ua ls w it h m o d e r a t e t o s e v e r e h e m o p h ilia A o r B und e r g o in g e nd o s c o p y . M o r e t ha n o ne inf usio n o f f a c t o r m a y b e r e q u ir e d . ● M i l d h e m o p h i l i a● F o r m ild h e m o p h ilia A , D D A V P m a y b e s uf f ic ie nt b a s e d o n t he p a t ie nt 's f a c t o r le v e l a nd r e s p o n s e ; r e s p o n s e t o D D A V P n e e d s t o b e d o c u m e n t e d b e f o r e t his a p p r o a c h is use d . (S e e \" v o n W ille b r a n d d is e a s e (V W D ): T r e a t m e n t o f m in o r b le e d ing , use o f D D A V P, a nd r o u t in e p r e v e n t iv e c a r e \" , s e c t io n o n 'D D A V P t r ia l'.) • F o r m ild h e m o p h ilia B , f a c t o r r e p la c e m e nt is use d .• D o s in g t o a c h ie v e t h e a p p r o p r ia t e f a c t o r le v e l, inc lud in g c a lc ula t io ns f o r b o lus d o s ing o r c o n t in u o u s in f u s io n , w h ic h m a y p r o v id e m o r e c o nsis t e nt f a c t o r le v e ls a nd r e d uc e f a c t o r u s a g e , is d e s c r ib e d a b o v e . (S e e 'A c u t e t h e r a p y f o r b le e d in g ' a b o v e .) A n t i f i b r i n o l y t i c t h e r a p y – I f b io p s ie s a r e t a k e n , p o s t p r o c e d ur a l a ntif ib r ino ly t ic t he r a p y s h o u ld b e c o n s id e r e d . (S e e \" G a s t r o in t e s t in a l e n d o s c o p y in p a t ie nts w it h d is o r d e r s o f h e m o s t a s is \" .) ● P a t i e n t s w i t h h e m o p h i l i a A r e c e i v i n g e m i c i z u m a b  — I n d iv id u a ls w it h h e m o p h ilia A w h o a r e r e c e iv in g e m ic iz u m a b , a b is p e c if ic m o n o c lo n a l a n t ib o d y (m A b ) t ha t s ub s t it ute s f o r t he f u nc t io n o f f a c t o r V I I I in h e m o s t a s is ( f ig u r e 1 ), h a v e a n u m b e r o f c o n s id e r a t io n s r e la t e d t o t r e a t m e n t o f b le e d in g o r s u r g e r y . E m ic iz u m a b ha lf - lif e is v e r y lo ng ; t he m A b r e m a ins in t he p a t ie nt f o r a s lo n g a s s ix m o n t h s a f t e r d is c o n t in ua t io n. (S e e \" H e m o p h ilia A a n d B : R o u t in e m a na g e m e nt in c lu d in g p r o p h y la x is \" , s e c t io n o n 'E m ic iz um a b f o r he m o p hilia A '.) A h e m o p h ilia t r e a t m e n t c e n t e r s h o uld b e c o nsult e d t o e nsur e t ha t t he s e a r e t a k e n into a c c o unt w h e n d e t e r m in in g t h e t r e a t m e n t p la n. P a t i e n t s w i t h o u t i n h i b i t o r s – E m ic iz u m a b is n o t u s e d f o r a c u t e b le e d in g ; f a c t o r V I I I r e p la c e m e n t is r e q u ir e d . F o r in d iv id u a ls r e c e iv ing e m ic iz um a b w ho d o no t ha v e a f a c t o r V I I I in h ib it o r, f a c t o r d o s in g is s im ila r t o o t he r he m o p hilia A p a t ie nts w it ho ut inhib it o r s , w it h t h e c a v e a t t h a t m e a s u r e m e n t o f f a c t o r V I I I a c t iv it y r e q u ir e s a b o v ine s ub s t r a t e - b a s e d f a c t o r V I I I a s s a y . F o r t h o s e w h o r e q uir e f a c t o r inf u s io ns, t he c a lc ula t io ns f o r d o s ing g e n e r a lly a s s u m e t h a t t h e p a t ie n t is a t t he ir b a s e line le v e l (ie , c a lc ula t io ns s ho uld b e t he s a m e a s f o r a n y o t h e r p a t ie n t s ). C o nsult a t io n w it h a he m o p hilia e x p e r t o r t he lo c a l h e m o p h ilia t r e a t m e n t c e n t e r is a d v is e d . (S e e 'A c u t e t h e r a p y f o r b le e d in g ' a b o v e a n d 'C h e c k t h e f a c t o r le v e l' a b o v e .) ● R e p o r t s d e s c r ib in g s u r g e r y in in d iv id u a ls w it h he m o p hilia A r e c e iv ing e m ic iz u m a b w h o r e q u ir e s u r g e r y h a v e d o c u m e n t e d t ha t m in o r s ur g e r y m a y no t r e q u ir e f a c t o r r e p la c e m e nt a n d m a jo r s u r g e r y o r m in o r s u r g e r y w it h p e r s is t e nt b le e d ing m a y b e e f f e c t iv e ly t r e a t e d w it h f a c t o r V I I I [3 9 ,4 0 ]. N e e d f o r b o v i n e s u b s t r a t e - b a s e d f a c t o r V I I I a c t i v i t y a s s a y – E m ic iz u m a b in t e r f e r e s w it h t h e a s s a y f o r f a c t o r V I I I a c t iv it y b a s e d o n t he a c t iv a t e d p a r t ia l t hr o m b o p la s t in t im e (a P T T ). A s t a n d a r d a P T T - b a s e d a s s a y f o r f a c t o r V I I I a c t iv it y c a n n o t b e u s e d b e c a u s e it is f a ls e ly n o r m a liz e d / e le v a t e d b y e m ic iz u m a b . A b o v in e s ub s t r a t e - b a s e d c hr o m o g e nic a s s a y f o r f a c t o r V I I I a c t iv it y m u s t b e u s e d [2 0 ]. ● I n h i b i t o r p a t i e n t s – E m ic iz u m a b is n o t u s e d f o r a c u t e b le e d in g ; p a t ie nts w it h hig h r e s p o n d in g f a c t o r V I I I in h ib it o r s r e q u ir e a b y p a s s ing a g e n t t o t r e a t c linic a lly r e le v a nt b le e d in g , a n d f o r p a t ie n t s o n e m ic iz u m a b , r F V I I a is r e c o m m e nd e d . F o r p a t ie nts r e c e iv ing a b y p a s s in g a g e n t , d o s in g c o n s id e r a t io ns ne e d t o b e f o llo w e d t o a v o id t he p o t e ntia l r is k o f t h r o m b o t ic m ic r o a n g io p a t h y (T M A ). R e c o m b in a nt a c t iv a t e d f a c t o r V I I (r F V I I a ) is t he r e c o m m e n d e d f ir s t - lin e t r e a t m e n t f o r b r e a k t hr o ug h b le e d ing in p a t ie nts w it h he m o p hilia A w it h h ig h r e s p o n d in g o r h ig h t it e r inhib it o r s w ho a r e r e c e iv ing e m ic iz um a b . (S e e 'H ig h t it e r o r h ig h r e s p o n d in g in h ib it o r - U s e a b y p a s s ing p r o d u c t (r F V I I a o r F E I B A )' b e lo w .) ● I n h i b i t o r s O v e r v i e w o f p a t i e n t w i t h a n i n h i b i t o r  — M a n a g e m e n t o f b le e d in g o r s u r g e r y in a p a t ie nt w it h a n in h ib it o r (n e u t r a liz in g a llo a n t ib o d y a g a inst inf u s e d f a c t o r ) is e s p e c ia lly c ha lle ng ing b e c a u s e in h ib it o r s b in d t o t h e in f use d f a c t o r a nd r e nd e r it ine f f e c t iv e . I nhib it o r s a r e m uc h m o r e lik e ly t o o c c u r in in d iv id u a ls w it h h e m o p hilia A a nd t ho s e w it h s e v e r e d is e a s e . S o m e p a t ie nts m a y o n ly b e c o m e a w a r e t h a t t h e y h a v e a n inhib it o r in t he m id s t o f a n a c ute b le e d ing e p is o d e o r s u r g e r y , w h e n f a c t o r in f u s io n s n o lo ng e r r a is e f a c t o r a c t iv it y le v e ls t o t he e x p e c t e d r a ng e o r if t h e r e is a n a lle r g ic / a n a p h y la c t ic r e a c t io n t o t he inf u s io n, a s s e e n in s o m e p a t ie nts w it h f a c t o r I X d e f ic ie n c y . (S e e \" I n h ib it o r s in h e m o p h ilia : M e c h a n is m s , p r e v a le nc e , d ia g n o s is , a nd e r a d ic a t io n \" .) A n y p a t ie n t w it h a n in h ib it o r is b e s t t r e a t e d in c o nsult a t io n w it h a c o m p r e he nsiv e he m o p hilia t r e a t m e n t c e n t e r, e s p e c ia lly w h e n a d e c is io n is b e in g m a d e t o a d m inis t e r t he f a c t o r in w hic h t h e y a r e d e f ic ie n t r a t h e r t h a n t o u s e b y p a s s ing t he r a p y . T his is p a r t ic ula r ly t r ue f o r ind iv id ua ls r e c e iv in g e m ic iz u m a b . (S e e 'P a t ie n t s w it h h e m o p h ilia A r e c e iv ing e m ic iz um a b ' a b o v e .) P r o t o c o ls f o r m a n a g in g in h ib it o r s s ho uld b e a v a ila b le a t e a c h instit utio n t ha t c a r e s f o r p a t ie nts w it h h e m o p h ilia . T h e lo c a l h e m o p h ilia t r e a t m e n t c e nte r c a n a s s is t in d e v e lo p ing g e ne r a l p r o t o c o ls a n d p r o t o c o ls f o r s p e c if ic p a t ie nts. (S e e \" H e m o p h ilia A a n d B : R o u t in e m a na g e m e nt in c lu d in g p r o p h y la x is \" , s e c t io n o n 'H e m o p h ilia t r e a t m e n t c e nte r s '.) M a n a g e m e n t o f b le e d in g o r s u r g e r y in p a t ie nts w it h inhib it o r s d e p e nd s o n t he s e v e r it y o f b le e d in g a n d t h e t y p e a n d t it e r o f t he inhib it o r [7 ]. I n h ib it o r s a r e d ia g n o s e d a n d c la s s if ie d b y t it e r u s in g t h e B e t h e s d a a s s a y , in w hic h s e r ia l d ilu t io n o f p a t ie nt p la s m a is use d t o d e t e r m ine a n T M A h a s o c c u r r e d w h e n t h e a c t iv a t e d p r o t h r o m b in c o m p le x c o n c e ntr a t e (a P C C ) F E I B A is u s e d a t d o s e s > 1 0 0 u n it s / k g w it h in a 2 4 - ho ur p e r io d f o r ≥ 2 4 ho ur s . P r e s c r ib ing in f o r m a t io n f o r e m ic iz u m a b c a r r ie s a B o x e d W a r n in g f o r t h is r is k [4 1 ]. I f a n a P C C is n e e d e d t o t r e a t b r e a k t h r o u g h b le e d ing w hile r e c e iv ing e m ic iz um a b (o r w it hin s ix m o n t h s o f d is c o n t in u a t io n ), t h e a P C C d o s e s ho uld b e k e p t < 1 0 0 unit s / k g in a 2 4 - ho ur p e r io d ; t h e p a t ie n t s h o u ld b e m o n it o r e d c lo s e ly f o r t hr o m b o s is a nd T M A ; a nd if o ne o f t h e s e c o m p lic a t io n s o c c u r s , t h e a P C C s ho uld b e d is c o ntinue d . • T h e r e c o m b in a n t a c t iv a t e d f a c t o r V I I (r F V I I a ) p r o d u c t N o v o S e v e n w a s no t a s s o c ia t e d w it h t h e s e t h r o m b o t ic e v e n t s o r T M A w he n use d a s t he s o le b y p a s s ing a g e nt; s im ila r d a t a f o r t h e n e w e r r F V I I a a g e n t S e v e n F a c t a r e no t a v a ila b le . • F o r t h o s e w it h lo w t it e r in h ib it o r s (< 5 B U ), it m a y b e p o s s ib le t o t r e a t w it h hig h d o s e s o f f a c t o r V I I I t o o v e r c o m e t h e in h ib it o r. (S e e 'L o w t it e r in h ib it o r - H ig h - d o s e f a c t o r inf u s io n is a n o p t io n ' b e lo w .) in h ib it o r t it e r in B e t h e s d a u n it s (B U ). I nhib it o r s w it h a t it e r o f < 5 B U d e s p it e r e p e a t e d f a c t o r in f u s io n s a r e r e f e r r e d t o a s lo w - r e s p o n d in g inhib it o r s [4 2 ]. A n y in h ib it o r ≥ 5 B U / m L a t a n y t im e is c o n s id e r e d h ig h r e s p o n d in g , e v e n if t he t it e r s ub s e q u e ntly b e c o m e s und e t e c t a b le d ue t o la c k o f r e - e x p o s u r e . C la s s ic a lly , h ig h - r e s p o n d in g inhib it o r s r a p id ly inc r e a s e up o n r e - e x p o s ur e t o in f u s e d f a c t o r in a n a n a m n e s t ic r e s p o n s e t ha t t a k e s f o u r t o s e v e n d a y s . (S e e \" I n h ib it o r s in h e m o p h ilia : M e c h a n is m s , p r e v a le nc e , d ia g n o s is , a nd e r a d ic a t io n \" , s e c t io n o n ' Te r m ino lo g y a nd d e f in it io n s '.) I n d iv id u a ls w it h a n in h ib it o r t it e r o f ≥ 5 B U a nd t ho s e w it h a n unk no w n t it e r b ut w it h a k no w n h ig h - r e s p o n d in g in h ib it o r a r e le s s lik e ly t o b e e f f e c t iv e ly t r e a t e d w it h f a c t o r inf usio ns in a n e m e r g e n c y s it u a t io n b e c a u s e t h e q ua ntit y o f c ir c ula t ing a ntib o d y is lik e ly t o o g r e a t t o b e o v e r c o m e b y f a c t o r in f u s io n . O t h e r p o t e n t ia l h e m o s t a t ic t h e r a p ie s a r e und e r inv e s t ig a t io n b u t a r e no t y e t a v a ila b le f o r c lin ic a l u s e . (S e e \" H e m o p h ilia A a n d B : R o u t in e m a na g e m e nt inc lud in g p r o p h y la x is \" , s e c t io n o n 'P r o p h y la c t ic t h e r a p ie s u n d e r d e v e lo p m e nt '.) F o r p a t ie n t s w it h a h ig h - r e s p o n d in g inhib it o r w ho s e c ur r e nt t it e r is < 5 B U , it m a y b e p o s s ib le in s o m e c ir c u m s t a n c e s t o t r e a t t he m w it h f a c t o r c o v e r a g e ; t his d e c is io n s ho uld o n ly b e m a d e in c o n s u lt a t io n w it h a c o m p r e he nsiv e he m o p hilia t r e a t m e nt c e nte r a s a n a m n e s is is e x p e c t e d . ● F o r a p a t ie n t w it h a t it e r ≥ 5 B U w it h a hig h - r e s p o n d in g inhib it o r a nd s e r io us b le e d ing w it h a n e e d f o r m a jo r s u r g e r y , a b y p a s s ing p r o d u c t is use d . (S e e 'H ig h t it e r o r h ig h r e s p o n d in g in h ib it o r - U s e a b y p a s s in g p r o d u c t (r F V I I a o r F E I B A )' b e lo w .) ● I n a n e m e r g e n c y s e t t in g w h e n a p a t ie nt is r e c e iv ing f a c t o r inf u s io ns a nd f a c t o r a c t iv it y le v e l d o e s n o t in c r e a s e a t o n e h o u r p o s t - inf u s io n (o r b le e d ing d o e s no t r e s p o nd t o f a c t o r in f u s io n a n d a f a c t o r a c t iv it y le v e l o r inhib it o r t it e r is no t a v a ila b le ), t he p a t ie nt s ho uld b e t r e a t e d a s if t h e y h a v e a h ig h t it e r / hig h - r e s p o n d in g inhib it o r until inhib it o r t e s t ing w it h a B e t h e s d a a s s a y c a n b e p e r f o r m e d . T he m a in c a v e a t s a r e t ha t t he o r ig ina l he m o p hilia A o r B d ia g n o s is is c o r r e c t , t h e c o r r e c t r e p la c e m e n t f a c t o r w a s g iv e n , t he r e is no he p a r in c o n t a m in a t io n in t h e s a m p le , a n d t he a s s a y is p e r f o r m e d c o r r e c t ly (inc lud ing t he use o f a b o v in e s u b s t r a t e - b a s e d f a c t o r a s s a y in ind iv id ua ls r e c e iv ing e m ic iz u m a b ). (S e e 'H ig h t it e r o r h ig h r e s p o n d in g in h ib it o r - U s e a b y p a s s ing p r o d u c t (r F V I I a o r F E I B A )' b e lo w .) ● F o r p a t ie n t s w it h h e m o p h ilia A a n d a n inhib it o r w ho a r e r e c e iv ing e m ic iz u m a b , t h e r e is a r is k o f t h r o m b o t ic m ic r o a n g io p a t h y w he n a n a P C C is c o - a d m inis t e r e d . (S e e 'P a t ie n t s w it h h e m o p h ilia A r e c e iv in g e m ic iz u m a b ' a b o v e a n d 'H ig h t it e r o r h ig h r e s p o n d in g in h ib it o r - U s e a b y p a s s in g p r o d u c t (r F V I I a o r F E I B A )' b e lo w .) ● I n h ib it o r e r a d ic a t io n / im m u n e t o le r a nc e ind u c t io n s ho uld b e a d d r e s s e d o nc e t he p a t ie nt is s t a b le a n d t h e b le e d in g e p is o d e h a s r e s o lv e d o r a t t he t im e o f inhib it o r d e v e lo p m e nt. (S e e \" I n h ib it o r s in h e m o p h ilia : M e c h a n is m s , p r e v a le nc e , d ia g n o s is , a nd e r a d ic a t io n \" , s e c t io n o n 'I m m u n e t o le r a n c e in d u c t io n '.) H i g h t i t e r o r h i g h r e s p o n d i n g i n h i b i t o r - U s e a b y p a s s i n g p r o d u c t (r F V I I a o r F E I B A ) — A b y p a s s in g p r o d u c t is g e n e r a lly t h e f ir s t c ho ic e in a p a t ie nt w it h he m o p hilia A o r B w ho ha s a h ig h t it e r in h ib it o r a n d r e q u ir e s t r e a t m e n t f o r b le e d ing o r s ur g e r y . T he s e c lo t t ing f a c t o r p r o d u c t s c o n t a in a n a c t iv a t e d f o r m o f a c lo t t ing f a c t o r in t he c o a g u la t io n c a s c a d e . A c t iv a t e d f a c t o r V I I (f a c t o r V I I a ) c a n d ir e c t ly a c t iv a t e f a c t o r X , b y p a s s ing t he ne e d f o r f a c t o r s V I I I a nd I X . A v a ila b le p r o d u c t s in c lu d e r e c o m b in a nt hum a n f a c t o r V I I (r F V I I a ; inc lud ing N o v o S e v e n, N o v o S e v e n R T , a n d S e v e n F a c t ) a n d a c t iv a t e d p r o t h r o m b in c o m p le x c o n c e ntr a t e (a P C C ), s u c h a s F E I B A (f a c t o r e ig h t in h ib it o r b y p a s s in g a g e n t ; t he o nly a P C C a v a ila b le in m o s t s e t t ing s ) ( t a b le 4 ). T h e r F V I I a p r o d u c t s a r e a ls o a p p r o p r ia t e in ind iv id ua ls w it h he m o p hilia A w ho ha v e c r it ic a l b le e d in g w h ile r e c e iv in g e m ic iz u m a b . B o t h r F V I I a p r o d u c t s a n d F E I B A c o nta in a c t iv a t e d c lo t t ing f a c t o r s , a nd b o t h a r e e f f e c t iv e f o r h e m o s t a s is in h e m o p h ilia . F o r h e m o p hilia B w it h a n inhib it o r, r F V I I a p r o d uc t s a r e p r e f e r r e d b e c a u s e t h e y d o n o t c o n t a in f a c t o r I X ; t his is e s p e c ia lly t r ue in ind iv id ua ls w it h he m o p hilia B w it h a n in h ib it o r w h o h a v e e x p e r ie nc e d r e a c t io ns o r a na p h y la x is up o n e x p o s ur e t o f a c t o r I X . F o r h e m o p h ilia A , e it h e r p r o d u c t c a n b e use d , unle s s t he p a t ie nt is r e c e iv ing e m ic iz u m a b , in w h ic h c a s e r F V I I a is u s e d . I f t h e p a t ie n t ha s ha d a f a v o r a b le r e s p o n s e w it h o ne o f t he s e p r o d uc t s , it is r e a s o n a b le t o u s e t h e s a m e p r o d uc t a g a in. r F V I I a – T h e r e a r e t w o r F V I I a p r o d u c t s a p p r o v e d f o r ind iv id ua ls w it h he m o p hilia w it h in h ib it o r s ; t h e y h a v e d if f e r e n t p r o p e r t ie s a nd d if f e r e nt d o s ing (s e e \" R e c o m b in a n t f a c t o r V I I a : A d m in is t r a t io n a n d a d v e r s e e f f e c t s \" , s e c t io n o n 'A v a ila b le p r o d u c t s a nd t he ir p r o p e r t ie s '): ● N o v o S e v e n – D o s in g o f N o v o S e v e n in in d iv id u a ls w it h he m o p hilia is t y p ic a lly 9 0 t o 1 2 0 m c g / k g (r o u n d e d t o t h e n e a r e s t v ia l s iz e ) e v e r y t w o t o t hr e e ho ur s until he m o s t a s is is a c h ie v e d a n d a t t h r e e - t o s ix - h o u r in t e r v a ls a f t e r he m o s t a s is ha s b e e n r e s t o r e d [4 3 ]. • S e v e n F a c t – S e v e n F a c t (a r e c o m b in a n t f a c t o r V I I a p r o d u c t lic e nse d in 2 0 2 0 ) in h e m o p h ilia c a n b e d o s e d a s f o llo w s f o r ind iv id ua ls ≥ 1 2 y e a r s o f a g e ; it is no t lic e nse d f o r y o u n g e r c h ild r e n [4 4 ]: • S e v e r e b l e e d i n g – 2 2 5 m c g / k g , f o llo w e d if n e c e s s a r y s ix ho ur s la t e r w it h 7 5 m c g / k g e v e r y t w o h o u r s . - D o s in g is a d ju s t e d b a s e d o n c lin ic a l r e s p o n s e (e g , c e s s a t io n o f b le e d ing ) r a t he r t ha n la b o r a t o r y t e s t in g [4 2 ]. S t a n d a r d in t e r v a l d o s in g is g e n e r a lly c o ntinue d f o r a t le a s t 4 8 t o 7 2 ho ur s f o r s e v e r e b le e d in g o r m a jo r s u r g e r y (g e ne r a lly 7 2 ho ur s o r lo ng e r f o r m a jo r s ur g e r y ; s ho r t e r d u r a t io n s f o r m in o r s u r g e r y ), f o llo w e d b y a t a p e r in w hic h t he d o s ing inte r v a l is g r a d ua lly in c r e a s e d . I n c a s e s o f s e v e r e u n c o n t r o lle d b le e d ing , it is im p o r t a nt t o r e m e m b e r t ha t t he r a p y w it h o n e b y p a s s in g p r o d u c t m a y b e e f f e c t iv e e v e n if t he o t he r b y p a s s ing p r o d uc t ha s f a ile d . A ls o , t h e p a t ie n t m a y h a v e a s u r g ic a l, t r a um a t ic , o r a na t o m ic r e a s o n f o r c o ntinue d b le e d ing t ha t m a y n e e d t o b e a d d r e s s e d s u r g ic a lly o r e nd o s c o p ic a lly . I n r a r e c a s e s o f o ng o ing jo int b le e d ing , a r t e r ia l e m b o liz a t io n h a s b e e n u s e d [4 6 ]. A lt h o u g h F E I B A a n d / o r r F V I I a m a y b e lif e s a v ing in ind iv id ua ls w it h s e v e r e he m o p hilic b le e d ing f o r w h o m f a c t o r r e p la c e m e n t is in e f f e c t iv e , t he s e p r o d u c t s m a y b e p r o t hr o m b o t ic a nd t hus a t t e n t io n t o t h e o c c u r r e n c e o f t h is p o t e ntia l c o m p lic a t io n s ho uld b e m a inta ine d [4 7 ]. F E I B A is n o t t h e b e s t c h o ic e f o r p a t ie nts o n e m ic iz u m a b , d u e t o t h e r is k o f t h r o m b o t ic m ic r o a n g io p a t h y . I f a p a t ie n t w it h a n inhib it o r is r e c e iv ing e m ic iz um a b a nd r e q uir e s a b y p a s s ing a g e n t , r F V I I a is u s e d . (S e e 'P a t ie n t s w it h h e m o p h ilia A r e c e iv ing e m ic iz um a b ' a b o v e a n d 'I n h ib it o r s ' a b o v e .) I n t h e F E N O C (F E I B A N o v o S e v e n C o m p a r a t iv e ) t r ia l, 6 6 p a t ie nts w it h he m o p hilia A (a g e r a ng e , 8 t o 5 5 y e a r s ; m e d ia n in h ib it o r t it e r, 8 .6 B U / m L ) a nd a jo int b le e d w e r e r a nd o m ly a s s ig ne d t o r e c e iv e o n e d o s e o f F E I B A (8 5 u n it s / k g ) o r t w o d o s e s o f r F V I I a (1 0 5 m c g / k g , t w ic e ); p a t ie nts w e r e t h e n in s t r u c t e d t o u s e t h e o t h e r p r o d uc t f o r t he ir ne x t jo int b le e d [4 8 ]. P a r t ic ip a n t s w e r e in s t r u c t e d t o in it ia t e t h e t r e a t m e n t w it hin f o u r ho ur s o f b le e d ing s y m p t o m s a nd t o r e c o r d t he h e m o s t a t ic e f f ic a c y a t s e v e r a l t im e p o in t s . A t s ix ho ur s p o s t - b le e d ing , t he o v e r a ll e f f ic a c y o f F E I B A a n d r F V I I a w e r e s im ila r (8 1 a nd 7 9 p e r c e nt, r e s p e c t iv e ly ); o t he r t im e p o ints a nd e f f ic a c y M i l d t o m o d e r a t e b l e e d i n g – O n e d o s in g s t r a t e g y is 7 5 m c g / k g r e p e a t e d e v e r y t h r e e h o u r s u n t il h e m o s t a s is is a c h ie v e d . A n a lt e r na t iv e d o s ing s t r a t e g y is a n init ia l d o s e o f 2 2 5 m c g / k g , f o llo w e d if n e c e s s a r y nine ho ur s la t e r w it h a d d it io na l 7 5 m c g / k g d o s e s e v e r y t h r e e h o u r s a s ne e d e d . - F E I B A – D o s in g o f F E I B A is t y p ic a lly 5 0 t o 1 0 0 unit s / k g e v e r y 6 t o 1 2 ho ur s , no t t o e x c e e d 1 0 0 u n it s / k g / d o s e o r 2 0 0 u n it s / k g / d a y [4 5 ]. I n d iv id u a ls r e c e iv in g e m ic iz u m a b a r e a t r is k f o r t h r o m b o t ic m ic r o a n g io p a t h y (T M A ) a nd t hr o m b o s is w he n t r e a t e d w it h F E I B A ; t his is t he r e a s o n f o r a v o id in g F E I B A a t h o m e in p a t ie nts r e c e iv ing e m ic iz um a b . S p e c if ic d o s ing g u id e lin e s s h o u ld b e f o llo w e d , a n d p a t ie nts s ho uld b e m o n it o r e d f o r s ig ns a nd s y m p t o m s o f t h r o m b o s is a n d t h r o m b o t ic m ic r o a ng io p a t hy . (S e e 'P a t ie n t s w it h h e m o p h ilia A r e c e iv ing e m ic iz u m a b ' a b o v e .) ● m e a s u r e s d id n o t s h o w o n e p r o d uc t t o b e c le a r ly s up e r io r. H o w e v e r, s o m e ind iv id ua l p a t ie nts d e r iv e d g r e a t e r e f f ic a c y f r o m o n e p r o d u c t o r t he o t he r, e s p e c ia lly d u r ing t he f ir s t 1 2 ho ur s . A d d it io n a l s m a lle r r a n d o m iz e d t r ia ls ha v e a ls o f o u nd c o m p a r a b le e f f ic a c y o f F E I B A a nd r F V I I a in t r e a t in g b le e d in g [4 9 - 5 1 ]. P e r io p e r a t iv e u s e o f b y p a s s in g a g e n t s ha s a ls o b e e n r e p o r t e d t o s ho w c o m p a r a b le e f f ic a c y o f F E I B A a n d r F V I I a , a lt ho ug h t he r e is a g r e a t e r b o d y o f e x p e r ie nc e w it h r F V I I a in s u r g ic a l p a t ie n t s [7 ]. T h e r a t e o f t h r o m b o s is w it h r F V I I a (N o v o S e v e n R T ) a p p e a r s t o b e lo w w he n use d f o r t r e a t m e nt o f h e m o p h ilia w it h in h ib it o r s . T r ia ls a nd r e g is t r ie s inv o lv ing > 1 2 ,0 0 0 p a t ie nts use d t o s up p o r t lic e n s u r e f o u n d a n o v e r a ll t h r o m b o s is r a t e o f 0 .2 p e r c e nt [5 2 ,5 3 ]. a P C C s m a y b e a s s o c ia t e d w it h r e a c t io ns d u e t o a c t iv a t io n o f t he c o m p le m e nt a nd b r a d y k inin s y s t e m s w h e n in f u s e d r a p id ly , a s w e ll a s p r o t hr o m b o t ic c o m p lic a t io ns inc lud ing v e no us t h r o m b o e m b o lis m , m y o c a r d ia l in f a r c t io n, a nd d is s e m in a t e d intr a v a s c ula r c o a g ula t io n [4 7 ]. T h e s e r is k s a p p e a r t o b e g r e a t e r w he n a n a P C C is use d in t r a um a , s ur g e r y , s e r io us b le e d ing , la r g e , r e p e a t e d d o s e s , o r p r o lo n g e d a d m inis t r a t io n. I nd iv id ua ls r e c e iv ing e m ic iz u m a b h a v e a d d it io n a l r is k s in c lu d in g t h r o m b o t ic m ic r o a ng io p a t hy (T M A ) o r t hr o m b o s is w it h a P C C d o s e s > 1 0 0 / k g in a 2 4 - h o u r p e r io d . (S e e \" H e m o p h ilia A a n d B : R o u t in e m a na g e m e nt inc lud in g p r o p h y la x is \" , s e c t io n o n 'E m ic iz u m a b e f f ic a c y a nd a d v e r s e e v e nts' a n d 'P a t ie n t s w it h h e m o p h ilia A r e c e iv in g e m ic iz u m a b ' a b o v e .) I n d iv id u a ls w it h h e m o p h ilia B a n d a n inhib it o r c a n ha v e a na p h y la c t ic r e a c t io ns t o f a c t o r I X , w h ic h is p r e s e n t in a ll P C C s a n d a P C C s . r F V I I a a nd a P C C ha v e b e e n use d t o g e t he r in s o m e p a t ie n t s , b u t t h is s h o u ld o n ly b e d o ne in t he ho s p it a l b y e x p e r ie nc e d c linic ia ns a t a he m o p hilia t r e a t m e n t c e n t e r [5 4 ,5 5 ]. (S e e 'I n h ib it o r s ' a b o v e .) R e c o m b i n a n t p o r c i n e f a c t o r V I I I (h e m o p h i l i a A ) — A n o t h e r o p t io n f o r a p a t ie n t w it h h e m o p h ilia A a n d a h ig h t it e r in h ib it o r is r e c o m b in a n t p o r c in e f a c t o r V I I I (s u s o c t o c o g a lf a ; O b iz u r ), w h ic h w a s in it ia lly d e v e lo p e d f o r t r e a t ing p a t ie nts w it h a uto a ntib o d ie s t o e nd o g e no us f a c t o r V I I I (ie , a c q u ir e d f a c t o r V I I I d e f ic ie n c y [a c q u ir e d he m o p hilia A ]). (S e e \"A c q u ir e d h e m o p h ilia A (a n d o t h e r a c q u ir e d c o a g u la t io n f a c t o r inhib it o r s )\" .) T h is p r o d u c t h a s t h e t h e o r e t ic a l a d v a nta g e o f a c hie v ing he m o s t a s is w it h d e c r e a s e d c r o s s r e a c t iv it y t o t h e n e u t r a liz in g a n t ib o d ie s a g a inst hum a n f a c t o r V I I I a nd ha s b e e n use d e f f e c t iv e ly in in d iv id u a ls w it h h e m o p h ilia A a n d a n inhib it o r. H o w e v e r, c r o s s - r e a c t ing a ntib o d ie s t o r e c o m b in a n t p o r c in e f a c t o r V I I I a n d p o r c in e - s p e c if ic s e q u e n c e a n t ib o d ie s ha v e b e e n d e s c r ib e d . U s e o f r e c o m b in a n t p o r c in e f a c t o r V I I I in in h e r it e d h e m o p h ilia A is o f f - la b e l in t he U nit e d S t a t e s . ● W e r e s e r v e r e c o m b in a n t p o r c in e f a c t o r V I I I f o r p a t ie n t s w it h h e m o p h ilia A a n d lif e - t hr e a t e ning o r lim b - t h r e a t e n in g b le e d in g t h a t c a nno t b e c o ntr o lle d w it h a b y p a s s ing a g e nt. W he n use d , t he p r o d u c t is d o s e d a c c o r d in g t o t h e w e ig h t o f t he p a t ie nt a nd t he s t a nd a r d d o s ing g uid e line s f o r a c q u ir e d h e m o p h ilia A u n t il a t it e r o f a nti- p o r c ine f a c t o r V I I I a ntib o d ie s is a v a ila b le . M o nit o r ing f a c t o r V I I I le v e ls is e s s e n t ia l. S u b s e q u e nt d o s ing is g u id e d b y s t a nd a r d f a c t o r V I I I a c t iv it y le v e ls , w it h t h e e x c e p t io n o f in d iv id u a ls r e c e iv ing e m ic iz u m a b , in w h o m a b o v in e s u b s t r a t e - b a s e d f a c t o r V I I I a c t iv it y a s s a y m u s t b e u s e d d u e t o t e s t inte r f e r e nc e w it h a s t a nd a r d f a c t o r V I I I a s s a y . (S e e 'P a t ie n t s w it h h e m o p h ilia A r e c e iv ing e m ic iz um a b ' a b o v e .) P l a s m a p h e r e s i s i f a b y p a s s i n g p r o d u c t i s i n e f f e c ti v e  — P la s m a p h e r e s is m a y b e u s e f u l in p a t ie n t s w it h a h ig h t it e r in h ib it o r t o a c ute ly lo w e r t he inhib it o r t it e r a nd a llo w t r a nsie nt use o f r e p la c e m e n t f a c t o r. T h is a p p r o a c h is g e n e r a lly r e s e r v e d f o r a n ind iv id ua l w it h lif e - t hr e a t e ning o r lim b - t hr e a t e ning b le e d in g a n d a n in h ib it o r t it e r > 5 B U f o r w ho m b y p a s s ing t he r a p y is no t e f f e c t iv e o r r e c o m b in a n t p o r c in e f a c t o r V I I I is n o t a v a ila b le . D e t a ils a n d c o m p lic a t io n s a r e d is c u s s e d s e p a r a t e ly . (S e e \" T h e r a p e u t ic a p h e r e s is (p la s m a e x c h a n g e o r c y t a p h e r e s is ): I n d ic a t io n s a nd t e c hno lo g y \" a n d \" T h e r a p e u t ic a p h e r e s is (p la s m a e x c h a n g e o r c y t a p h e r e s is ): C o m p lic a t io ns\" .) L o w t i t e r i n h i b i t o r - H i g h - d o s e f a c to r i n f u s i o n i s a n o p t i o n  — A n in d iv id u a l w it h b le e d in g a n d a n in h ib it o r c a n b e t r e a t e d w it h hig h - d o s e f a c t o r inf u s io n o r a b y p a s s ing a g e nt. T he c ho ic e b e t w e e n t h e s e is in d iv id u a liz e d . R e c o m b in a n t p o r c in e f a c t o r V I I I h a s n o r o le in h e m o p h ilia B .● B y p a s s i n g a g e n t – A b y p a s s in g a g e n t m a y b e u s e d if t he inhib it o r c ha r a c t e r is t ic s (w he t he r it is h ig h o r lo w r e s p o n d in g ) a r e u n k no w n, o r in a n e m e r g e n c y w he n it m ig ht b e c h a lle n g in g t o d e t e r m in e t h e a m o unt o f f a c t o r ne e d e d t o b y p a s s t he inhib it o r. ● H i g h d o s e f a c t o r i n f u s i o n – H ig h d o s e f a c t o r in f u s io n t o o v e r c o m e t he inhib it o r m a y b e e f f e c t iv e f o r p a t ie n t s w it h h e m o p hilia A o r B a nd a lo w t it e r (< 5 B U ) o r lo w - r e s p o nd ing in h ib it o r, a s lo n g a s t h e p a t ie n t d o e s no t ha v e a n inf u s io n r e a c t io n t o t he r e p la c e m e nt f a c t o r (r e a c t io n s a r e m o s t c o m m o n ly s e e n w it h f a c t o r I X inhib it o r s ). ● H ig h - d o s e f a c t o r a ls o m a y b e u s e f u l f o r p a t ie nts w it h hig h - r e s p o n d in g inhib it o r s c ur r e ntly a t a lo w t it e r o r a t it e r lo w e r e d b y p la s m a p h e r e s is , w it h t he und e r s t a nd ing t ha t t his is o nly lik e ly t o b e e f f e c t iv e f o r a lim it e d t im e p e r io d (f o u r t o s e v e n d a y s ) a nd is lik e ly t o ind uc e a n a m n e s is [4 2 ]. F a c t o r d o s in g t o o v e r c o m e a n in h ib it o r ha s no t b e e n e s t a b lis he d f r o m p r o s p e c t iv e t r ia ls . O ne a p p r o a c h is t o a d m in is t e r t h e f u ll r e p la c e m e n t d o s e a s d e s c r ib e d f o r a p a t ie nt w it ho ut a n in h ib it o r a b o v e , p lu s a n a d d it io n a l 5 0 p e r c e nt c o r r e c t io n f o r e v e r y B U o f inhib it o r. A s a n e x a m p le , f o r a 6 0 k g p a t ie n t w it h f a c t o r V I I I d e f ic ie nc y t r e a t e d w it h a s t a nd a r d ha lf - lif e p r o d uc t s u c h a s A d v a t e a n d a n in h ib it o r o f 2 B U w ho r e q u ir e s c o r r e c t io n t o 1 0 0 p e r c e nt f a c t o r a c t iv it y , t h e p a t ie n t w o u ld b e g iv e n t h e u s u a l r e p la c e m e n t d o s e (6 0 k g x 1 0 0 x 0 .5 = 3 0 0 0 inte r na t io na l u n it s o f f a c t o r V I I I ) p lu s a n a d d it io n a l d o s e (2 B U x 6 0 k g x 5 0 x 0 .5 = 3 0 0 0 inte r na t io na l unit s o f f a c t o r V I I I ) f o r a t o t a l d o s e o f 6 0 0 0 unit s o f f a c t o r V I I I . T h is m a y b e f o llo w e d b y b o lu s d o s ing , b a s e d o n f a c t o r a c t iv it y le v e l m e a s ur e d 1 0 t o 1 5 m inute s a f t e r t h e in f u s io n is c o m p le t e d , o r b y c o ntinuo us inf u s io n, a t a s t a r t ing r a t e a d e q ua t e t o c o m p e n s a t e f o r a lt e r e d p h a r m a c o k ine t ic s b a s e d o n t he p r e s e nc e o f a n inhib it o r, w it h d o s e a d ju s t m e n t s b a s e d o n f a c t o r a c t iv it y le v e ls . B r e a k t h r o u g h b l e e d i n g d u r i n g p r o p h y l a x i s w i t h a l o n g e r - l a s ti n g f a c t o r  — S o m e p a t ie n t s u s e a lo n g e r - la s t in g f a c t o r f o r r o u t in e p r o p h y la x is o r a c ute b le e d ing a nd t hus m a y ha v e a lo n g e r - la s t in g p r o d u c t in t h e ir s y s t e m o r a v a ila b le f o r use . (S e e \" H e m o p h ilia A a n d B : R o u t in e m a n a g e m e n t in c lu d in g p r o p h y la x is \" , s e c t io n o n 'L o ng e r la s t ing r e c o m b ina nt f a c t o r V I I I ' a n d \" H e m o p h ilia A a n d B : R o u t in e m a na g e m e nt inc lud in g p r o p h y la x is \" , s e c t io n o n 'L o ng e r - la s t ing r e c o m b in a n t f a c t o r I X '.) M a n a g e m e n t o f b le e d in g is t h e s a m e a s f o r o t he r p a t ie nts, w it h f a c t o r inf usio n t o m a inta in t he f a c t o r le v e l a b o v e t h e t h r e s h o ld d e t e r m in e d ne c e s s a r y f o r t he lo c a t io n a nd s e v e r it y o f b le e d ing . T h e c a lc u la t io n s f o r d o s in g g e n e r a lly a s s um e t ha t t he p a t ie nt is a t t he ir b a s e line le v e l (ie , c a lc u la t io n s s h o u ld b e t h e s a m e a s f o r a ny o t he r p a t ie nts). (S e e 'A c u t e t h e r a p y f o r b le e d in g ' a b o v e .) F o r e le c t iv e s u r g e r y , it is b e s t t o u s e t he s a m e lo ng e r - la s t ing f a c t o r t ha t t he p a t ie nt use s a t h o m e , a s t h is s im p lif ie s c a r e a n d p o t e ntia lly s im p lif ie s is s ue s o f a d v e r s e e v e nts a nd t he d if f ic ult y in d e t e r m in in g h o w t o a s c r ib e t h e s e if c ha ng in g p r o d u c t s . I s s ue s r e la t e d t o t he use o f lo ng e r - la s t in g p r o d u c t s f o r s u r g ic a l p r o c e d u r e s a r e e s s e ntia lly t he s a m e a s f o r s t a nd a r d ha lf - lif e p r o d u c t s a n d in c lu d e u s e o f a p p r o p r ia t e m o n it o r ing a s s a y s f o r le v e ls a nd a s s ur a nc e o f a d e q u a t e h e m o s t a t ic le v e ls . U s e o f lo ng e r - la s t ing p r o d u c t s m a y r e d u c e t he num b e r o f inf usio ns n e e d e d d u r in g a n d a f t e r p r o c e d u r e s , d e p e nd in g o n t he p r o d u c t , t he p a t ie nt, a nd t he ind iv id ua l h a lf - lif e . I t is im p o r t a n t t o u s e a n a s s a y f o r f a c t o r a c t iv it y t ha t is t a ilo r e d t o t he s p e c if ic f a c t o r b e in g u s e d [1 ]. P a t i e n t w i t h m i l d h e m o p h i l i a  — I n d iv id u a ls w it h m ild h e m o p h ilia (f a c t o r le v e l b e t w e e n 5 a nd 4 9 p e r c e n t ) m a y r e q u ir e f a c t o r r e p la c e m e n t t he r a p y f o r a c ute b le e d ing , s ur g e r y , o r inv a s iv e p r o c e d u r e s . I t is im p o r t a n t t o r e m e m b e r t ha t p a t ie nts w it h m ild he m o p hilia a r e a ls o a t r is k o f in h ib it o r d e v e lo p m e n t a n d s h o u ld b e f o llo w e d c lo s e ly d u r ing t im e s o f inte nsiv e r e p la c e m e nt t h e r a p y . K n o w le d g e o f t h e s p e c if ic g e n e t ic v a r ia nt m a y he lp in p r e d ic t ing t he r is k o f inhib it o r d e v e lo p m e n t (s e e \" I n h ib it o r s in h e m o p h ilia : M e c h a n is m s , p r e v a le nc e , d ia g n o s is , a nd e r a d ic a t io n \" , s e c t io n o n 'P a t ie n t c h a r a c t e r is t ic s '). T h e s e in d iv id u a ls s h o u ld b e m a n a g e d b y e x p e r t s a n d a c a r e t e a m k n o w le d g e a b le a b o u t he m o p hilia a t a f a c ilit y w it h a c c e s s t o f a c t o r s h o u ld it b e n e e d e d , s im ila r t o t h o s e w it h m o r e s e v e r e d e f ic ie nc y . R e s o u r c e - p o o r s e t t i n g s (n o a c c e s s t o p u r i f i e d f a c t o r ) — P u r if ie d f a c t o r p r o d u c t s (v ir a lly in a c t iv a t e d p la s m a - d e r iv e d c o n c e n t r a t e s o r r e c o m b ina nt p r o d u c t s ) s ho uld b e use d w he ne v e r p o s s ib le , t o a v o id p o t e n t ia l t r a n s f u s io n- t r a nsm it t e d inf e c t io n a nd t r a nsf usio n r e a c t io ns. H o w e v e r, in d iv id u a ls in r e s o u r c e - p o o r s e t t ing s m a y no t ha v e a c c e s s t o t he s e p r o d uc t s . F o r s uc h in d iv id u a ls , o p t io n s in c lu d e F r e s h F r o z e n P la s m a (F F P ), o r, f o r t ho s e w it h he m o p hilia A , C r y o p r e c ip it a t e . D o s in g is b a s e d o n t he f a c t o r c o nc e ntr a t io n in t he p r o d uc t , p a t ie nt w e ig ht, a nd t h e d e s ir e d f a c t o r le v e l. O n e b a g o f C r y o p r e c ip it a t e is m a d e f r o m a p p r o x im a t e ly 2 5 0 m L o f F F P a n d c o n t a in s a p p r o x im a t e ly 7 0 t o 8 0 unit s o f f a c t o r V I I I in a v o lum e o f 3 0 t o 4 0 m L (c o n c e n t r a t io n o f f a c t o r V I I I in C r y o p r e c ip it a t e , a p p r o x im a t e ly 3 t o 5 unit s / m L ) [2 ]. O n e m L o f F F P c o n t a in s o n e u n it o f f a c t o r a c t iv it y . A d o s e o f 1 5 t o 2 0 m L / k g w ill r a is e t he f a c t o r V I I I le v e l b y S e v e r e b l e e d i n g – P a t ie n t s w it h m ild h e m o p h ilia A o r B w ho ha v e s e r io us b le e d ing o r r e q u ir e m a jo r s u r g e r y s h o u ld b e t r e a t e d s im ila r ly t o t ho s e w it h s e v e r e o r m o d e r a t e d e f ic ie n c y . (S e e 'A c u t e t h e r a p y f o r b le e d in g ' a b o v e a n d 'M a jo r s u r g e r y ' a b o v e .) ● M i l d h e m o p h i l i a A , m i n o r b l e e d i n g – P a t ie n t s w it h m ild h e m o p h ilia A m a y ha v e a s u f f ic ie n t in c r e a s e in f a c t o r V I I I a c t iv it y le v e l up o n a d m inis t r a t io n o f D D A V P ( d e s m o p r e s s in ; a s y n t h e t ic a n a lo g o f v a s o p r e s s in / a ntid iu r e t ic ho r m o n e t ha t la c k s p r e s s o r a c t iv it y ), w hic h p r o m o t e s r e le a s e o f e n d o g e n o u s f a c t o r V I I I . A D D A V P t e s t d o s e s ho uld b e p e r f o r m e d b e f o r e u s e in a n in v a s iv e p r o c e d u r e t o a s s ur e a n a d e q ua t e he m o s t a t ic r e s p o nse , a s d is c u s s e d s e p a r a t e ly . (S e e \" H e m o p h ilia A a n d B : R o u t in e m a na g e m e nt inc lud in g p r o p h y la x is \" , s e c t io n o n 'D D A V P t e s t d o s e f o r m ild he m o p hilia A '.) ● D D A V P a d m in is t r a t io n a n d a d v e r s e e v e nts a r e d is c usse d b e lo w . (S e e 'D D A V P f o r m ild h e m o p h ilia A ' b e lo w .) M i l d h e m o p h i l i a B , m i n o r b l e e d i n g – M ild h e m o p h ilia B c a n n o t b e t r e a t e d w it h D D A V P b e c a u s e f a c t o r I X is n o t s t o r e d f o r r e le a s e in p la t e le t s o r e nd o t he lia l c e lls . P a t ie nts w it h m ild h e m o p h ilia B a r e t r e a t e d w it h f a c t o r I X o r o t he r he m o s t a t ic t he r a p ie s s uc h a s a n t if ib r in o ly t ic a g e n t s a n d / o r t o p ic a l t he r a p ie s . (S e e 'A n t if ib r in o ly t ic t h e r a p y f o r m u c o s a l b le e d in g o r s u r g e r y ' b e lo w a n d 'A d ju n c t iv e lo c a l t h e r a p ie s ' b e lo w .) ● a p p r o x im a t e ly 3 0 t o 4 0 p e r c e n t a n d t he f a c t o r I X le v e l b y a p p r o x im a t e ly 1 5 t o 2 0 p e r c e nt (d if f e r e n t in c r e a s e s a r e d u e t o d if f e r e nt v o lum e s o f d is t r ib u t io n o f f a c t o r s V I I I a nd I X ). (S e e \" C lin ic a l u s e o f p la s m a c o m p o n e n t s \" , s e c t io n o n 'P la s m a p r o d u c t s ' a n d \" C r y o p r e c ip it a t e a n d f ib r in o g e n c o n c e n t r a t e \" .) A D J U V A N T T H ER A P I ES A n t i f i b r i n o l y t i c t h e r a p y f o r m u c o s a l b l e e d i n g o r s u r g e r y  — A n t if ib r in o ly t ic a g e n t s in c lu d e t r a n e x a m ic a c id (T X A ) a n d e p s ilo n a m in o c a p r o ic a c id (E A C A ). T h e s e m a y b e u s e d in c o m b in a t io n w it h f a c t o r r e p la c e m e n t t h e r a p y f o r ind iv id ua ls w it h a m u c o s a l s o ur c e o f b le e d ing , o r a s s ing le a g e n t s in s e t t in g s w it h m u c o s a l b le e d ing t ha t is le s s s e v e r e (e g , d e n t a l p r o c e d ur e s ). To p ic a l a d m in is t r a t io n t o s k in s it e s h a s a ls o b e e n r e p o r t e d [5 6 ]. T h e s e a g e n t s a r e m o s t u s e f u l f o r s t a b iliz ing c lo t s in a r e a s o f inc r e a s e d f ib r ino ly s is s uc h a s t he o r a l o r n a s a l c a v it y (e g , d e n t a l b le e d in g , e p is t a x is ) o r f o r he a v y m e n s t r ua l b le e d ing in w o m e n w it h b le e d in g d is o r d e r s [3 8 ,5 7 ]. T h e ir m e c h a n is m o f a c t io n is t o inhib it f ib r ino ly s is b y inhib it ing p la s m in o g e n a c t iv a t io n in t h e f ib r in c lo t , t he r e b y e nha nc ing c lo t s t a b ilit y . T he d e c is io n b e t w e e n t h e s e a g e n t s is b a s e d o n lo c a l p r e f e r e nc e ; t he y ha v e no t b e e n d ir e c t ly c o m p a r e d in p a t ie nts w it h h e m o p h ilia a n d h a v e a p p e a r e d t o ha v e c o m p a r a b le e f f ic a c y in o t he r s e t t ing s . T h e s e d r u g s c a n b e a d m in is t e r e d o r a lly o r intr a v e no usly . W he n g iv e n o r a lly , t he y m ust b e g iv e n t h r e e o r f o u r t im e s o v e r a 2 4 - h o u r p e r io d b e c a use o f t he ir s ho r t ha lf - liv e s . D o s ing is o f t e n c o n t in u e d f o r s e v e r a l d a y s , d e p e n d ing o n t he d e g r e e o f injur y a nd b le e d ing . A n t if ib r in o ly t ic a g e n t s s h o u ld n o t b e use d f o r ur ina r y t r a c t b le e d ing d ue t o t he r is k o f o b s t r u c t io n b y c lo t s . N e it h e r T X A n o r E A C A s ho uld b e g iv e n s im u lt a ne o usly w it h a n a c t iv a t e d p r o t h r o m b in c o m p le x c o n c e n t r a t e (a P C C ), a s t h is w ill in c r e a s e t h e r is k o f t hr o m b o e m b o lis m . I f a n a n t if ib r in o ly t ic a g e n t a n d a n a P C C a r e use d , t he y s ho uld b e s e p a r a t e d b y a t le a s t 1 2 ho ur s [2 ]. T h e r e is s o m e e x p e r ie n c e u s in g T X A a nd r e c o m b ina nt f a c t o r V I I a (r F V I I a ) t o g e t he r in t he T X A – T h e u s u a l o r a l d o s e is 2 5 m g / k g p e r d o s e e v e r y s ix t o e ig h t ho ur s . S t a nd a r d d o s ing f o r c e r t a in in d ic a t io n s b a s e d o n p ill s iz e m a y b e use f u l, s uc h a s 1 3 0 0 m g o r a lly t hr e e t im e s a d a y f o r h e a v y m e n s t r u a l b le e d in g (use f o r up t o f iv e d a y s , lo ng e r f o r s o m e ind iv id ua ls ) o r 1 0 0 0 t o 1 5 0 0 m g e v e r y 8 t o 1 2 h o u r s f o r e p is t a x is f o r up t o 1 0 d a y s (o f f - la b e l d o s ing ). ● T h e in t r a v e n o u s (I V ) d o s e is 1 0 m g / k g , a d m inis t e r e d e v e r y s ix t o e ig h t ho ur s . E A C A – T h e u s u a l d o s e is 7 5 t o 1 0 0 m g / k g p e r d o s e e v e r y s ix ho ur s (m a x im um s ing le d o s e 3 t o 4 g ). ● s u r g ic a l s e t t in g ; c o n s u lt a t io n w it h a he m o p hilia t r e a t m e n t c e nte r is a d v is e d . (S e e 'H ig h t it e r o r h ig h r e s p o n d in g in h ib it o r - U s e a b y p a s s ing p r o d u c t (r F V I I a o r F E I B A )' a b o v e .) A d j u n c t i v e l o c a l t h e r a p i e s  — O t h e r a d ju n c t iv e h e m o s t a t ic t h e r a p ie s inc lud e m ic r o f ib r illa r c o lla g e n , e s p e c ia lly f o r b le e d in g in t he o r a l c a v it y , a nd f ib r in g lu e , w hic h ha s b e e n use d f o llo w in g c ir c u m c is io n [5 8 ]. (S e e \" F ib r in s e a la n t s \" .) D D A V P f o r m i l d h e m o p h i l i a A  — D D A V P ( d e s m o p r e s s in ) is a s y n t h e t ic a n a lo g o f v a s o p r e s s in (a n t id iu r e t ic h o r m o n e ]) t h a t la c k s p r e s s o r a c t iv it y a nd m a y b e e f f e c t iv e f o r m ino r b le e d ing o r c e r t a in e le c t iv e p r o c e d u r e s in p a t ie nts w it h m ild he m o p hilia A w ho ha v e ha d a d o c um e nte d r e s p o n s e t o a t e s t d o s e [1 9 ,5 8 - 6 2 ]. T h e t e s t d o s e is g e n e r a lly p e r f o r m e d a s p a r t o f r o utine c o m p r e he nsiv e c a r e . I f no t d o ne p r e v io u s ly it s h o u ld b e p e r f o r m e d a t le a s t o ne w e e k p r io r t o use f o r he m o s t a s is , t o a llo w r e v ie w o f t h e r e s u lt s , s u r g ic a l p la n n in g , a n d c o m m unic a t io n a m o n g t r e a t ing c linic ia ns. D e t a ils o f t he t e s t d o s e a r e d e s c r ib e d s e p a r a t e ly . (S e e \" H e m o p h ilia A a n d B : R o u t in e m a na g e m e nt inc lud in g p r o p h y la x is \" , s e c t io n o n 'D D A V P t e s t d o s e f o r m ild he m o p hilia A '.) F o r t h o s e w h o h a v e a r e s p o n s e , a t y p ic a l d o s e is 0 .3 m c g / k g (m a x im u m d o s e , 2 0 t o 3 0 m c g ), a d m in is t e r e d in t r a v e n o u s ly o r s u b c uta ne o usly ; o r a s a na s a l s p r a y (S t im a t e ), o ne p uf f (1 5 0 m c g ) in o n e n o s t r il in p a t ie n t s w e ig h in g < 5 0 k g a nd t w o p u f f s (1 5 0 m c g in b o t h no s t r ils ) in p a t ie nts w e ig h in g ≥ 5 0 k g . F o r a d u lt s , a r e p e a t d o s e m a y b e g iv e n a t 1 2 ho ur s , a nd s ub s e q u e nt d o s e s a r e o f t e n a d m in is t e r e d o n c e d a ily , a s lo n g a s t he ind iv id ua l is und e r t he s up e r v is io n o f a he m o p hilia e x p e r t . A d m in is t r a t io n o f D D A V P is usua lly no lo ng e r t ha n t hr e e d a y s d ue t o t a c hy p hy la x is a nd h y p o n a t r e m ia r is k . W h e n u s in g t h e na s a l s p r a y it is im p o r t a nt t o use t he s p r a y inte nd e d f o r h e m o s t a s is a n d n o t t h e s p r a y f o r e nur e s is , w hic h ha s a lo w e r c o nc e ntr a t io n. D D A V P c a n in c r e a s e t h e f a c t o r V I I I le v e l t w o - t o f o u r f o ld . A p a t ie nt w it h a b a s e line f a c t o r a c t iv it y o f 2 5 p e r c e n t w h o h a s a n in c r e a s e t o 5 0 p e r c e nt m a y ha v e a d e q ua t e he m o s t a s is w it h D D A V P in t h e s e t t in g o f m in o r b le e d in g o r p r o c e d u r e s a nd t hus a v o id f a c t o r inf usio n. Ta c hy p hy la x is m a y o c c u r ; t h e a d m in is t r a t io n s h o u ld b e t im e d t o p r o v id e t he m a x im a l r e s p o nse a t t he t im e o f g r e a t e s t b le e d in g r is k , w h ile lim it in g t he num b e r o f d o s e s . T h e f o llo w in g c a v e a t s a p p ly t o D D A V P use : D D A V P is n o t e f f e c t iv e f o r p a t ie n t s w it h s e v e r e h e m o p h ilia A (f a c t o r V I I I a c t iv it y < 1 p e r c e nt) b e c a u s e f a c t o r a c t iv it y le v e l c a n n o t b e inc r e a s e d s uf f ic ie ntly , a nd usua lly is no t use d in ● I n r a r e p a t ie n t s w it h m ild h e m o p h ilia A w ho ha v e m ild b le e d ing a nd w is h t o a v o id f a c t o r in f u s io n b u t h a v e n o t b e e n t e s t e d f o r D D A V P r e s p o n s e , it m a y b e r e a s o na b le t o use D D A V P, e s p e c ia lly if a p o s t - d o s e f a c t o r V I I I le v e l is o b t a ine d ; ho w e v e r, e v id e n c e t o s up p o r t t his p r a c t ic e is la c k in g . E f f e c t iv e t h e r a p y s h o u ld no t b e d e la y e d in a b le e d ing p a t ie nt, w hic h m a y o c c ur if t he r e s p o n s e t o D D A V P is n o t d o c u m e n t e d . C O V I D - 1 9 O R O T H ER C R I T I C A L I L L N ES S I n d iv id u a ls h o s p it a liz e d w it h c o r o n a v ir us d is e a s e 2 0 1 9 (C O V I D - 1 9 ) o r o t he r c r it ic a l illne s s m a y r e q u ir e a n t ic o a g u la t io n , e it h e r a s p r o p h y la x is a g a inst o r t r e a t m e n t o f a c ute t hr o m b o s is . in d iv id u a ls w it h m o d e r a t e h e m o p h ilia A (f a c t o r V I I I a c t iv it y f r o m 1 t o 5 p e r c e nt) f o r t he s a m e r e a s o n . D D A V P s h o u ld o n l y b e u s e d f o r m ild b le e d in g f o r w h ic h a 3 0 - t o 6 0 - m in ute d e la y is a c c e p t a b le (9 0 - m in u t e d e la y f o r n a s a l s p r a y ) a nd a t w o - t o f o u r f o ld f a c t o r V I I I inc r e a s e a r e lik e ly t o b e s u f f ic ie n t f o r h e m o s t a s is . F o r m o r e s e r io us b le e d ing , f a c t o r V I I I inf usio n s ho uld b e u s e d . ● D D A V P is n o t e f f e c t iv e f o r p a t ie n t s w it h h e m o p h ilia B b e c a use f a c t o r I X is no t s t o r e d in p la t e le t s o r e n d o t h e lia l c e lls . ● D D A V P g e n e r a lly is n o t u s e d in c h ild r e n und e r t w o y e a r s o f a g e d u e t o a n inc r e a s e d r is k o f w a t e r r e t e n t io n t h a t m a y r e s u lt in a s y nd r o m e o f ina p p r o p r ia t e A D H (S I A D H )- lik e p ic t ur e a n d p o t e n t ia lly c e r e b r a l e d e m a a nd s e iz u r e s [2 ]. I f u s e d in t h is a g e g r o u p , it s h o uld b e d o n e u n d e r h e m a t o lo g is t s u p e r v is io n. ● D D A V P h a s a n t id iu r e t ic a c t iv it y a n d c a n c a use hy p o n a t r e m ia , e s p e c ia lly w it h p r o lo ng e d use o r e x c e s s f r e e w a t e r in t a k e . A s a r e s ult , d o s e s o f t e n a r e lim it e d t o o nc e d a ily f o r t hr e e c o n s e c u t iv e d a y s , a n d w a t e r i n t a k e i s r e s t r i c t e d . T h e s e r u m s o d iu m c o n c e n t r a t io n is m o n it o r e d in h o s p it a liz e d in d iv id u a ls , e s p e c ia lly t ho s e r e c e iv ing m o r e t ha n o ne o r t w o d o s e s o f D D A V P. ● A d d it io n a l a d v e r s e e f f e c t s in c lu d e f a c ia l f lu s hing , he a d a c he , na use a , a nd t ing ling s e n s a t io n s . T h e s e c a n o f t e n b e c o n t r o lle d b y d e c r e a s ing t he r a t e o f t he inf usio n w he n a d m in is t e r in g t h e m e d ic a t io n in t r a v e n o usly [6 3 ]. C a s e s o f t h r o m b o s is h a v e b e e n r e p o r t e d , a lt h o u g h a c a u s a l r e la t io n s h ip is d if f ic ult t o e s t a b lis h. H y p o t e nsio n a nd hy p e r t e nsio n ha v e b e e n r e p o r t e d b u t a r e n o t c o m m o n a nd usua lly a r e m ild . D D A V P is g e ne r a lly a v o id e d in p a t ie n t s w it h a h is t o r y o f s e iz u r e s , s t r o k e , c a r d io v a s c ula r d is e a s e , a nd hy p e r t e nsio n. ● I f a p e r s o n w it h h e m o p h ilia is h o s p it a liz e d w it h C O V I D - 1 9 , w e f a v o r t r e a t ing w it h a n t ic o a g u la t io n (p r o p h y la c t ic o r t he r a p e u t ic d o s e , d e p e nd in g o n t he c linic a l s c e na r io ). T he f o llo w in g r e c o m m e n d a t io n s a r e b a s e d o n a 2 0 2 3 c linic a l p r a c t ic e e x p e r t g uid a nc e d o c um e nt b y t h e E H A - I S T H - E A H A D - E S O (E u r o p e a n H e m a t o lo g y A s s o c ia t io n, I nte r na t io na l S o c ie t y o n T h r o m b o s is a n d H a e m o s t a s is , E u r o p e a n A s s o c ia t io n f o r H e m o p h ilia a nd A llie d D is o r d e r s , a nd E u r o p e a n S t r o k e O r g a n iz a t io n ) [6 4 ]. W e p r e v io u s ly u s e d t h e in t e r im g uid a nc e f r o m t he W o r ld F e d e r a t io n o f H e m o p h ilia a n d t h a t o f o t he r e x p e r t s f o r t r e a t m e n t o f ind iv id ua ls w it h he m o p hilia a n d C O V I D - 1 9 [1 ,6 5 - 6 8 ]. P r o p h y la x is w it h f a c t o r in f u s io n s o r o t he r t he r a p y (s uc h a s e m ic iz u m a b in h e m o p h ilia A ) s h o u ld b e c o n t in u e d . F o r t h o s e r e c e iv in g e m ic iz um a b , f a c t o r V I I I c a n b e a d d e d ; f o r t ho s e r e c e iv ing f a c t o r V I I I , t h e d o s e c a n b e in t e n s if ie d . I nd iv id ua ls r e c e iv ing e m ic iz um a b a t a s t a b le d o s e d o no t r e q u ir e in f u s io n s o f f a c t o r V I I I if n o t ho s p it a liz e d a nd s t a b le a t ho m e . O t h e r c o n s id e r a t io n s in c lu d e [6 6 ]: D e t a ils o f a n t ic o a g u la t io n in C O V I D - 1 9 a r e p r e s e nte d s e p a r a t e ly . (S e e \" C O V I D - 1 9 : H y p e r c o a g u la b ilit y \" , s e c t io n o n 'M a na g e m e nt '.) A lt h o u g h e x p e r ie n c e is m o r e lim it e d w it h o t he r a c ute o r c r it ic a l illne s s e s , w e w o uld use a s im ila r a p p r o a c h in w h ic h t h e a p p r o p r ia t e c lo t t ing f a c t o r is a d m inis t e r e d o r o t he r t he r a p y s uc h a s e m ic iz u m a b is c o n t in u e d t o a llo w a n t ic o a g u la t io n if ne e d e d . Ta r g e t f a c t o r le v e ls in p e r s o n s w it h he m o p hilia ho s p it a liz e d w it h C O V I D - 1 9 a r e in d iv id u a liz e d ; f o r t h o s e r e c e iv in g p r o p h y la c t ic - d o s e a ntic o a g u la t io n, w e g e ne r a lly inc lud e a t r o u g h le v e l o f a t le a s t 2 0 p e r c e nt a nd a v o id a nc e o f p e a k le v e ls a b o v e 1 0 0 p e r c e nt [6 4 ]. ● I f f u ll (t h e r a p e u t ic - d o s e ) a n t ic o a g u la t io n is r e q u ir e d f o r t r e a t m e n t o f t hr o m b o s is , t he t r o u g h f a c t o r le v e l c a n b e m a in t a ine d b e t w e e n 2 0 a nd 1 0 0 p e r c e nt f o r he m o p hilia A a nd b e t w e e n 2 0 a n d 8 0 p e r c e n t f o r h e m o p h ilia B . ● M o n it o r in g o f a n t ic o a g u la t io n is im p o r t a nt, w it h t he a s s a y (s ) a p p r o p r ia t e t o t he a n t ic o a g u la n t . ● F a c t o r V I I I le v e ls in in d iv id u a ls w it h he m o p hilia B o r m ild he m o p hilia A m a y b e inc r e a s e d d u e t o a c u t e in f la m m a t io n . M o n it o r ing o f f a c t o r le v e ls b e f o r e a nd d u r ing t he r a p y is e s s e n t ia l in a ll in d iv id u a ls w it h h e m o p h ilia . ● H e m o p h ilia b y it s e lf d o e s n o t a f f e c t D - d im e r le v e ls ; D - d im e r, f ib r ino g e n, a nd p la t e le t c o unt c a n b e u s e d f o r t h e a s s e s s m e n t o f d is e a s e s e v e r it y s im ila r t o ind iv id ua ls w it ho ut h e m o p h ilia . ● S O C I ET Y G U I D EL I N E L I N K S L in k s t o s o c ie t y a n d g o v e r n m e n t - s p o nso r e d g u id e lin e s f r o m s e le c t e d c o untr ie s a nd r e g io ns a r o u n d t h e w o r ld a r e p r o v id e d s e p a r a t e ly . (S e e \" S o c ie t y g u id e lin e lin k s : H e m o p h ilia A a nd B \" .) I N F O R M A T I O N F O R P A T I EN T S U p To D a t e o f f e r s t w o t y p e s o f p a t ie nt e d u c a t io n m a t e r ia ls , \" T he B a s ic s \" a nd \" B e y o nd t he B a s ic s .\" T h e B a s ic s p a t ie n t e d u c a t io n p ie c e s a r e w r it t e n in p la in la ng u a g e , a t t he 5 t o 6 g r a d e r e a d in g le v e l, a n d t h e y a n s w e r t h e f o u r o r f iv e k e y q u e s t io ns a p a t ie nt m ig ht ha v e a b o ut a g iv e n c o n d it io n . T h e s e a r t ic le s a r e b e s t f o r p a t ie nts w ho w a nt a g e n e r a l o v e r v ie w a nd w ho p r e f e r s h o r t , e a s y - t o - r e a d m a t e r ia ls . B e y o nd t he B a s ic s p a t ie nt e d u c a t io n p ie c e s a r e lo ng e r, m o r e s o p h is t ic a t e d , a n d m o r e d e t a ile d . T he s e a r t ic le s a r e w r it t e n a t t he 1 0 t o 1 2 g r a d e r e a d in g le v e l a n d a r e b e s t f o r p a t ie n t s w h o w a nt in- d e p t h inf o r m a t io n a nd a r e c o m f o r t a b le w it h s o m e m e d ic a l ja r g o n . H e r e a r e t h e p a t ie n t e d u c a t io n a r t ic le s t ha t a r e r e le v a nt t o t his t o p ic . W e e nc o ur a g e y o u t o p r int o r e - m a il t h e s e t o p ic s t o y o u r p a t ie n t s . (Y o u c a n a ls o lo c a t e p a t ie nt e d uc a t io n a r t ic le s o n a v a r ie t y o f s u b je c t s b y s e a r c h in g o n \"p a t ie nt inf o \" a nd t he k e y w o r d (s ) o f inte r e s t .) S U M M A R Y A N D R EC O M M EN D A T I O N S t h t h t h t h B a s ic s t o p ic (s e e \" P a t ie n t e d u c a t io n : H e m o p h ilia (T h e B a s ic s )\" )● S e r i o u s b l e e d i n g – S e r io u s o r lif e - t h r e a t e n in g b le e d ing (intr a c r a nia l, o c ula r, s e r io us t r a u m a ) r e q u ir e s u r g e n t t r e a t m e n t w it h f a c t o r c o nc e ntr a t e , t a r g e t ing a f a c t o r a c t iv it y o f 8 0 t o 1 0 0 p e r c e n t ( t a b le 1 ). I f a v a ila b le , g iv e t h e p a t ie n t 's o w n f a c t o r p r o d u c t ; r e c o m b ina nt f a c t o r is a r e a s o n a b le a lt e r n a t iv e . (S e e 'S e r io u s , lif e - t h r e a t e n in g b le e d in g a nd he a d t r a u m a ' a b o v e .) ● H e m o p h ilia t r e a t m e n t c e n t e r (H T C ) inv o lv e m e n t o r e q u iv a le nt e x p e r t is e is e s s e ntia l. H o w e v e r, lif e - s a v in g t r e a t m e n t s s h o u ld no t b e d e la y e d w hile c o nta c t ing t he H T C o r a w a it in g t h e ir r e s p o n s e . H e m o p h i l i a A (i n c l u d i n g i n d i v i d u a l s o n e m i c i z u m a b ) w i t h o u t a n i n h i b i t o r – G iv e 5 0 u n it s / k g o f f a c t o r V I I I (h a lf - lif e is a t le a s t 8 t o 1 2 ho ur s ) ( t a b le 2 ). • H e m o p h i l i a B w i t h o u t a n i n h i b i t o r – G iv e 1 0 0 t o 1 4 0 u n it s / k g o f f a c t o r I X (ha lf - lif e is a t le a s t 1 8 t o 2 4 h o u r s ) ( t a b le 3 ). I f t h e r e is t im e f o r c a lc u la t io n , d o s ing c a n b e b a s e d o n t h e p r o d u c t 's v o lu m e o f d is t r ib u t io n (V d ): D o s e (unit s ) = % c o r r e c t io n x V d x w e ig ht (k g ), u s in g t h e V d f o r t h e s p e c if ic p r o d u c t . • I n h i b i t o r s – I n h ib it o r s (n e u t r a liz in g a n t ib o d ie s ) w ill ina c t iv a t e inf u s e d f a c t o r. (S e e 'O v e r v ie w o f p a t ie n t w it h a n in h ib it o r ' a b o v e .) • F o r a h ig h t it e r a n d h ig h - r e s p o n d in g inhib it o r (≥ 5 B e t he s d a unit s ) a nd s e r io us b le e d in g o r m a jo r s u r g e r y , w e r e c o m m e n d a b y p a s s ing p r o d u c t (F E I B A o r r e c o m b in a n t f a c t o r V I I a ) r a t h e r t h a n f a c t o r c o nc e ntr a t e ( G r a d e 1 C ). P o r c in e f a c t o r V I I I is a n o t h e r o p t io n f o r h e m o p h ilia A no t t r e a t e d w it h a b y p a s s ing a g e nt. P la s m a p h e r e s is m a y b e u s e d t o lo w e r t he inhib it o r t it e r in lif e - t hr e a t e ning b le e d ing if a b y p a s s in g a g e n t is in e f f e c t iv e . (S e e 'H ig h t it e r o r h ig h r e s p o n d in g in h ib it o r - U s e a b y p a s s in g p r o d u c t (r F V I I a o r F E I B A )' a b o v e a n d 'R e c o m b in a n t p o r c in e f a c t o r V I I I (h e m o p h ilia A )' a b o v e a n d 'P la s m a p h e r e s is if a b y p a s s in g p r o d u c t is ine f f e c t iv e ' a b o v e .) - F o r a lo w - r e s p o n d in g in h ib it o r, t r e a t m e n t d e c is io ns a r e ind iv id ua liz e d . O p t io ns in c lu d e a b y p a s s in g a g e n t , p o r c in e f a c t o r V I I I (f o r he m o p hilia A ), o r hig h d o s e f a c t o r c o n c e n t r a t e . (S e e 'L o w t it e r in h ib it o r - H ig h - d o s e f a c t o r inf u s io n is a n o p t io n ' a b o v e .) - I n d iv id u a ls w it h h e m o p h ilia A w it h a n inhib it o r w ho a r e r e c e iv ing e m ic iz u m a b c a n b e t r e a t e d w it h r F V I I a . F E I B A is n o t c o m b ine d w it h e m ic iz um a b d u e t o r is k o f t h r o m b o s is . - S u b s e q u e n t d o s in g d e p e n d s o n p e a k a nd t r o ug h f a c t o r a c t iv it y a nd b le e d ing s it e a nd s e v e r it y . (S e e 'M o n it o r in g a n d d o s e c a lc u la t io n f o r s ub s e q u e nt d o s e s ' a b o v e .) J o i n t b l e e d i n g – I n f u s e f a c t o r w it h in t w o h o u r s o f b le e d id e n t if ic a t io n; t a r g e t f a c t o r a c t iv it y a t a p p r o x im a t e ly 5 0 p e r c e n t (t r a um a m a y r e q u ir e hig h e r t a r g e t s ). R e p e a t e d f a c t o r in f u s io n s a s s u r e a d e q u a t e r e s o lu t io n. (S e e 'H e m a r t h r o s e s ' a b o v e .) ● S u r g e r y – M a n a g e d in c o n s u lt a t io n w it h t h e H T C , inc lud in g (s e e 'E le c t iv e s u r g e r y ' a b o v e ):● C o o r d in a t io n a m o n g p a t ie n t / f a m ily / c a r e g iv e r s a nd r e le v a nt c linic ia ns.• P r e o p e r a t iv e in h ib it o r s c r e e n in g .• D e t e r m in in g d e s ir e d f a c t o r a c t iv it y .• A C K N O W L ED G M EN T P la n n in g f o r m o n it o r in g a n d f a c t o r a d m inis t r a t io n (s p e c ia l c o nsid e r a t io ns f o r in d iv id u a ls r e c e iv in g e m ic iz u m a b ). • C e r t a in s it e s m a y b e e s p e c ia lly s e r io us d u e t o t he ir lo c a t io n a nd p o s s ib ilit y o f c a using a ir w a y c o m p r o m is e (r e t r o p h a r y n g e a l b le e d ing f r o m t o nsille c t o m y o r im p a c t e d m a nd ib ula r w is d o m t o o t h e x t r a c t io n ). A d j u v a n t t h e r a p i e s● A n t i f i b r i n o l y t i c t h e r a p y – F o r b le e d in g o r s u r g e r y in a r e a s o f inc r e a s e d f ib r ino ly s is (o r a l, n a s a l, g a s t r o in t e s t in a l, g y n e c o lo g ic ), w e s ug g e s t a n a ntif ib r ino ly t ic a g e nt ( G r a d e 2 C ). T r a n e x a m ic a c id (T X A ) o r e p s ilo n a m in o c a p r o ic a c id (E A C A ) c a n b e u s e d . D u r a t io n o f t h e r a p y is in d iv id u a liz e d . T h is m a y b e t he s o le t he r a p y r e q u ir e d (e g , m ild he m o p hilia , d e n t a l p r o c e d u r e ). S o m e in d iv id u a ls m a y r e a s o na b ly o m it a ntif ib r ino ly t ic t he r a p y if t he y a r e r e c e iv in g f a c t o r in f u s io n s . (S e e 'A n t if ib r in o ly t ic t h e r a p y f o r m u c o s a l b le e d ing o r s u r g e r y ' a b o v e .) • D D A V P – D D A V P ( d e s m o p r e s s in ) m a y b e e f f e c t iv e f o r e le c t iv e p r o c e d ur e s in m ild h e m o p h ilia A (f a c t o r V I I I a c t iv it y 5 t o 4 0 p e r c e nt), p r o v id e d t he r e w a s a p r e v io us d o c u m e n t e d r e s p o n s e t o a t e s t d o s e . (S e e \" H e m o p h ilia A a n d B : R o u t in e m a na g e m e nt in c lu d in g p r o p h y la x is \" , s e c t io n o n 'D D A V P t e s t d o s e f o r m ild he m o p hilia A ' a n d 'D D A V P f o r m ild h e m o p h ilia A ' a b o v e .) • H o s p i t a l i z a t i o n (C O V I D - 1 9 o r o t h e r a c u te i l l n e s s ) – I n d iv id u a ls h o s p it a liz e d w it h a c r it ic a l illn e s s s u c h a s C O V I D - 1 9 m a y r e q uir e a ntic o a g u la t io n a s p r o p h y la x is o r t r e a t m e nt o f a c ute t h r o m b o s is . I f a p e r s o n w it h h e m o p h ilia r e q u ir e s a ntic o a g u la t io n, f a c t o r inf usio ns o r o t he r t h e r a p y (s u c h a s e m ic iz u m a b in h e m o p h ilia A ) s h o u ld b e c o n t in ue d o r s t a r t e d if ne e d e d . (S e e 'C O V I D - 1 9 o r o t h e r c r it ic a l illn e s s ' a b o v e .) ● W F H G u i d e l i n e s – O u r a p p r o a c h is c o n s is t e n t w it h 2 0 2 0 W o r ld F e d e r a t io n o f H e m o p h ilia G u id e lin e s ( h t t p s :/ / w w w 1 .w f h .o r g / p u b lic a t io n s / f ile s / p d f - 1 8 6 3 .p d f ). ● O t h e r a s p e c t s o f c a r e – (S e e \" C lin ic a l m a n if e s t a t io n s a n d d ia g n o s is o f he m o p hilia \" a n d \" H e m o p h ilia A a n d B : R o u t in e m a na g e m e nt inc lud in g p r o p h y la x is \" a n d \" I n h ib it o r s in h e m o p h ilia : M e c h a n is m s , p r e v a le nc e , d ia g n o s is , a nd e r a d ic a t io n \" a n d \" G e n e t ic s o f h e m o p h ilia A a n d B \" .) ● T h e U p To D a t e e d it o r ia l s t a f f a c k n o w le d g e s e x t e nsiv e c o ntr ib u t io ns o f D o na ld H M a ho ne y , Jr, M D , a n d L a w r e n c e L K L e u n g , M D , t o e a r lie r v e r s io ns o f t his t o p ic r e v ie w . U s e o f U p To D a t e is s u b je c t t o t h e Te r m s o f U s e . R E F E R E N C E S 1 . S r iv a s t a v a A , S a n t a g o s t in o E , D o u g a ll A , e t a l. W F H G uid e lin e s f o r t he M a na g e m e nt o f H e m o p h ilia , 3 r d e d it io n . H a e m o p hilia 2 0 2 0 ; 2 6 S up p l 6 :1 . 2 . S r iv a s t a v a A , B r e w e r A K , M a u s e r - B unsc ho t e n E P, e t a l. G uid e lin e s f o r t he m a na g e m e nt o f h e m o p h ilia . H a e m o p h ilia 2 0 1 3 ; 1 9 :e 1 . 3 . V a n d e r h a v e K L , C a ir d M S , H a k e M , e t a l. M u s c ulo s k e le t a l c a r e o f t he he m o p hilia c p a t ie nt. J A m A c a d O r t h o p S u r g 2 0 1 2 ; 2 0 :5 5 3 . 4 . F o w le r H , L a c e y R , K e a n e y J, e t a l. E m e r g e n c y a nd o ut o f ho ur s c a r e o f p a t ie nts w it h in h e r it e d b le e d in g d is o r d e r s . H a e m o p h ilia 2 0 1 2 ; 1 8 :e 1 2 6 . 5 . h t t p :/ / w w w .u k h c d o .o r g / w p - c o n t e n t / u p lo a d s / 2 0 1 5 / 1 2 / E m e r g e n c y C a r e S t a nd a r d s F ina lV e r s io n Ju n e 2 0 0 9 - F o r - W e b s it e .p d f (A c c e s s e d o n A ug u s t 1 6 , 2 0 1 6 ). 6 . M A S A C D o c u m e n t 2 5 7 - G u id e lin e s f o r E m e r g e n c y D e p a r t m e n t M a na g e m e nt o f I nd iv id ua ls w it h H e m o p h ilia a n d O t h e r B le e d in g D is o r d e r s ; M e d ic a l a nd S c ie ntif ic A d v is o r y C o unc il (M A S A C ) o f t h e N a t io n a l H e m o p h ilia F o und a t io n (N H F ) http s :/ / w w w .h e m o p hilia .o r g / he a lt hc a r e - p r o f e s s io n a ls / g u id e lin e s - o n - c a r e / m a s a c - d o c u m e n t s / m a s a c - d o c u m e n t - 2 5 7 - g uid e line s - f o r - e m e r g e n c y - d e p a r t m e n t - m a n a g e m e nt- o f - ind iv id ua ls - w it h- he m o p hilia - a nd - o t he r - b le e d ing - d i s o r d e r s (A c c e s s e d o n S e p t e m b e r 1 8 , 2 0 2 3 ). 7 . B e r n t o r p E , S h a p ir o A D . M o d e r n h a e m o p hilia c a r e . L a nc e t 2 0 1 2 ; 3 7 9 :1 4 4 7 . 8 . L ju n g R C , K n o b e K . H o w t o m a n a g e inv a s iv e p r o c e d u r e s in c hild r e n w it h ha e m o p hilia . B r J H a e m a t o l 2 0 1 2 ; 1 5 7 :5 1 9 . 9 . H o o t s K W . E m e r g e n c y m a n a g e m e n t o f he m o p hilia . I n: Te x t b o o k o f H e m o p hilia , 3 r d e d , L e e C A , B e r n t o r p E E , H o o t s W K (E d s ), Jo hn W ile y & S o ns, L t d , 2 0 1 4 . p .4 6 3 . 1 0 . H o o t s W K . E m e r g e n c y m a n a g e m e n t in he m o p hilia . I n: Te x t b o o k o f H e m o p hilia , 2 nd e d , L e e C A , B e r n t o r p E E , H o o t s W K (E d s ), W ile y - B la c k w e ll, O x f o r d , U K 2 0 1 0 . p .3 9 4 . 1 1 . G ilc h r is t G S , P ie p g r a s D G , R o s k o s R R . N e ur o lo g ic C o m p lic a t io ns in H e m o p hilia . I n: H e m o p hi lia in t h e C h ild a n d A d u lt , H ilg a r t n e r M W , P o c he d ly C (E d s ), R a v e n P r e s s , N e w Y o r k 1 9 8 9 . p .4 5 . 1 2 . S im p s o n M L , V a le n t in o L A . M a n a g e m e n t o f jo int b le e d ing in he m o p hilia . E x p e r t R e v H e m a t o l 2 0 1 2 ; 5 :4 5 9 . 1 3 . K is k e r C T , B u r k e C . D o u b le - b lin d s t ud ie s o n t he use o f s t e r o id s in t he t r e a t m e nt o f a c ute h e m a r t h r o s is in p a t ie n t s w it h h e m o p h ilia . N E ng l J M e d 1 9 7 0 ; 2 8 2 :6 3 9 . 1 4 . M a n c o - Jo h n s o n M J, A b s h ir e T C , S h a p ir o A D , e t a l. P r o p h y la x is v e r s us e p is o d ic t r e a t m e nt t o p r e v e n t jo in t d is e a s e in b o y s w it h s e v e r e he m o p hilia . N E ng l J M e d 2 0 0 7 ; 3 5 7 :5 3 5 . 1 5 . P a t o n R W , E v a n s D I . S ile n t a v a s c u la r ne c r o s is o f t he f e m o r a l he a d in ha e m o p hilia . J B o ne Jo in t S u r g B r 1 9 8 8 ; 7 0 :7 3 7 . 1 6 . B a k e e r N , S h a p ir o A D . M e r g in g in t o t he m a instr e a m : t he e v o lutio n o f t he r o le o f p o int- o f - c a r e m u s c u lo s k e le t a l u lt r a s o u n d in he m o p hilia . F 1 0 0 0 R e s 2 0 1 9 ; 8 . 1 7 . K id d e r W , N g u y e n S , L a r io s J, e t a l. P o int- o f - c a r e m u s c ulo s k e le t a l ult r a s o und is c r it ic a l f o r t h e d ia g n o s is o f h e m a r t h r o s e s , in f la m m a t io n a nd s o f t t is s ue a b n o r m a lit ie s in a d ult p a t ie n t s w it h p a in f u l h a e m o p h ilic a r t hr o p a t hy . H a e m o p hilia 2 0 1 5 ; 2 1 :5 3 0 . 1 8 . B a k e e r N , D o v e r S , B a b y n P, e t a l. M usc ulo s k e le t a l ult r a s o und in he m o p hilia : R e s ult s a nd r e c o m m e n d a t io n s f r o m a g lo b a l s ur v e y a nd c o nse nsus m e e t ing . R e s P r a c t T hr o m b H a e m o s t 2 0 2 1 ; 5 :e 1 2 5 3 1 . 1 9 . F r a n c h in i M , F a v a lo r o E J, L ip p i G . M ild he m o p hilia A . J T hr o m b H a e m o s t 2 0 1 0 ; 8 :4 2 1 . 2 0 . A d c o c k D M , S t r a n d b e r g K , S h im a M , M a r la r R A . A d v a nta g e s , d is a d v a nta g e s a nd o p t im iz a t io n o f o n e - s t a g e a n d c h r o m o g e nic f a c t o r a c t iv it y a s s a y s in ha e m o p hilia A a nd B . I n t J L a b H e m a t o l 2 0 1 8 ; 4 0 :6 2 1 . 2 1 . H e n r a r d S , S p e y b r o e c k N , H e r m a n s C . B o d y w e ig h t a nd f a t m a s s ind e x a s s t r o ng p r e d ic t o r s o f f a c t o r V I I I in v iv o r e c o v e r y in a d u lt s w it h he m o p hilia A . J T hr o m b H a e m o s t 2 0 1 1 ; 9 :1 7 8 4 . 2 2 . S c h u lm a n S , V a r o n D , K e lle r N , e t a l. M o n o c lo na l p u r if ie d F V I I I f o r c o ntinuo us inf usio n: s t a b ilit y , m ic r o b io lo g ic a l s a f e t y a n d c linic a l e x p e r ie nc e . T hr o m b H a e m o s t 1 9 9 4 ; 7 2 :4 0 3 . 2 3 . M a r t in o w it z U P, S c h u lm a n S . C o n t inuo us inf u s io n o f f a c t o r c o nc e ntr a t e s : r e v ie w o f use in h e m o p h ilia A a n d d e m o n s t r a t io n o f s a f e t y a nd e f f ic a c y in he m o p hilia B . A c t a H a e m a t o l 1 9 9 5 ; 9 4 S u p p l 1 :3 5 . 2 4 . H a y C R , D o u g h t y H I , S a v id g e G F. C o n t inuo us inf u s io n o f f a c t o r V I I I f o r s ur g e r y a nd m a jo r b le e d in g . B lo o d C o a g u l F ib r in o ly s is 1 9 9 6 ; 7 S up p l 1 :S 1 5 . 2 5 . H o lm e P A , T jø n n f jo r d G E , B a t o r o v a A . C o ntinuo us inf u s io n o f c o a g u la t io n f a c t o r c o n c e n t r a t e s d u r in g in t e n s iv e t r e a t m e n t . H a e m o p hilia 2 0 1 8 ; 2 4 :2 4 . 2 6 . S c h u lm a n S , W a lle n s t e n R , W h it e B , S m it h O P. E f f ic a c y o f a hig h p u r it y , c he m ic a lly t r e a t e d a n d n a n o f ilt e r e d f a c t o r I X c o n c e n t r a t e f o r c o ntinuo us inf u s io n in ha e m o p hilia p a t ie nts u n d e r g o in g s u r g e r y . H a e m o p h ilia 1 9 9 9 ; 5 :9 6 . 2 7 . Y a m a m o t o M , N a k a d a t e H , I g u c h i U , e t a l. [S uc c e s s f u l m a na g e m e nt o f ne ur o s ur g ic a l p r o c e d u r e s w it h c o n t in u o u s in f u s io n o f r e c o m b ina nt f a c t o r I X in a c hild w it h he m o p hilia B ]. R in s h o K e t s u e k i 2 0 1 3 ; 5 4 :3 0 0 . 2 8 . E s c o b a r M A , B r e w e r A , C a v ig lia H , e t a l. R e c o m m e n d a t io ns o n m u lt id is c ip lina r y m a n a g e m e n t o f e le c t iv e s u r g e r y in p e o p le w it h ha e m o p hilia . H a e m o p hilia 2 0 1 8 ; 2 4 :6 9 3 . 2 9 . P o o n M C , A le d o r t L M , A n d e r le K , e t a l. C o m p a r is o n o f t he r e c o v e r y a nd ha lf - lif e o f a hig h- p u r it y f a c t o r I X c o n c e n t r a t e w it h t h o s e o f a f a c t o r I X c o m p le x c o nc e ntr a t e . F a c t o r I X S t ud y G r o u p . T r a n s f u s io n 1 9 9 5 ; 3 5 :3 1 9 . 3 0 . P o w e ll JS , P a s i K J, R a g n i M V , e t a l. P h a s e 3 s t ud y o f r e c o m b ina nt f a c t o r I X F c f usio n p r o t e in in h e m o p h ilia B . N E n g l J M e d 2 0 1 3 ; 3 6 9 :2 3 1 3 . 3 1 . B r a n d B , G r u p p o R , W y n n T T , e t a l. E f f ic a c y a nd s a f e t y o f p e g y la t e d f u ll- le ng t h r e c o m b ina nt f a c t o r V I I I w it h e x t e n d e d h a lf - lif e f o r p e r io p e r a t iv e ha e m o s t a s is in ha e m o p hilia A p a t ie nts. H a e m o p h ilia 2 0 1 6 ; 2 2 :e 2 5 1 . 3 2 . M a h la n g u J, P o w e ll JS , R a g n i M V , e t a l. P ha s e 3 s t ud y o f r e c o m b ina nt f a c t o r V I I I F c f usio n p r o t e in in s e v e r e h e m o p h ilia A . B lo o d 2 0 1 4 ; 1 2 3 :3 1 7 . 3 3 . M o o r e M F, To b a s e P, A lle n D D . M e t a - a na ly s is : o utc o m e s o f t o t a l k ne e a r t hr o p la s t y in t he h a e m o p h ilia p o p u la t io n . H a e m o p h ilia 2 0 1 6 ; 2 2 :e 2 7 5 . 3 4 . M a r t in o w it z U , V a r o n D , Jo n a s P, e t a l. C ir c um c is io n in he m o p hilia : t he use o f f ib r in g lue f o r lo c a l h e m o s t a s is . J U r o l 1 9 9 2 ; 1 4 8 :8 5 5 . 3 5 . K e a r n e y S , S h a r a t h k u m a r A , R o d r ig ue z V , e t a l. N e o na t a l c ir c um c is io n in s e v e r e h a e m o p h ilia : a s u r v e y o f p a e d ia t r ic ha e m a t o lo g is t s a t U nit e d S t a t e s H e m o p hilia T r e a t m e nt C e n t e r s . H a e m o p h ilia 2 0 1 5 ; 2 1 :5 2 . 3 6 . H e r m a n s C , A lt is e n t C , B a t o r o v a A , e t a l. R e p la c e m e n t t he r a p y f o r inv a s iv e p r o c e d ur e s in p a t ie n t s w it h h a e m o p h ilia : lit e r a t u r e r e v ie w , E ur o p e a n s ur v e y a nd r e c o m m e nd a t io ns. H a e m o p h ilia 2 0 0 9 ; 1 5 :6 3 9 . 3 7 . A n d e r s o n JA , B r e w e r A , C r e a g h D , e t a l. G uid a nc e o n t he d e n t a l m a na g e m e nt o f p a t ie nts w it h h a e m o p h ilia a n d c o n g e n it a l b le e d ing d is o r d e r s . B r D e nt J 2 0 1 3 ; 2 1 5 :4 9 7 . 3 8 . D ju lb e g o v ic B , M a r a s a M , P e s t o A , e t a l. S a f e t y a nd e f f ic a c y o f p u r if ie d f a c t o r I X c o nc e ntr a t e a n d a n t if ib r in o ly t ic a g e n t s f o r d e n t a l e x t r a c t io ns in he m o p hilia B . A m J H e m a t o l 1 9 9 6 ; 5 1 :1 6 8 . 3 9 . L e w a n d o w s k a M , R a n d a ll N , B a k e e r N , e t a l. M a na g e m e nt o f p e o p le w it h ha e m o p hilia A u n d e r g o in g s u r g e r y w h ile r e c e iv in g e m ic iz um a b p r o p h y la x is : R e a l- w o r ld e x p e r ie nc e f r o m a la r g e c o m p r e h e n s iv e t r e a t m e n t c e ntr e in t he U S . H a e m o p hilia 2 0 2 1 ; 2 7 :9 0 . 4 0 . M c C a r y I , G u e lc h e r C , K u h n J, e t a l. R e a l- w o r ld use o f e m ic iz um a b in p a t ie nts w it h h a e m o p h ilia A : B le e d in g o u t c o m e s a nd s ur g ic a l p r o c e d u r e s . H a e m o p hilia 2 0 2 0 ; 2 6 :6 3 1 . 4 1 . h t t p s :/ / w w w .a c c e s s d a t a .f d a .g o v / d r ug s a t f d a _ d o c s / la b e l/ 2 0 1 7 / 7 6 1 0 8 3 s 0 0 0 lb l.p d f (A c c e s s e d o n N o v e m b e r 2 0 , 2 0 1 7 ). 4 2 . K e m p t o n C L , W h it e G C 2 n d . H o w w e t r e a t a he m o p hilia A p a t ie nt w it h a f a c t o r V I I I inhib it o r. B lo o d 2 0 0 9 ; 1 1 3 :1 1 . 4 3 . h t t p :/ / w w w .f d a .g o v / d o w n lo a d s / .../ uc m 0 5 6 9 5 4 .p d f. 4 4 . h t t p s :/ / w w w .f d a .g o v / m e d ia / 1 3 6 6 1 0 / d o w nlo a d (A c c e s s e d o n July 2 8 , 2 0 2 0 ). 4 5 . h t t p :/ / w w w .f d a .g o v / d o w n lo a d s / B io lo g ic s B lo o d V a c c ine s / B lo o d B lo o d P r o d uc t s / A p p r o v e d P r o d u c t s / L ic e n s e d P r o d u c t s B L A s / F r a c t io na t e d P la s m a P r o d u c t s / U C M 2 2 1 7 4 9 .p d f. 4 6 . M a u s e r - B u n s c h o t e n E P, Z ijl JA , M a li W , e t a l. S uc c e s s f u l t r e a t m e n t o f s e v e r e b le e d ing in h e m o p h ilic t a r g e t jo in t s b y s e le c t iv e a ng io g r a p h ic e m b o liz a t io n. B lo o d 2 0 0 5 ; 1 0 5 :2 6 5 4 . 4 7 . L u s h e r JM . U s e o f p r o t h r o m b in c o m p le x c o nc e ntr a t e s in m a na g e m e nt o f b le e d ing in h e m o p h ilia c s w it h in h ib it o r s - - b e n e f it s a nd lim it a t io ns. S e m in H e m a t o l 1 9 9 4 ; 3 1 :4 9 . 4 8 . A s t e r m a r k J, D o n f ie ld S M , D iM ic h e le D M , e t a l. A r a nd o m iz e d c o m p a r is o n o f b y p a s s ing a g e n t s in h e m o p h ilia c o m p lic a t e d b y a n inhib it o r : t he F E I B A N o v o S e v e n C o m p a r a t iv e (F E N O C ) S t u d y . B lo o d 2 0 0 7 ; 1 0 9 :5 4 6 . 4 9 . Y o u n g G , S h a f e r F E , R o ja s P, S e r e m e t is S . S ing le 2 7 0 m ic r o g k g (- 1 )- d o s e r F V I I a v s . s t a nd a r d 9 0 m ic r o g k g (- 1 )- d o s e r F V I I a a n d A P C C f o r ho m e t r e a t m e n t o f jo int b le e d s in ha e m o p hilia p a t ie n t s w it h in h ib it o r s : a r a n d o m iz e d c o m p a r is o n. H a e m o p hilia 2 0 0 8 ; 1 4 :2 8 7 . 5 0 . S a n t a g o s t in o E , M a n c u s o M E , R o c ino A , e t a l. A p r o s p e c t iv e r a nd o m iz e d t r ia l o f hig h a nd s t a n d a r d d o s a g e s o f r e c o m b in a n t f a c t o r V I I a f o r t r e a t m e n t o f he m a r t hr o s e s in h e m o p h ilia c s w it h in h ib it o r s . J T h r o m b H a e m o s t 2 0 0 6 ; 4 :3 6 7 . 5 1 . K a v a k li K , M a k r is M , Z u lf ik a r B , e t a l. H o m e t r e a t m e n t o f ha e m a r t hr o s e s using a s ing le d o s e r e g im e n o f r e c o m b in a n t a c t iv a t e d f a c t o r V I I in p a t ie nts w it h ha e m o p hilia a nd inhib it o r s . A m u lt i- c e n t r e , r a n d o m is e d , d o u b le - b lind , c r o s s - o v e r t r ia l. T hr o m b H a e m o s t 2 0 0 6 ; 9 5 :6 0 0 . 5 2 . M a r s h K , G r e e n D , R a c o V , e t a l. A n t it hr o m b o t ic a nd he m o s t a t ic s t e w a r d s hip : e v a lua t io n o f c lin ic a l o u t c o m e s a n d a d v e r s e e v e n t s o f r e c o m b ina nt f a c t o r V I I a (N o v o s e v e n® ) utiliz a t io n a t a la r g e a c a d e m ic m e d ic a l c e n t e r. T he r A d v C a r d io v a s c D is 2 0 2 0 ; 1 4 :1 7 5 3 9 4 4 7 2 0 9 2 4 2 5 5 . 5 3 . R a jp u r k a r M , C r o t e a u S E , B o g g io L , C o o p e r D L . T hr o m b o t ic e v e nts w it h r e c o m b ina nt a c t iv a t e d f a c t o r V I I (r F V I I a ) in a p p r o v e d ind ic a t io ns a r e r a r e a nd a s s o c ia t e d w it h o ld e r a g e , c a r d io v a s c u la r d is e a s e , a n d c o n c o m it a nt use o f a c t iv a t e d p r o t hr o m b in c o m p le x c o n c e n t r a t e s (a P C C ). J B lo o d M e d 2 0 1 9 ; 1 0 :3 3 5 . 5 4 . S c h n e id e r m a n J, R u b in E , N u g e n t D J, Y o ung G . S e q u e ntia l t he r a p y w it h a c t iv a t e d p r o t h r o m b in c o m p le x c o n c e n t r a t e s a nd r e c o m b ina nt F V I I a in p a t ie nts w it h s e v e r e h a e m o p h ilia a n d in h ib it o r s : u p d a t e o f o ur p r e v io us e x p e r ie nc e . H a e m o p hilia 2 0 0 7 ; 1 3 :2 4 4 . 5 5 . G r in g e r i A , F is c h e r K , K a r a f o u lid o u A , e t a l. S e q u e ntia l c o m b ine d b y p a s s ing t he r a p y is s a f e a n d e f f e c t iv e in t h e t r e a t m e n t o f u nr e s p o n s iv e b le e d ing in a d u lt s a nd c hild r e n w it h h a e m o p h ilia a n d in h ib it o r s . H a e m o p h ilia 2 0 1 1 ; 1 7 :6 3 0 . 5 6 . N o b le S , C h it n is J. C a s e r e p o r t : u s e o f t o p ic a l t r a ne x a m ic a c id t o s t o p lo c a lis e d b le e d ing . E m e r g M e d J 2 0 1 3 ; 3 0 :5 0 9 . 5 7 . S t a jc ić Z . T h e c o m b in e d lo c a l/ s y s t e m ic use o f a ntif ib r ino ly t ic s in he m o p hilia c s und e r g o ing d e n t a l e x t r a c t io n s . I n t J O r a l S u r g 1 9 8 5 ; 1 4 :3 3 9 . 5 8 . H e m o p h ilia a n d v o n W ille b r a n d 's d is e a s e : 2 . M a na g e m e nt. A s s o c ia t io n o f H e m o p hilia C linic D ir e c t o r s o f C a n a d a . C M A J 1 9 9 5 ; 1 5 3 :1 4 7 . 5 9 . R e v e l- V ilk S , B la n c h e t t e V S , S p a r lin g C , e t a l. D D A V P c ha lle ng e t e s t s in b o y s w it h m ild / m o d e r a t e h a e m o p h ilia A . B r J H a e m a t o l 2 0 0 2 ; 1 1 7 :9 4 7 . 6 0 . R o s e E H , A le d o r t L M . N a s a l s p r a y d e s m o p r e s s in (D D A V P ) f o r m ild he m o p hilia A a nd v o n W ille b r a n d d is e a s e . A n n I n t e r n M e d 1 9 9 1 ; 1 1 4 :5 6 3 . 6 1 . N o la n B , W h it e B , S m it h J, e t a l. D e s m o p r e s s in: t he r a p e u t ic lim it a t io ns in c hild r e n a nd a d u lt s w it h in h e r it e d c o a g u la t io n d is o r d e r s . B r J H a e m a t o l 2 0 0 0 ; 1 0 9 :8 6 5 . 6 2 . M a n n u c c i P M , R u g g e r i Z M , P a r e t i FI , C a p it a nio A . 1 - D e a m in o - 8 - d - a r g inine v a s o p r e s s in: a n e w p h a r m a c o lo g ic a l a p p r o a c h t o t he m a na g e m e nt o f ha e m o p hilia a nd v o n W ille b r a nd s ' d is e a s e s . L a n c e t 1 9 7 7 ; 1 :8 6 9 . 6 3 . D u n n A L , P o w e r s JR , R ib e ir o M J, e t a l. A d v e r s e e v e nts d u r ing use o f intr a na s a l d e s m o p r e s s in a c e t a t e f o r h a e m o p hilia A a nd v o n W ille b r a nd d is e a s e : a c a s e r e p o r t a nd r e v ie w o f 4 0 p a t ie n t s . H a e m o p h ilia 2 0 0 0 ; 6 :1 1 . 6 4 . S c h u t g e n s R E G , Jim e n e z - Y u s t e V , E s c o b a r M , e t a l. A ntit hr o m b o t ic T r e a t m e nt in P a t ie nts W it h H e m o p h ilia : a n E H A - I S T H - E A H A D - E S O C linic a l P r a c t ic e G uid a nc e . H e m a s p he r e 2 0 2 3 ; 7 :e 9 0 0 . 6 5 . H e r m a n s C , L a m b e r t C , S o g o r b A , e t a l. I n- ho s p it a l m a na g e m e nt o f p e r s o ns w it h h a e m o p h ilia a n d C O V I D - 1 9 : P r a c t ic a l g u id a nc e . H a e m o p hilia 2 0 2 0 ; 2 6 :7 6 8 . 6 6 . P ip e S W , K a c z m a r e k R , S r iv a s t a v a A , e t a l. M a na g e m e nt o f C O V I D - 1 9 - a s s o c ia t e d c o a g u lo p a t h y in p e r s o n s w it h h a e m o p h ilia . H a e m o p hilia 2 0 2 1 ; 2 7 :4 1 . 6 7 . R iv a s - P o llm a r M I , Á lv a r e z - R o m á n M T , B u t t a - C o ll N V , e t a l. T hr o m b o p r o p hy la x is in a p a t ie nt w it h C O V I D - 1 9 a n d s e v e r e h e m o p h ilia A o n e m ic iz um a b p r o p h y la x is . J T hr o m b H a e m o s t 2 0 2 0 ; 1 8 :2 2 0 2 . 6 8 . I S T H A c a d e m y : M a n a g e m e n t o f a h e m o p hilia p a t ie nt w it h C O V I D - 1 9 r e q uir ing p r o he m o s t a t ic a g e n t s h t t p s :/ / a c a d e m y .is t h .o r g / is t h/ 2 0 2 0 / is t h- 2 0 2 0 - v ir t ua l- c o ng r e s s - s s c - s e s s io ns/ 3 0 3 1 7 5 / (A c c e s s e d o n M a r c h 0 8 , 2 0 2 1 ). To p ic 1 3 1 4 V e r s io n 7 4 .0 G R A P H I C S T r e a t m e n t o f b l e e d i n g i n h e m o p h i l i a   H e m o p h i l i a A H e m o p h i l i a B M a j or / s e v e r e b l e e d i n g * R a is e f a c t o r le v e l t o 8 0 t o 1 0 0 % F a c t o r V I I I d o s e o f a p p r o x im a t e ly 5 0 u n it s / k g F a c t o r I X d o s e o f a p p r o x im a t e ly 1 0 0 t o 1 2 0 u n it s / k g H e m a r t h r os i s R a is e f a c t o r le v e l t o 4 0 t o 5 0 % F a c t o r V I I I d o s e o f a p p r o x im a t e ly 2 5 u n it s / k g F a c t o r I X d o s e o f a p p r o x im a t e ly 5 0 t o 6 0 u n it s / k g T h is  t a b le is a  g e n e r a l g u id e a n d d o e s n o t r e p la c e c lin ic a l ju d g m e n t in d e t e r m in in g t h e s e v e r it y o f b le e d in g , r is k o f m o r b id it y , f a c t o r d o s in g , a n d n e e d f o r o t h e r t r e a t m e n t s . M u c o s a l b le e d in g c a n b e t r e a t e d w it h a n t if ib r in o ly t ic s o r lo c a l h e m o s t a t ic t h e r a p ie s c o n c o m it a n t ly w it h f a c t o r in f u s io n . P a t ie n t s w it h m ild h e m o p h ilia A a n d m in o r b le e din g m a y b e t r e a t e d w it h D D A V P if t h e y h a v e p r e v io u s ly d e m o n s t r a t e d a r e s p o n s e . P a t ie n t s w it h in h ib it o r s m a y r e q u ir e a b y p a s s in g a g e n t s u c h a s r e c o m b in a n t a c t iv a t e d f a c t o r V I I (r F V I I a ) o r F E I B A . D o n o t u s e a n t if ib r in o ly t ic s w it h F E I B A c o n c o m it a n t ly . R e f e r t o U p To D a t e f o r a d d it io n a l in f o r m a t io n a b o u t m a n a g e m e n t o f b le e d in g in p a t ie n t s w it h h e m o p h ilia . F E I B A : F a c t o r e ig h t in h ib it o r b y p a s s in g a g e n t . * E x a m p le s o f m a jo r b le e d in g in c lu d e ble e d in g a f f e c t in g t h e c e n t r a l n e r v o u s s y s t e m , a ir w a y , h ip , d e e p m u s c le w it h n e u r o v a s c u la r in ju r y , o r a bd o m e n ; b le e d in g t h a t c a n n o t b e c o n t r o lle d w it h lo c a l t h e r a p ie s , o r b le e d in g n e c e s s it a t in g t r a n s f u s io n . G r a p h ic 1 1 0 8 2 0 V e r s io n 1 .0 Se l e c t e d a v a i l a b l e f a c t o r V I I I p r o d u c t s f o r p a t i e n t s w i t h h e m o p h i l i a A P r o d u c t n a m e H a l f - l i f e (h o u r s )* C h a r a c t e r i s t i c s St a n d a r d h a l f - l i f e p r o d u c t s A d v a t e 9 t o 1 2 R e c o m b in a n t H e m o f il M 1 5 P la s m a - d e r iv e d ; m A b - p u r if ie d Ko g e n a t e F S 1 1 t o 1 5 R e c o m b in a n t Ko a t e (p r e v io u s ly c a lle d Ko a t e D V I ) 1 6 P la s m a - d e r iv e d ; c h r o m a t o g r a p h y - p u r if ie d Ko v a lt r y 1 2 t o 1 4 R e c o m b in a n t N o v o e ig h t 8 t o 1 2 R e c o m b in a n t N u w iq 1 2 t o 1 7 R e c o m b in a n t R e c o m b in a t e 1 5 R e c o m b in a n t X y n t h a 8 t o 1 1 R e c o m b in a n t L o n g e r - l a s t i n g p r o d u c t s A d y n o v a t e 1 3 t o 1 6 R e c o m b in a n t ; P E G y la t e d A f s t y la 1 0 t o 1 4 R e c o m b in a n t ; s in g le c h a in A lt u v iiio 4 0 t o 4 8 R e c o m b in a n t ; F c - V W F - X T E N f u s io n E lo c t a t e 1 3 t o 2 0 R e c o m b in a n t ; F c f u s io n E s p e r o c t 1 7 t o 2 2 R e c o m b in a n t , g ly c o P E G y la t e d Jiv i 1 7 t o 2 1 R e c o m b in a n t ; P E G y la t e d T h is t a b le is in t e n d e d a s a g u id e f o r r a p id id e n t if ic a t io n o f t h e p r o d u c t t h e p a t ie n t is u s in g a n d it s c h a r a c t e r is t ic s a n d s h o u ld n o t b e u s e d t o s e le c t a p r o d u c t o r c a lc u la t e d o s in g . R e f e r t o p r e s c r ib in g in f o r m a t io n in t h e p r o d u c t in s e r t a n d t o U p To D a t e f o r t h e u s e o f f a c t o r r e p la c e m e n t in p a t ie n t s w it h h e m o p h ilia . T h e p la s m a - d e r iv e d p r o d u c t s lis t e d h e r e a r e u lt r a - h ig h p u r it y ( m A b - p u r if ie d ) o r h ig h p u r it y (c h r o m a t o g r a p h y - p u r if ie d ). F S : f o r m u la t e d w it h s u c r o s e ; m A b : m o n o c lo n a l a n t ib o d y ; F c : f r a g m e n t c r y s t a lliz a b le ; V W F : v o n W ille b r a n d f a c t o r ; X T E N : h a lf - lif e e x t e n s io n p o ly p e pt id e s ; P E G : p o ly e t h y le n e g ly c o l. * H a lf - liv e s a r e a p p r o x im a t e . H a lf - liv e s a r e g e n e r a lly s h o r t e r f o r c h ild r e n t h a n a d u lt s w h e n a s s e s s e d in p h a r m a c o k in e t ic s t u d ie s . T h e h a lf - lif e o f f a c t o r V I I I p r o d u c t s w it h o u t m o d if ic a t io n s t o e x t e n d h a lf - lif e is c o n s id e r e d t o b e a p p r o x im a t e ly 1 2 h o u r s . T h e h a lf - lif e s h o u ld b e d e t e r m in e d f o r t h e in d iv id u a l p a t ie n t . R e f e r t o p r o d u c t in f o r m a t io n a n d in s t it u t io n a l g u id e lin e s f o r a d d it io n a l d o s in g a n d m o n it o r in g in f o r m a t io n . ¶ Δ ¶ M o n o c la t e - P w a s d is c o n t in u e d in e a r ly 2 0 1 8 . H e lix a t e F S m a n u f a c t u r in g w a s d is c o n t in u e d in 2 0 1 8 , w it h s u p p ly a v a ila b le t h r o u g h e a r ly 2 0 1 9 . Δ A d u lt s o n ly . G r a p h ic 1 0 9 8 3 8 V e r s io n 1 0 .0 Se l e c t e d a v a i l a b l e f a c t o r I X p r o d u c t s f o r p a t i e n t s w i t h h e m o p h i l i a B P r o d u c t n a m e H a l f - l i f e (h o u r s )* C h a r a c t e r i s t i c s St a n d a r d h a l f - l i f e p r o d u c t s A lp h a N in e S D 1 8 P la s m a - d e r iv e d ; s o lv e n t / d e t e r g e n t t r e a t e d B e n e F I X 1 6 t o 1 9 R e c o m b in a n t I x in it y 2 4 R e c o m b in a n t M o n o n in e 2 3 P la s m a - d e r iv e d ; m A b p u r if ie d R ix u b is 2 3 t o 2 6 R e c o m b in a n t L o n g e r - l a s t i n g p r o d u c t s A lp r o lix 5 4 t o 9 0 R e c o m b in a n t ; F c f u s io n I d e lv io n 1 0 4 R e c o m b in a n t ; a lb u m in f u s io n R e b in y n 1 0 3 t o 1 1 5 R e c o m b in a n t ; g ly c o P E G y la t e d T h is t a b le is in t e n d e d a s a g u id e f o r r a p id id e n t if ic a t io n o f t h e p r o d u c t t h e p a t ie n t is u s in g a n d it s c h a r a c t e r is t ic s . R e f e r t o t h e p r o d u c t in f o r m a t io n a n d t o  U p To D a t e f o r t h e u s e o f f a c t o r r e p la c e m e n t in p a t ie n t s w it h h e m o p h ilia . S D : s o lv e n t / d e t e r g e n t t r e a t e d ; m A b : m o n o c lo n a l a n t ib o d y . * H a lf - liv e s a r e a p p r o x i m a t e . H a lf - liv e s a r e g e n e r a lly s h o r t e r f o r c h ild r e n t h a n a d u lt s w h e n a s s e s s e d in p h a r m a c o k in e t ic s t u d ie s . T h e h a lf - lif e o f f a c t o r I X p r o d u c t s w it h o u t m o d if ic a t io n s t o e x t e n d h a lf - lif e is c o n s id e r e d t o b e a p p r o x im a t e ly 2 4 h o u r s . T h e h a lf - lif e s h o u ld b e d e t e r m in e d f o r t h e in d iv id u a l p a t ie n t . R e f e r t o p r o d u c t in f o r m a t io n a n d in s t it u t io n a l g u id e lin e s f o r a d d it io n a l d o s in g a n d m o n it o r in g in f o r m a t io n . ¶ A d u lt s o n ly . Δ 1 2 y e a r s a n d o ld e r. G r a p h ic 1 0 9 8 3 9 V e r s io n 4 .0 ¶ Δ ¶ ¶ B i sp e c i f i c a n t i b o d y t h a t c o u l d b e u s e d t o r e p l a c e t h e f u n c t i o n o f F V I I I a R e f e r t o U p To D a t e c o n t e n t o n t r e a t m e n t o f h e m o p h ilia f o r f u r t h e r d e t a ils . (A ) I n n o r m a l h e m o s t a s is , F V I I I a (o r a n g e ) f o r m s a c o m p le x w it h F I X a ( r e d ) a n d  p r o m o t e s in t e r a c t io n b e t w e e n F I X a a n d  F X (b lu e ) b y b in d in g t o b o t h f a c t o r s o n t h e p h o s p h o lip id m e m b r a n e . (B ) A b is p e c if ic a n t ib o d y  t h a t c a n s im u lt a n e o u s ly b in d  t o F I X a ( r e d )  a n d F X ( b lu e )  c o u ld m im ic t h e a c t iv it y o f F V I I I a a n d p r o m o t e in t e r a c t io n b e t w e e n F I X a a n d F X o n t h e p h o s p h o lip id m e m b r a n e . F V I I I a : a c t iv a t e d c o a g u la t io n f a c t o r V I I I ( e ig h t ); F I X a : a c t iv a t e d c o a g u la t io n f a c t o r I X ( n in e ) ; F X : c o a g u la t io n f a c t o r X (t e n ). F r o m: S a mp e i Z , I g a w a T, S o e d a e t a l. I d e n t iﬁ c a t io n a n d M u lt id ime n s io n a l O p t imiz a t io n o f a n A s y mme t r ic B is p e c iﬁ c I g G A n t ib o d y M imic k in g t h e F u n c t io n o f F a c t o r V I I I C o f a c t o r A c t iv it y . P L o S O n e 2 0 1 3 ; 8 :e 5 7 4 7 9 . A v a ila b le a t : h t t p :/ / jo u r n a ls .p lo s .o r g / p lo s o n e / a r t ic le ? id = 1 0 .1 3 7 1 / jo u r n a l.p o n e .0 0 5 7 4 7 9 (A c c e s s e d o n M a y 1 0 , 2 0 1 6 ). C o p y r ig h t © 2 0 1 3 S a mp e i e t a l. R e p r o d u c e d u n d e r t h e t e r ms o f t h e C r e a t iv e C o mmo n s A t t r ib u t io n L ic e n s e , w h ic h p e r mit s u n r e s t r ic t e d u s e , d is t r ib u t io n , a n d r e p r o d u c t io n in a n y me d iu m, p r o v id e d t h e o r ig in a l a u t h o r a n d s o u r c e a r e c r e d it e d . G r a p h ic 1 0 7 8 0 1 V e r s io n 2 .0P C C p r o d u c t s a v a i l a b l e i n t h e U n i t e d St a t e s * U n a c t i v a t e d p r o t h r o m b i n c o m p l e x c o n c e n t r a t e s (P C C s ) 4 f a c t o r : Kc e n t r a C o n t a in s in a c t iv e f o r m s o f 4  f a c t o r s : F a c t o r s  I I , V I I , I X , a n d X A ls o c o n t a in s h e p a r in 3 f a c t o r : P r o f iln in e C o n t a in s in a c t iv e f o r m s o f  3 f a c t o r s : F a c t o r s  I I , I X , a n d X C o n t a in s lit t le o r n o f a c t o r V I I D o e s n o t c o n t a in h e p a r in A c t i v a t e d p r o t h r o m b i n c o m p l e x c o n c e n tr a t e (a P C C ) 4 f a c t o r : F E I B A C o n t a in s 4 f a c t o r s : F a c t o r s I I , V I I , I X , a n d X . O f t h e s e , o n ly  f a c t o r V I I is m o s t ly t h e a c t iv a t e d f o r m D o e s n o t c o n t a in h e p a r in T h e t a b le lis t s 4 - f a c t o r a n d 3 - f a c t o r P C C p r o d u c t s a v a ila b le in t h e U n it e d S t a t e s . K c e n t r a is  a v a ila b le a s B e r ip le x  in C a n a d a . B e b u lin (a 3 - f a c t o r P C C ) w a s d is c o n t in u e d in 2 0 1 8 d u e t o d e c r e a s e d d e m a n d f o r t h e p r o d u c t . P o t e n c y is d e t e r m in e d d if f e r e n t ly f o r d if f e r e n t p r o d u c t s ; r e f e r t o p r o d u c t in f o r m a t io n . A ll P C C s a r e p la s m a d e r iv e d a n d c o n t a in o t h e r pr o t e in s , in c lu d in g a n t ic o a g u la n t p r o t e in s ( p r o t e in s C a n d S ). U n a c t iv a t e d f a c t o r s a r e p r o e n z y m e s ( in a c t iv e p r e c u r s o r p r o t e in s ) . A c t iv a t e d f a c t o r s h a v e h ig h e r e n z y m a t ic a c t iv it y . R e f e r t o U p To D a t e t o p ic s f o r u s e o f t h e s e p r o d u c t s . U S : U n it e d S t a t e s ; P C C : p r o t h r o m b in c o m p le x c o n c e n t r a t e ; F E I B A : f a c t o r e ig h t in h ib it o r b y p a s s in g a c t iv it y . * O t h e r 4 - f a c t o r P C C s a v a ila b le  o u t s id e t h e U S in c lu d e O c t a p le x a n d  C o f a c t P r o p le x .  ¶ S in g le - f a c t o r r e c o m b in a n t a c t iv a t e d f a c t o r V I I ( r F V I I a ) p r o d u c t s  a r e a ls o a v a ila b le . G r a p h ic 9 4 2 1 0 V e r s io n 8 .0 ¶ ","libVersion":"0.3.1","langs":""}